Document:

EX-10.4

 Exhibit 10.4 

EXECUTION VERSION 
 EMPLOYEE
MATTERS AGREEMENT 
 This EMPLOYEE MATTERS AGREEMENT (this “Agreement”), dated as of November 16, 2020, is by and
between PFIZER INC., a Delaware corporation (“Pluto”), and UPJOHN INC., a Delaware corporation (“Spinco”). Pluto and Spinco are sometimes referred to herein individually as a “Party” and
collectively as the “Parties.” 
 R E C I T A L S: 

WHEREAS, the Board of Directors of Pluto has determined that it is appropriate and desirable to separate the Spinco Business from the Pluto
Business so that, as of the Distribution Date, the Spinco Business is held by members of the Spinco Group and the Pluto Business is held by members of the Pluto Group (the “Separation”); and 

WHEREAS, in furtherance of the foregoing, the Parties have entered into this Agreement, which is an Ancillary Agreement to the Separation and
Distribution Agreement by and between the Parties, dated as of July 29, 2019, as amended (the “Separation Agreement”), to govern the rights and obligations of the Parties with respect to employment, compensation, employee
benefits and related matters in connection with the Transactions, and to ratify actions previously taken in connection with the Contribution, as set forth herein. 

NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants contained in this Agreement, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows: 

ARTICLE I 

DEFINITIONS 
 Capitalized terms
used but not defined herein shall have the meaning ascribed to them in the Separation Agreement. For purposes of this Agreement the terms set forth below shall have the following meanings: 

“Actuarial Assumptions” has the meaning set forth in Section 5.02(e). 

“Agreement” has the meaning set forth in the Preamble. 

“Asset Sale Effective Time” has the meaning set forth in the Business Combination Agreement. 

“China Heating Allowance” has the meaning set forth in Section 12.03. 

“COBRA” means the continuation coverage requirements for “group health plans” under Title X of the Consolidated
Omnibus Budget Reconciliation Act of 1985, as amended from time to time, and as codified in Section 4980B of the Code and Sections 601 through 608 of ERISA and any similar foreign, state or local Laws. 

 “Code” means the Internal Revenue Code of 1986, as amended. 

“Converted Spinco RSU Awards” has the meaning set forth in the Business Combination Agreement. 

“Delayed Market” shall have the meaning set forth in the NEB Agreement. 

“Determination Date” has the meaning set forth in the Business Combination Agreement. 

“Employee” means any Pluto Employee or Spinco Employee. 

“Employment Tax” means any Tax with respect to wages or other compensation of Employees and Former Employees, including the
employers’ and the employees’ portion of any such Tax. 
 “ERISA” means the Employee Retirement Income Security
Act of 1974, as amended from time to time. 
 “FMLA” means the Family and Medical Leave Act of 1993, as amended from time
to time, and any similar foreign, state or local Laws. 
 “Forfeited Pluto Equity Awards” has the meaning set forth in
Section 11.02(b). 
 “Former Employee” means a Former Pluto Employee or a Former Spinco Employee.

 “Former Pluto Employee” means any individual who is a former employee of Pluto or any of its Subsidiaries as of the
Distribution Time and who is not a Former Spinco Employee. 
 “Former Pluto Independent Contractor” means any individual
who is a former independent contractor of Pluto or any of its Subsidiaries as of the Distribution Time and who is not a Former Spinco Independent Contractor. 

“Former Pluto Service Provider” means a Former Pluto Employee or Former Pluto Independent Contractor. 

“Former Service Provider” means a Former Pluto Service Provider or Former Spinco Service Provider. 

“Former Spinco Employee” means any individual whose employment with Pluto and its Subsidiaries terminated (or who went on
long-term disability leave) on or after December 1, 2018 (for individuals employed outside the United States) or January 1, 2019 (for individuals employed in the United States) and prior to the Distribution Time, and who immediately prior
to such termination (or, for individuals on long-term disability leave, immediately prior to ceasing active employment) was exclusively or primarily engaged in the Spinco Business. 

“Former Spinco Independent Contractor” means any individual independent contractor whose engagement with Pluto and its
Subsidiaries terminated on or after December 1, 2018 (for individuals providing services outside the United States) or January 1, 2019 (for individuals providing services in the United States) and prior to the Distribution Time, and who
immediately prior to such termination was exclusively or primarily engaged in the Spinco Business. 

  
 -2- 

 “Former Spinco Service Provider” means a Former Spinco Employee or Former
Spinco Independent Contractor. 
 “Health and Welfare Plans” means, when immediately preceded by “Pluto,” the
Pluto Health Plans, the Pluto Health and Insurance Program, and the other health and welfare plans established and maintained by the Pluto Group and, when immediately preceded by “Spinco,” Spinco Health Plans, and the other health and
welfare plans sponsored or maintained by or to be established, sponsored or maintained by the Spinco Group. 
 “Health
Plans” means, when immediately preceded by “Pluto,” the group health plans and such other health plans or programs, including medical, prescription drug, dental and vision plans and programs established and maintained by the Pluto
Group and, when immediately preceded by “Spinco,” the health plans, programs and arrangements sponsored or maintained by or to be established, sponsored or maintained by the Spinco Group. 

“Initial Monthly Transfer Amount” has the meaning set forth in Section 5.01(b)(ii). 

“IRS” means the United States Internal Revenue Service. 

“Japan Lyrica Employee” means any Spinco Employee who, as of the Distribution Time, is primarily engaged in the sale or
marketing of Lyrica in Japan. 
 “Labor Agreement” has the meaning set forth in Section 2.01.

 “Life Insurance Plans” means, when immediately preceded by “Pluto,” the life insurance plans of the Pluto
Group, and, when immediately preceded by “Spinco,” the life insurance plans sponsored or maintained or to be established or maintained by the Spinco Group that corresponds to the respective Pluto Life Insurance Plan. 

“Mercer” means the business unit of Marsh & McLennan Companies, Inc. operating under the name “Mercer.”

 “Monthly Assets” has the meaning set forth in Section 5.01(b)(ii). 

“Monthly Asset Transfer Amount” has the meaning set forth in Section 5.01(b)(ii). 

“Monthly Valuation Date” has the meaning set forth in Section 5.01(b)(ii). 

“Non-U.S. Defined Benefit Plan Transfer Amounts” has the meaning set forth in
Section 5.02(a). 
 “Participating Company” means, with respect to any Plan: (a) any Person
(other than an individual) that Pluto has approved for participation in, has accepted participation in, and which is participating in, a Plan sponsored by the Pluto Group; or (b) any Person (other than an individual) which, by the terms of such
Plan, participates in such Plan or any employees of which, by the terms of such Plan, participate in or are covered by such Plan. 

  
 -3- 

 “Party” has the meaning set forth in the Preamble. 

“PBO” has the meaning set forth in Section 5.02(a). 

“Plan” means any written or unwritten plan, policy, program, payroll practice, arrangement, contract, trust, insurance
policy, or any agreement or funding vehicle providing compensation or benefits to Service Providers, Former Service Providers or directors of a member of the Pluto Group or the Spinco Group. 

“Pluto” has the meaning set forth in the Preamble. 

“Pluto Canada Retiree Medical Plan” means the Pfizer Canada ULC Post-Retirement Benefit Plan. 

“Pluto Cash Awards” means a cash-based long-term incentive award. 

“Pluto Delayed Employment Period” has the meaning set forth in Section 4.01(e). 

“Pluto Delayed Transfer Employee” has the meaning set forth in Section 4.01(e). 

“Pluto Employees” has the meaning set forth in Section 4.01(a). 

“Pluto Equity Awards” means a Pluto Option Award, Pluto RSU Award, Pluto TSRU Award, Pluto Performance Share Award or Pluto
Portfolio Performance Share Award. 
 “Pluto Dependent Care Flexible Benefits Plan” means the Pluto Dependent Care Spending
Account Plan. 
 “Pluto Healthcare Flexible Benefits Plan” means the Pluto Health Care Spending Account Plan. 

“Pluto Independent Contractors” has the meaning set forth in Section 4.02. 

“Pluto Individual Agreement” means any individual (a) employment contract or offer letter, (b) retention, severance
or change in control agreement, (c) expatriate (including any international assignee) contract or agreement (including agreements and obligations regarding repatriation, relocation or equalization of Taxes and living standards in the host
country) or (d) other agreement containing restrictive covenants (including confidentiality, non-competition and non-solicitation provisions) between a member of
the Pluto Group and (i) a Pluto Employee or (ii) a Former Pluto Employee, in each case, as in effect immediately prior to the Distribution Date. 

“Pluto Japan Pension Plan” means Pfizer Kigyougata Nenkin Kiyaku. 

  
 -4- 

 “Pluto Leave of Absence Programs” means the personal, medical, military and
FMLA leave and other leaves of absence required by applicable Law or offered from time to time under the personnel policies and practices of the Pluto Group. 

“Pluto Master Trust” has the meaning set forth in Section 5.01(b). 

“Pluto Non-U.S. Defined Benefit Plans” has the meaning set forth in
Section 5.02(a). 
 “Pluto Nonqualified Plans” means the plans identified in Annex A. 

“Pluto Option Award” means an award of an option to purchase Pluto Shares pursuant to a Pluto Stock Plan. 

“Pluto Performance Share Award” means an award to receive Pluto Shares that is subject to corporate performance criteria,
issued pursuant to a Pluto Stock Plan. 
 “Pluto Plans” means the Plans established, sponsored or maintained by any member
of the Pluto Group but excluding any Spinco Plans. 
 “Pluto Portfolio Performance Share Award” means an award to receive
Pluto Shares that is subject to corporate performance criteria related to Pluto’s long-term product portfolio during a five (5)-year period, issued pursuant to a Pluto Stock Plan. 

“Pluto RSU Award” means an award representing a contractual right to receive Pluto Shares or the cash value thereof, which
right is subject to transfer restrictions or to employment and/or performance vesting conditions, issued pursuant to a Pluto Stock Plan. 

“Pluto Service Provider” means a Pluto Employee or Pluto Independent Contractor. 

“Pluto Share” means a share of Pluto Common Stock. 

“Pluto Stock Plan” means the Pluto Inc. 2019 Stock Plan, Pluto Inc. 2014 Stock Plan, Pluto Inc. 2004 Stock Plan and any other
plan, program or arrangement, pursuant to which employees and other service providers hold Pluto Option Awards, Pluto RSU Awards, Pluto TSRU Awards, Pluto Performance Share Awards, Pluto Portfolio Performance Share Awards or other Pluto equity
incentives. 
 “Pluto TSRU Award” means an award of total shareholder return units with respect to Pluto Shares granted
pursuant to a Pluto Stock Plan that is settled based on the change in the stock price of Pluto Shares over the applicable settlement period, as well as accrued dividend equivalents, subject to certain restrictions. 

“Puerto Rico DB Plans” has the meaning set forth in Section 5.01(b). 

“Puerto Rico Health Plan” means the Spinco Puerto Rico Health and Welfare Plan. 

“Puerto Rico Retiree Medical Plan” means the Pluto Puerto Rico Retiree Medical and Dental Plan. 

  
 -5- 

 “Puerto Rico Savings Plan” means the Pluto Puerto Rico Savings Plan for
Employees Resident in Puerto Rico. 
 “QDRO” means a domestic relations order that qualifies under Section 414(p) of
the Code and Section 206(d) of ERISA and that creates or recognizes an alternate payee’s right to, or assigns to an alternate payee, all or a portion of the benefits payable to a participant under a plan qualified under Section 401(a)
of the Code. 
 “Quarterly Asset” has the meaning set forth in Section 5.01(b)(iii). 

“Quarterly Asset Transfer Amount” has the meaning set forth in Section 5.01(b)(iii). 

“Quarterly Valuation Date” has the meaning set forth in Section 5.01(b)(iii). 

“Requesting Party” has the meaning set forth in Section 14.05. 

“Savings Plan” means, when immediately preceded by “Pluto,” the Pluto Savings Plan, a defined contribution plan,
and, when immediately preceded by “Spinco,” the defined contribution plan funded by a trust that is qualified under Section 401(a) of the Code and exempt from taxation under Section 501(a)(1) of the Code, to be established,
sponsored or maintained by Spinco pursuant to Section 6.01(c). 
 “Service Provider” means a
Pluto Service Provider or Spinco Service Provider. 
 “Separation” has the meaning set forth in the Recitals. 

“Separation Agreement” has the meaning set forth in the Recitals. 

“Share Sale Effective Time” has the meaning set forth in the Business Combination Agreement. 

“Spinco” has the meaning set forth in the Preamble. 

“Spinco Delayed Employment Period” has the meaning set forth in Section 4.01(d). 

“Spinco Delayed Transfer Employee” has the meaning set forth in Section 4.01(d). 

“Spinco Delayed Transfer Employee Transfer Date” has the meaning set forth in Section 4.01(d). 

“Spinco Employee” has the meaning set forth in Section 4.01(a). 

“Spinco Flexible Benefits Plan” means the Spinco Dependent Care Spending Account Plan to be established, sponsored or
maintained by Spinco to accept a spin-off of the flexible spending reimbursement accounts of Spinco Employees under the Pluto Dependent Care Flexible Benefits Plan in accordance with
Section 8.04. 
 “Spinco Fringe Benefits” means any fringe benefits, plans, programs and
arrangements sponsored or maintained or to be established, sponsored or maintained by the Spinco Group. 

  
 -6- 

 “Spinco Independent Contractors” has the meaning set forth in
Section 4.02. 
 “Spinco Individual Agreement” means any individual (a) employment contract
or offer letter, (b) retention, severance or change in control agreement, (c) expatriate (including any international assignee) contract or agreement (including agreements and obligations regarding repatriation, relocation or equalization
of Taxes and living standards in the host country) or (d) other agreement containing restrictive covenants (including confidentiality, non-competition and
non-solicitation provisions) between a member of the Pluto Group or Spinco Group and (i) a Spinco Employee or (ii) Former Spinco Employee, as in effect immediately prior to the Distribution Date.

 “Spinco Long-Term Disability Plans” means the long-term disability plans sponsored or maintained or to be established,
sponsored or maintained by the Spinco Group. 
 “Spinco Make-Whole Award” has the meaning set forth in
Section 11.02(b). 
 “Spinco Master Trust” has the meaning set forth in
Section 5.01(b). 
 “Spinco Non-U.S. Defined Benefit
Plans” has the meaning set forth in Section 5.02(a). 
 “Spinco Plans” means the Plans
sponsored or maintained by Spinco or to be established, sponsored or maintained by any member of the Spinco Group as of or after the Distribution Time. 

“Spinco Retiree Medical Plan” has the meaning set forth in Section 9.01. 

“Spinco Savings Plan” has the meaning set forth in Section 6.01(c). 

“Spinco Service Provider” means a Spinco Employee or Spinco Independent Contractor. 

“Spinco Short-Term Disability Plans” means the short-term disability plans sponsored or maintained or to be established,
sponsored or maintained by the Spinco Group. 
 “Spinco Stock Plan” means the Spinco Stock Plan established by Spinco as of
the Distribution Time pursuant to Section 11.01. 
 “Transferred Account Balances” has the
meaning set forth in Section 8.04. 
 “Transferred Defined Benefit Plan Participants” has the
meaning set forth in Section 5.02(a). 
 “Transition Benefits” has the meaning set forth in
Section 3.01(a). 
 “U.S. Retiree Medical Plan” means the Pluto Retiree Medical Plan providing for medical and
voluntary dental coverage. 
 “Utah Ordinary Share” has the meaning set forth in the Business Combination Agreement. 

  
 -7- 

 “WARN” has the meaning set forth in Section 4.07.

 ARTICLE II 

GLOBAL PROVISION; GENERAL ALLOCATION OF LIABILITIES 

Section 2.01 General Principles. All provisions herein shall be subject to the requirements of all applicable Law and any
collective bargaining, works council or similar agreement or arrangement with any labor union, works council or other labor representative (each, a “Labor Agreement”). Notwithstanding anything in this Agreement to the contrary, if
the terms of a Labor Agreement or applicable Law require that any Assets or Liabilities be retained or assumed by, or transferred to, a Party in a manner that is different than what is set forth in this Agreement, such retention, assumption or
transfer shall be made in accordance with the terms of such Labor Agreement and applicable Law and shall not be made as otherwise set forth in this Agreement; provided that, in such case, the Parties shall take all necessary action to
preserve the economic terms of the allocation of Assets and Liabilities contemplated by this Agreement. The provisions of this Agreement shall apply in respect of all jurisdictions wherever situated; provided, however, that to the
extent a Local Separation Agreement addresses employment, the services of individual independent contractors, compensation or benefit matters, the terms of such Local Separation Agreement shall govern in respect of matters relating to Service
Providers employed or providing services in the applicable jurisdiction or Former Service Providers previously employed or providing services in the applicable jurisdiction; provided further that, unless otherwise agreed, such Local
Separation Agreement shall be consistent with the principles set forth herein. 
 Section 2.02 Acceptance and Assumption of Spinco
Liabilities. Except as otherwise provided by this Agreement, as of no later than immediately prior to the Distribution Time, Spinco and the applicable Spinco Designees shall accept, assume and agree faithfully to perform, discharge and fulfill
all of the following Liabilities in accordance with their respective terms (each of which shall be considered a Spinco Liability), regardless of when or where such Liabilities arose or arise, or whether the facts on which they are based occurred
prior to or subsequent to the Distribution Time, regardless of where or against whom such Liabilities are asserted or determined (including any Liabilities arising out of Actions by Pluto’s or Spinco’s respective directors, officers,
Service Providers, Former Service Providers, agents, Subsidiaries or Affiliates against any member of the Pluto Group or the Spinco Group) or whether asserted or determined prior to the date hereof, and regardless of whether arising from or alleged
to arise from negligence, recklessness, violation of Law, fraud or misrepresentation by any member of the Pluto Group or the Spinco Group, or any of their respective directors, officers, Service Providers, Former Service Providers, agents,
Subsidiaries or Affiliates: 
 (a) any and all wages, salaries, incentive compensation, equity compensation, commissions, bonuses and any
other compensation or benefits payable to or on behalf of any Spinco Service Providers and Former Spinco Service Providers after the Distribution Time, without regard to when such wages, salaries, incentive compensation, equity compensation,
commissions, bonuses or other compensation or benefits are or may have been awarded or earned, including any and all Liabilities with respect to Transition Benefits; provided that if, pursuant to the NEB Agreement or other agreements between
the Parties, the Spinco Group bears any Liabilities with respect to Transition Benefits, the Spinco Group shall not be required to provide duplicative reimbursement of, or otherwise compensate the Pluto Group for, such Liabilities; 

  
 -8- 

 (b) any and all Liabilities arising out of, relating to or resulting from the employment,
service, termination of employment or termination of service of all Spinco Service Providers and Former Spinco Service Providers and their respective dependents and beneficiaries, other than any Liabilities expressly assumed or retained by Pluto
under the Separation Agreement or any Ancillary Agreement; 
 (c) any and all Liabilities whatsoever with respect to Actions under a Spinco
Plan; and 
 (d) any and all Liabilities expressly assumed or retained by any member of the Spinco Group pursuant to this Agreement. 

Section 2.03 Acceptance and Assumption of Pluto Liabilities. Except as otherwise provided by this Agreement, as of no later than
immediately prior to the Distribution Time, Pluto and certain members of the Pluto Group designated by Pluto shall accept, assume and agree faithfully to perform, discharge and fulfill all of the following Liabilities in accordance with their
respective terms (each of which shall be considered a Pluto Liability), regardless of when or where such Liabilities arose or arise, or whether the facts on which they are based occurred prior to or subsequent to the Distribution Time, regardless of
where or against whom such Liabilities are asserted or determined (including any Liabilities arising out of Actions by Pluto’s or Spinco’s respective directors, officers, Service Providers, Former Service Providers, agents, Subsidiaries or
Affiliates against any member of the Pluto Group or the Spinco Group) or whether asserted or determined prior to the date hereof, and regardless of whether arising from or alleged to arise from negligence, recklessness, violation of Law, fraud or
misrepresentation by any member of the Pluto Group or the Spinco Group, or any of their respective directors, officers, Service Providers, Former Service Providers, agents, Subsidiaries or Affiliates: 

(a) any and all wages, salaries, incentive compensation, equity compensation, commissions, bonuses and any other compensation or benefits
payable to or on behalf of any Pluto Service Providers and Former Pluto Service Providers after the Distribution Time, without regard to when such wages, salaries, incentive compensation, equity compensation, commissions, bonuses or other
compensation or benefits are or may have been awarded or earned; 
 (b) any and all Liabilities arising out of, relating to or resulting from
the employment, service, termination of employment or termination of service of all Pluto Service Providers and Former Pluto Service Providers and their respective dependents and beneficiaries, other than any Liabilities expressly assumed or
retained by Spinco under the Separation Agreement or any Ancillary Agreement; 
 (c) any and all Liabilities whatsoever with respect to
Actions under a Pluto Plan; 

  
 -9- 

 (d) all Liabilities arising out of, relating to or resulting from the transfer of Spinco
Employees from the Pluto Group to the Spinco Group that arise in respect of any applicable notice and/or severance obligations, obligations to transfer or obligations to notify and/or consult in compliance with a Labor Agreement or applicable Law,
in each case, solely with respect to transfers contemplated by the Internal Reorganization Plan, other than (i) any Liabilities arising in connection with the Spinco Group’s noncompliance with applicable Law, the Separation Agreement or
any Ancillary Agreement, any Labor Agreement, any Plan or any Spinco Individual Agreement, in each case, following the Distribution Date or relating to an action or inaction of Utah or its Affiliates before, on or after the Distribution Date, or
(ii) any Liabilities that are otherwise allocated to Spinco under the Separation Agreement or any Ancillary Agreement; and 
 (e) any
and all Liabilities expressly assumed or retained by any member of the Pluto Group pursuant to this Agreement. 
 Section 2.04
Unaddressed Liabilities. To the extent that this Agreement does not address particular Liabilities whether under a Plan or otherwise and the Parties later determine that they should be allocated in connection with the Distribution, the
Parties shall agree in good faith on the allocation, taking into account the handling of comparable Liabilities under this Agreement. 

ARTICLE III 
 GENERAL
PLAN MATTERS 
 Section 3.01 Pluto Plans. 

(a) Participation in Pluto Plans. Except as otherwise set forth herein or as set forth on Exhibit 3.01(a) with respect to certain
transition benefits for certain Spinco Employees and Former Spinco Employees, as applicable (the “Transition Benefits”), effective as of the Distribution Date, (i) all Spinco Employees and Former Spinco Employees shall cease
actively participating in, or accruing benefits in respect of, the Pluto Plans and (ii) Spinco and each member of the Spinco Group, to the extent applicable, shall cease to be a Participating Company in any Pluto Plan. 

(b) Spinco’s Obligations Regarding Pluto Plans. With respect to any Pluto Plan that provides benefits to a Spinco Employee or
Former Spinco Employee following the Distribution Time, the Spinco Group shall cooperate with the Pluto Group on a timely basis to assist with the Pluto Group’s administration of such Plans, including with respect to: (i) assisting in the
administration of claims, to the extent requested by the claims administrator of such Pluto Plan; (ii) cooperating fully with the Pluto Plan auditors; (iii) providing payroll processing support; (iv) certifying the qualification of
and administering QDROs; (v) preserving the confidentiality of all financial arrangements the Pluto Group has or may have with any entity or individual with which the Pluto Group has entered into an agreement relating to the administration of
such Pluto Plan; and (vi) preserving the confidentiality of participant Information to the extent not specified otherwise in this Agreement. 

  
 -10- 

 (c) Reporting and Disclosing Communications to Participants. Subject to any
limitations imposed by applicable Law, the Spinco Group shall provide to the Pluto Group all Information required by the Pluto Group to facilitate communications related to the Pluto Plans. If requested by Pluto, the Spinco Group shall take, or
cause to be taken, all actions necessary or appropriate to facilitate the timely distribution of all communications and materials related to the Pluto Plans to participating Spinco Employees or Former Spinco Employees; provided that such
communications shall be subject to the review of Spinco or the applicable member of the Spinco Group. 
 (d) Pluto Under No Obligation to
Maintain Pluto Plans. Nothing in this Agreement shall preclude the Pluto Group, at any time, from amending, merging, modifying, terminating, eliminating, reducing or otherwise altering in any respect any Pluto Plan, any benefit under any Pluto
Plan or any trust, insurance policy or funding vehicle related to any Pluto Plan. 
 Section 3.02 Spinco Plans. 

(a) Establishment of Spinco Plans. Effective as of the Distribution Date (or with respect to Transition Benefits for certain Spinco
Employees and Former Spinco Employees, as applicable, effective as of the dates indicated on Exhibit 3.01(a)), Spinco, or another member of the Spinco Group, shall adopt or designate Spinco Health and Welfare Plans, Spinco Fringe Benefits, a
Spinco Life Insurance Plan, a Spinco Long-Term Disability Plan, a Spinco Short-Term Disability Plan, a Spinco Flexible Benefits Plan, a Spinco Savings Plan, a Spinco Retiree Medical Plan, Spinco Non-U.S.
Defined Benefit Plans and such other Spinco Plans as may be determined to be appropriate by the Parties, which Spinco Plans shall generally correspond to the Pluto Plans in which Spinco Employees and Former Spinco Employees participated immediately
prior to the Distribution Date. Without limiting the generality of the foregoing, such designated Spinco Plans may be the plans sponsored or maintained by Utah or its Affiliates. 

(b) Cooperation in Establishment of Spinco Plans. Prior to the Distribution Date, the Pluto Group and the Spinco Group shall cooperate
to establish Spinco Plans and the related insurance contracts, third-party service provider agreements and other related agreements and arrangements. 

(c) Spinco Under No Obligation to Maintain Plans. From and after the Distribution Time, the Spinco Group shall retain all of the Spinco
Plans, including all related Liabilities and Assets, and any related trusts and other funding vehicles and insurance contracts of any such plans other than as specifically provided in this Agreement; provided, however, that the
applicable member of the Spinco Group may make such changes, modifications or amendments to such Spinco Plan as may be required by applicable Law or to reflect the Separation Agreement, including limiting participation in any such Spinco Plan to
Spinco Employees or Former Spinco Employees who participated in the corresponding Pluto Plan immediately prior to the Distribution Time. Except as otherwise specified in this Agreement or the Business Combination Agreement, Spinco or any member of
the Spinco Group may, at any time after the Distribution Date, amend, merge, modify, terminate, eliminate, reduce or otherwise alter in any respect any Spinco Plan, any benefit under any Spinco Plan or any trust, insurance contract or funding
vehicle related to any Spinco Plan. 

  
 -11- 

 (d) Transfers of Plan Assets. Except as expressly provided in this Agreement, nothing
in this Agreement shall require Pluto or any member of the Pluto Group to transfer to the Spinco Group any Assets of any member of the Pluto Group or any Pluto Plan. 

Section 3.03 Terms of Participation in Spinco Plans. 

(a) No Duplication or Acceleration of Benefits. In no event shall the Spinco Plans provide benefits that are duplicative of the benefits
provided under the Pluto Plans for the same period of service. Pluto and Spinco shall agree on methods and procedures, including amending the respective Plan documents, to prevent Spinco Employees and Former Spinco Employees from receiving duplicate
benefits from the Pluto Plans and Spinco Plans. Furthermore, unless expressly provided for in this Agreement, the Separation Agreement or in any Ancillary Agreement or required by applicable Law, no provision in this Agreement shall be construed to
create any right to accelerate vesting distributions or entitlements under any Plan sponsored or maintained by a member of the Pluto Group or member of the Spinco Group on the part of any Service Provider or Former Service Provider. 

(b) Service Credit. For all purposes under the Spinco Plans, the Spinco Group shall credit all service of each Spinco Employee and
Former Spinco Employee with Pluto or any of its Subsidiaries or their respective predecessor entities at or before the Distribution Time, to the same extent that such service was credited under the corresponding Pluto Plans prior to the Distribution
Time. The service-crediting provisions shall be subject to any respectively applicable “service bridging,” “break in service,” “employment date” or “eligibility date” rules under the Spinco Plans and the
corresponding Pluto Plans. 
 (c) Beneficiaries. References to Pluto Employees, Former Pluto Employees, Spinco Employees, Former
Spinco Employees, and current and former non-employee directors of either Pluto or Spinco shall be deemed to refer to their beneficiaries, dependents, survivors and alternate payees, as applicable. 

Section 3.04 Plans Not Required to Be Adopted. With respect to any Plan not addressed in this Agreement, the Parties shall agree
in good faith on the treatment of such Plan, taking into account the handling of any comparable Plan under this Agreement. 

ARTICLE IV 

EMPLOYMENT MATTERS FOR SPINCO EMPLOYEES 

Section 4.01 Transfer of Employees. 

(a) Assignment and Transfer of Employees Generally. Except as otherwise provided in this Section 4.01,
effective as of no later than the Distribution Date, the applicable member of the Pluto Group shall have taken such actions as are necessary to ensure that each Spinco Employee is employed by a member of the Spinco Group no later than as of the
Distribution Date. For purposes of this Agreement, “Spinco Employee” means each employee of any member of the Pluto Group or the Spinco Group who (A) is employed as of the Distribution Date, (B) is exclusively or primarily
engaged in the Spinco Business (in each case, including any such individual who is not actively working as of the Distribution Date as a result of an illness, 

  
 -12- 

 
injury or leave of absence approved by the Pluto Human Resources department or otherwise taken in accordance with applicable Law (but not including any individual on long-term disability)) and
(C) is listed on the census of employees of the Spinco Business as of June 13, 2019, as provided to Utah prior to the date of the Separation Agreement (or is hired or transferred into the Spinco Business to replace any such employee whose
employment terminates prior to the Distribution Date), or is one of up to 500 additional employees consistent with the needs and objectives of the Spinco Business and consistent with financial projections shared with Utah and ratings agencies in
connection the Transactions. At Utah’s request, Spinco shall provide updated census information, but in no event more frequently than on a monthly basis. Except as otherwise provided in this Section 4.01, effective as
of no later than the Distribution Date, the applicable member of the Pluto Group shall have taken such actions as are necessary to ensure that each Pluto Employee is employed by a member of the Pluto Group no later than as of the Distribution Date.
For purposes of this Agreement, “Pluto Employee” means each employee of any member of the Pluto Group or the Spinco Group who is employed as of the Distribution Date (including any such individual who is not actively working as of
the Distribution Date as a result of an illness, injury or leave of absence approved by the Pluto Human Resources department or otherwise taken in accordance with applicable Law), including any employee of any member of the Pluto Group or any member
of the Spinco Group who is on long-term disability as of the Distribution Date, other than the Spinco Employees and the Former Spinco Employees. Each of the Parties agrees to execute, and to seek to have the applicable Employees execute, such
documentation, if any, as may be necessary to reflect such assignment and/or transfer. 
 (b) Spinco Employees to Receive Offers. For
any jurisdiction in which there is a Spinco Employee but there will not be a member of the Spinco Group to employ such Spinco Employee until immediately following the Share Sale Effective Time or the Asset Sale Effective Time (as applicable), Spinco
shall or shall cause a member of the Spinco Group to make a written offer of employment to such Spinco Employee at least fifteen (15) Business Days prior to the Distribution Date (or earlier, if required by applicable Law), which offer shall
provide (i) compensation and benefits on terms that are consistent with Section 8.18 of the Business Combination Agreement, (ii) that the Spinco Employee’s employment with the Spinco Group shall commence immediately following the
Share Sale Effective Time or the Asset Sale Effective Time (as applicable) and (iii) other terms that satisfy all requirements of applicable Law and are sufficient to avoid triggering redundancy, severance, termination or similar entitlements
as a result of the transfer of employment from the Pluto Group to the Spinco Group. 
 (c) Employees with Work Visas or Permits; License
To Do Business. Notwithstanding anything to the contrary in this Section 4.01, a Spinco Employee who, on the Distribution Date, is employed pursuant to a work or training visa or permit that authorizes employment only
by a member of the Pluto Group shall remain employed by such member of the Pluto Group following the Distribution Date until the visa or permit is amended or a new visa or permit is granted to authorize employment by a member of the Spinco Group.
Any such Spinco Employee shall be treated as a Spinco Delayed Transfer Employee for purposes of this Agreement. 

  
 -13- 

 (d) Spinco Delayed Transfer Employees. Notwithstanding the foregoing, in the case of
a Spinco Employee who is not employed by a member of the Spinco Group as of immediately prior to the Distribution Date and whose employment cannot commence with, or be transferred to, the Spinco Group pursuant to
Section 4.01(b) or whose transfer of employment to the Spinco Group is otherwise delayed (a “Spinco Delayed Transfer Employee”), the Parties shall cooperate in good faith to cause such Spinco Delayed
Transfer Employee to provide services to the Spinco Group while remaining employed by the Pluto Group until such time as such Spinco Delayed Transfer Employee’s employment can be transferred to the Spinco Group or otherwise terminates with the
Pluto Group. The Parties shall cooperate in good faith to cause each Spinco Delayed Transfer Employee to commence employment with a member of the Spinco Group as soon as reasonably practicable following the Distribution Date as permitted by
applicable Law in such a manner that, to the maximum extent practical, does not trigger the right of such Spinco Employee to redundancy, severance, termination or similar pay and is otherwise consistent with the terms and conditions of this
Agreement, Section 8.18 of the Business Combination Agreement and applicable Law or Labor Agreement. In respect of the Spinco Delayed Transfer Employees, unless otherwise specified, references to “Distribution Date” and
“Distribution Time” in this Agreement shall be treated as references to the first date and time at which the applicable Spinco Delayed Transfer Employee’s employment commences with or transfers to a member of the Spinco Group (the
“Spinco Delayed Transfer Employee Transfer Date”). Notwithstanding the delayed transfer of a Spinco Delayed Transfer Employee, from and after the Distribution Date or, if earlier, the date of the applicable Spinco Delayed Transfer
Employee’s termination of employment (the “Spinco Delayed Employment Period”), any Liability related to a Spinco Delayed Transfer Employee in respect of the Spinco Delayed Employment Period (including with respect to
compensation and benefits paid by Pluto) shall be considered a Spinco Liability; provided that, during such period, the Spinco Group shall receive the benefit of such Spinco Delayed Transfer Employee’s services; provided
further, that if, pursuant to the NEB Agreement or other agreements between the Parties, the Spinco Group bears any Liabilities contemplated by this Section 4.01(d), the Spinco Group shall not be required to provide
duplicative reimbursement of, or otherwise compensate the Pluto Group for, such Liabilities under this Section 4.01(d). 

(e) Pluto Delayed Transfer Employees. Notwithstanding the foregoing, in the case of a Pluto Employee who is not employed by a member of
the Pluto Group as of immediately prior to the Distribution Date or whose transfer of employment to the Pluto Group is otherwise delayed (a “Pluto Delayed Transfer Employee”), the Parties shall cooperate in good faith to cause such
Pluto Delayed Transfer Employee to provide services to the Pluto Group while remaining employed by the Spinco Group until such time as such Pluto Delayed Transfer Employee’s employment can be transferred to the Pluto Group or otherwise
terminates with the Spinco Group. The Parties shall cooperate in good faith to cause each Pluto Delayed Transfer Employee to commence employment with a member of the Pluto Group as soon as reasonably practicable following the Distribution Date as
permitted by applicable Law in such a manner that, to the maximum extent practical, does not trigger the right of such Pluto Employee to redundancy, severance, termination or similar pay and is otherwise consistent with the terms and conditions of
this Agreement and applicable Law or Labor Agreement. Notwithstanding the delayed transfer of a Pluto Delayed Transfer Employee, from and after the Distribution Date or, if earlier, the date of the applicable Pluto Delayed Transfer Employee’s
termination of employment (the “Pluto Delayed Employment Period”), any Liability related to a Pluto Delayed Transfer Employee in respect of the Pluto Delayed Employment Period (including with respect to compensation and benefits
paid by Spinco) shall be considered a Pluto Liability; provided 

  
 -14- 

 
that, during such period, the Pluto Group shall receive the benefit of such Pluto Delayed Transfer Employee’s services; provided further, that if, pursuant to the NEB Agreement
or other agreements between the Parties, the Pluto Group bears any Liabilities contemplated by this Section 4.01(e), the Pluto Group shall not be required to provide duplicative reimbursement of, or otherwise compensate the
Spinco Group for, such Liabilities under this Section 4.01(e). 
 Section 4.02 Assignment and Transfer of
Independent Contractors. Effective as of no later than the Distribution Date, (a) the applicable member of the Pluto Group shall have taken such actions as are necessary to ensure that the contract of services of each individual who is an
independent contractor of any member of the Pluto Group or the Spinco Group who is actively providing services immediately prior to the Distribution Date and is exclusively or primarily engaged in the Spinco Business (collectively, the
“Spinco Independent Contractors”) is transferred to a member of the Spinco Group no later than as of the Distribution Date and (b) the applicable member of the Pluto Group shall have taken such actions as are necessary to
ensure that the contract of services of each individual who is an independent contractor of any member of the Pluto Group or the Spinco Group other than the Spinco Independent Contractors (collectively, the “Pluto Independent
Contractors”) is transferred to a member of the Pluto Group no later than as of the Distribution Date, in each case, to the extent permitted by the applicable contract of services and subject to the consent of the applicable independent
contractor to the extent required. Each of the Parties agrees to execute, and to seek to have the applicable independent contractors execute, such documentation, if any, as may be necessary to reflect such assignment and/or transfer. 

Section 4.03 At-Will Status. Nothing in this Agreement shall change the employment status
of any Employee from “at-will,” to the extent that such Employee is an “at-will” employee under applicable Law. 

Section 4.04 Severance. The Parties acknowledge and agree that the Separation, the Distribution and the assignment, transfer or
continuation of the employment of Employees as contemplated by this Article IV shall not be deemed an involuntary termination of employment or a termination of services entitling any Spinco Service Provider or Pluto Service
Provider to redundancy, termination, severance or similar payments or benefits. 
 Section 4.05 Individual Agreements. 

(a) Assignment by Pluto or Spinco. (i) Pluto shall assign, or cause an applicable member of the Pluto Group to assign, to Spinco or
another member of the Spinco Group, as designated by Spinco, all Spinco Individual Agreements, with such assignment to be effective as of no later than the Distribution Date and (ii) Spinco shall assign, or cause an applicable member of the
Spinco Group to assign, to Pluto or another member of the Pluto Group, as designated by Pluto, all Pluto Individual Agreements, with such assignment to be effective as of no later than the Distribution Date; provided, however, that to
the extent that assignment of any such Spinco Individual Agreement or Pluto Individual Agreement is not permitted by the terms of such agreement or by applicable Law, effective as of the Distribution Date, each member of the Spinco Group (in the
case of each Spinco Individual Agreement) or the Pluto Group (in the case of each Pluto Individual Agreement) shall be considered to be a successor to each member of the Spinco Group or Pluto Group, as applicable, for purposes of, and a third-party
beneficiary with 

  
 -15- 

 
respect to, such agreement, such that each member of the Spinco Group or Pluto Group, as applicable, shall enjoy all of the rights and benefits under such agreement (including rights and benefits
as a third-party beneficiary), with respect to the business operations of the Spinco Group or Pluto Group, as applicable; provided further that in no event shall (A) Pluto be permitted to enforce any Spinco Individual Agreement
(including any agreement containing non-competition or non-solicitation covenants) against a Spinco Employee for action taken in such individual’s capacity as a
Spinco Employee other than on behalf of the Spinco Group as requested by the Spinco Group in its capacity as a third-party beneficiary or (B) Spinco be permitted to enforce any Pluto Individual Agreement (including any agreement containing non-competition or non-solicitation covenants) against a Pluto Employee for action taken in such individual’s capacity as a Pluto Employee other than on behalf of the Pluto Group as requested by the Pluto Group
in its capacity as a third-party beneficiary. 
 (b) Assumption by Spinco and Pluto. Effective as of no later than the
Distribution Date, Spinco shall assume and honor any Spinco Individual Agreement and Pluto shall assume and honor any Pluto Individual Agreement. 

Section 4.06 Consultation with Labor Representatives; Labor Agreements. The Parties shall cooperate to inform and consult with any
labor union, works council or other labor representative regarding the Transactions to the extent required by Law or a Labor Agreement. No later than as of immediately before the Distribution Time, Spinco, or another member of the Spinco Group,
shall take or cause to be taken all actions that are necessary (if any) for Spinco or another member of the Spinco Group to (a) assume any Labor Agreements in effect with respect to Spinco Employees and Former Spinco Employees (excluding any
Pluto Employees or Former Pluto Employees to the extent applicable) and (b) unless otherwise provided in this Agreement, assume and honor any obligations of the Pluto Group under any Labor Agreements as such obligations relate to Spinco
Employees and Former Spinco Employees. No later than as of immediately before the Distribution Time, Pluto, or another member of the Pluto Group, shall take or cause to be taken all actions that are necessary (if any) for Pluto or another member of
the Pluto Group to (a) assume any Labor Agreements in effect with respect to Pluto Employees and Former Pluto Employees (excluding any Spinco Employees or Former Spinco Employees to the extent applicable) and (b) assume and honor any
obligations of the Spinco Group under any Labor Agreements as such obligations relate to Pluto Employees and Former Pluto Employees. Following the Distribution Time, (a) the Spinco Group shall indemnify and hold harmless the Pluto Indemnitees
against any Liabilities assumed by any member of the Spinco Group pursuant to this Section 4.06 and (b) the Pluto Group shall indemnify and hold harmless the Spinco Indemnitees against any Liabilities assumed by any
member of the Pluto Group pursuant to this Section 4.06. 
 Section 4.07 WARN Act and Other Notices.
The Spinco Group shall provide any required notice under the Worker Adjustment and Retraining Notification Act and any similar foreign, state, local or other applicable Law (collectively, “WARN”) and otherwise comply with any such
requirement with respect to any “plant closing” or “mass layoff” (as defined in WARN) or similar event, in each case, occurring after the Distribution Time and affecting Spinco Employees. The Spinco Group shall indemnify and hold
harmless the Pluto Indemnitees against any such Liabilities relating to WARN with respect to any events occurring after the Distribution Time, in accordance with Article IV of the Separation Agreement. 

  
 -16- 

 ARTICLE V 

DEFINED BENEFIT PLANS 

Section 5.01 U.S. Defined Benefit Plans. 

(a) Pluto Consolidated Pension Plan. As of the Distribution Time, the Pluto Group shall retain, and no member of the Spinco Group shall
assume or retain sponsorship of, or any Assets or Liabilities with respect to, the Pluto Consolidated Pension Plan. 
 (b) Puerto Rico
Defined Benefit Plans. The Pluto Group and the Spinco Group shall merge the Searle-Monsanto Puerto Rico Employees’ Retirement Plan and the Pluto Consolidated Pension Plan for Employees Resident in Puerto Rico (the “Puerto Rico DB
Plans”) prior to the Distribution Date. As of the Distribution Time, the Spinco Group shall retain, and no member of the Pluto Group shall assume or retain sponsorship of, or any Liabilities with respect to, the Puerto Rico DB Plans;
provided, however, except as provided in this Section 5.01(b), the Pluto Group shall retain all Assets relating to the Puerto Rico DB Plans in a master trust that holds the Assets attributable to the Puerto
Rico DB Plans (which trust shall be retained by the Pluto Group) from and following the Distribution Time (the “Pluto Master Trust”). In lieu of transferring the Assets attributable to the Puerto Rico DB Plans to a trust designated
by Spinco (the “Spinco Master Trust”) in kind, the Pluto Group shall transfer cash payments from the Pluto Master Trust to the Spinco Master Trust equal to the value of the Assets attributable to the Puerto Rico DB Plans on the
following schedule: 
 (i) Assets Valued on a Daily Basis. The pro rata share of the Puerto Rico DB Plans’
interest in the Assets held by the Pluto Master Trust with a readily ascertainable fair market value and that are valued on a daily basis shall be valued as of the close of the market (regular hours) on the last trading day immediately prior to the
Distribution and such value shall be transferred to the Spinco Master Trust in cash on the Distribution Date. 
 (ii)
Assets Valued on a Monthly Basis. The pro rata share of the Puerto Rico DB Plans’ interest in the Assets held by the Pluto Master Trust that are valued on a monthly basis (the “Monthly Assets”) shall be valued as of the
last day of the month coincident with or immediately prior to the Distribution (such date, the “Monthly Valuation Date” and such amount, the “Monthly Asset Transfer Amount”) and shall be transferred to the Spinco
Master Trust in cash on the Distribution Date plus simple interest (using the one month treasury rate in effect on the Distribution Date) on such amount from the date immediately following such Monthly Valuation Date through the date immediately
preceding the Distribution Date; provided, however, if the valuation for the Monthly Valuation Date for the Monthly Assets has not been received by Pfizer (or its authorized agent managing such Assets) prior to the Distribution Date,
then such transfer shall be in two tranches as follows: 

  
 -17- 

	 	A.	 The first tranche shall transfer on the Distribution Date and shall equal 80% of the pro rata share of the
Puerto Rico DB Plans’ interest in the Monthly Assets, valued as of the last day of the month for which such valuation is available (the “Initial Monthly Transfer Amount”) plus simple interest (using the one month treasury rate
in effect on the Distribution Date) on such amount from the date immediately following such Monthly Valuation Date through the date immediately preceding the Distribution Date. 

 

	 	B.	 The second tranche shall transfer as soon as practicable following the receipt by Pfizer (or any authorized
agent managing such Assets) of the valuations for the Monthly Valuation Date and shall equal the Monthly Asset Transfer Amount minus the Initial Monthly Transfer Amount, along with simple interest (using the one month treasury rate in effect on the
Distribution Date) on such difference from the date immediately following the Monthly Valuation Date through the date immediately preceding the date of transfer. 

 

	 	C.	 If the Initial Monthly Transfer Amount exceeds the Monthly Asset Transfer Amount, the Spinco Master Trust will
transfer back to the Pfizer Master Trust such excess plus simple interest (using the one month treasury rate in effect on the Distribution Date) from the date immediately following the Monthly Valuation Date through the date immediately preceding
the date of such transfer. 

 (iii) Assets Valued on a Quarterly Basis. The pro rata share of the
Puerto Rico DB Plans’ interest in each Asset held by the Pluto Master Trust that is valued on a Quarterly Basis (the “Quarterly Asset”) shall be valued as of the last day of the quarter for which a valuation is published or
available to Pfizer (or any authorized agent managing such Assets) for such Asset (the “Quarterly Valuation Date”) and shall be transferred to the Spinco Master Trust in cash (the “Quarterly Asset Transfer Amount”)
on the Distribution Date along with imputed earnings on the Quarterly Asset Transfer Amount from the date immediately following such Quarterly Valuation Date through the date immediately preceding the date of transfer. Such imputed earnings shall be
calculated based on the investment class of such Asset (private real estate, private equity, venture capital or private debt investment) and the historical rate of return on all Assets in such investment class in the Pfizer Master Trust over the 10
year period ending on the most recent month-end for which such returns are available for each Asset in such class prior to the Distribution Date. 

The amount transferred from the Pluto Master Trust to the Spinco Master Trust shall be adjusted to take into account any benefit payments made
from the Pluto Master Trust attributable to the Puerto Rico DB Plans after the Distribution Date but prior to the date of transfer. Notwithstanding anything to the contrary in the Separation Agreement, Pluto and Spinco agree that the Assets
described in this Section 5.01(b) (i) are the subject matter of this Agreement and not the Separation Agreement and (ii) shall not be included in the Spinco Cash Balance or the calculation of the Spinco Cash
Balance pursuant to the Separation Agreement. 

  
 -18- 

 (c) As soon as reasonably practicable following any cash transfers made pursuant to this
Section 5.01, the Pluto Group shall deliver to the Spinco Group copies of the relevant valuation reports used by the Pluto Group to make the determinations required by this Section 5.01(b) and any other supporting information as may be
reasonably requested by Spinco.                 

Section 5.02 Non-U.S. Defined Benefit Plans. 

(a) Establishment of Non-U.S. Defined Benefit Plans. Effective as of, or as soon as
practicable following, the Distribution Date, Spinco shall establish or designate defined benefit pension or termination benefit plans or arrangements, as applicable (collectively, the “Spinco Non-U.S.
Defined Benefit Plans”), for the benefit of the Spinco Employees and Former Spinco Employees who participate in or accrue benefits pursuant to the Plans set forth on Exhibit 5.02(a) or any other arrangement with respect to which a
transfer of Assets or Liabilities is required whether under a Plan or pursuant to applicable Law (collectively, the “Pluto Non-U.S. Defined Benefit Plans,” and the Spinco Employees and Former
Spinco Employees who participate in or accrue benefits pursuant to the Pluto Non-U.S. Defined Benefit Plans, the “Transferred Defined Benefit Plan Participants”). Each Spinco Non-U.S. Defined Benefit Plan shall provide, upon the transfer of Assets referred to below (or, if there is no transfer of Assets with respect to a particular Plan because the Plan is not funded, or is funded
through a funding vehicle that is not owned by the Pluto Group as of the Distribution Date), that the accrued benefits of the Transferred Defined Benefit Participants under such Spinco Non-U.S. Defined Benefit
Plan shall in no event be less than their accrued benefits under the corresponding Pluto Non-U.S. Defined Benefit Plan as of the Distribution Date (or in the case of Transition Benefits under a Pluto Non-U.S. Defined Benefit Plan, the date benefits are no longer accrued under such Pluto Non-U.S. Defined Benefit Plan). With respect to any Pluto Non-U.S. Defined Benefit Plan that is funded through a funding vehicle that is owned or controlled by the Pluto Group, Pluto shall cause to be transferred from the trusts or other funding vehicles under such Pluto Non-U.S. Defined Benefit Plan to the trusts or other funding vehicles under the corresponding Spinco Non-U.S. Defined Benefit Plan Assets in the form of cash, cash
equivalents, marketable securities or insurance contracts (to the extent allowable under the terms of such contracts and exclusively intended to cover plan benefits), the value of which shall be equal to: (i) the actuarial present value of
projected benefits (that is, the “projected benefit obligation” as defined in Topic 715 in the FASB’s Accounting Standards Codification, the “PBO”) under such Pluto Non-U.S.
Defined Benefit Plan as of the Distribution Date that is attributable to the Transferred Defined Benefit Plan Participants, divided by the PBO of all participants in such Pluto Non-U.S. Defined Benefit
Plan as of the Distribution Date, multiplied by the market value of the Assets of such Pluto Non-U.S. Defined Benefit Plan at the Distribution Date; or (ii) such greater amount as is required to
transfer by the applicable Plan, applicable Law or a Labor Agreement (such amounts, the “Non-U.S. Defined Benefit Plan Transfer Amounts”). 

(b) Non-U.S. Defined Benefit Plan Transfer Amounts. The transfer of the Non-U.S. Defined Benefit Plan Transfer Amounts, and the assumption by Spinco and its Affiliates of Liabilities with respect to or relating to the Transferred Defined Benefit Plan Participants under the applicable
Pluto Non-U.S. Defined Benefit Plans, shall be subject to such consents, approvals and other requirements as may apply under applicable Law. Spinco shall cause the corresponding Spinco Non-U.S. Defined Benefit Plans to accept the Non-U.S. Defined Benefit Plan Transfer Amounts. Actuarial determinations shall be made in accordance with
Section 5.02(e). If a Pluto Non-U.S. Defined Benefit Plan is not required to be funded by applicable Law or is funded through a funding vehicle that is not owned or controlled by the

  
 -19- 

 
Pluto Group as of the Distribution Date, there shall be no transfer of Assets by the Pluto Non-U.S. Defined Benefit Plan or by Pluto or its Affiliates.

 (c) Adjustments to Plan Transfer Amounts. The Non-U.S. Defined Benefit Plan Transfer
Amounts, if any, from each Pluto Non-U.S. Defined Benefit Plan shall be equitably adjusted to take into account benefit accrual for Transition Benefits (including the related cost to the Pluto Group of
providing such Transition Benefits, which may reduce the Non-U.S. Defined Benefit Plan Transfer Amounts), benefit payments made from the Pluto Non-U.S. Defined Benefit
Plan to the Transferred Defined Benefit Plan Participants after the Distribution Date but prior to the date of transfer and for any investment returns, earnings and losses on such amounts during such period. The
Non-U.S. Defined Benefit Plan Transfer Amounts, if any, shall be determined pursuant to Section 5.02(e). 

(d) Assumption of Liabilities. At the times of the transfers of the Non-U.S. Defined Benefit
Plan Transfer Amounts (or if there is no transfer of Assets with respect to a particular Plan because the Plan is not required to be funded under applicable Law, or is funded through a funding vehicle that is not owned or controlled by the Pluto
Group as of the Distribution Date, from and after the Distribution Date), the Transferred Defined Benefit Plan Participants shall cease to be participants in the Pluto Non-U.S. Defined Benefit Plans (and for
the avoidance of doubt, shall have ceased benefit accrual prior to the Distribution Date, other than benefit accrual for Transition Benefits under a Pluto Non-U.S. Defined Benefit Plan, which shall cease no
later than the date specified on Exhibit 3.01(a) with respect to such plan), and Spinco and the Spinco Non-U.S. Defined Benefit Plans shall assume all Liabilities under the corresponding Pluto Non-U.S. Defined Benefit Plans in respect of the Transferred Defined Benefit Plan Participants, and Pluto and its Affiliates and the corresponding Pluto Non-U.S. Defined
Benefit Plans shall be relieved of all such Liabilities under the Pluto Non-U.S. Defined Benefit Plans to the Transferred Defined Benefit Plan Participants. 

(e) Actuarial Determinations. For purposes of this Section 5.02, actuarial determinations shall be
based upon the actuarial assumptions and methodologies used in preparing the most recent audited financial statements of Pluto as of the date of the determination (except that the assumptions concerning the applicable discount rate and rate of
compensation increases will be determined as of the Distribution Date by Mercer but consistent with the manner in which those assumptions were determined for the most recent audited financial statements of Pluto) (the “Actuarial
Assumptions”). Unless otherwise agreed by the Parties, all actuarial determinations under this Agreement shall be made by Mercer. 

(f) Delayed Transfers. Notwithstanding the foregoing, the Parties may agree to delay any transfer contemplated by this
Section 5.02 to be effective as of a date coincident with or as soon as practicable following the transfer of a Spinco Delayed Transfer Employee to a member of the Spinco Group or a Delayed Asset (or such other date as
agreed by the Parties in the case of Ireland, Japan and Switzerland), with the references to “Distribution Date” in this Section 5.02 to be the effective date as agreed in writing by the Parties.  

Section 5.03 Pension Plan for Japan. The provisions set forth in Section 5.02 shall apply with respect to the Pluto Japan
Pension Plan, provided that the reference to Transferred Defined Benefit Plan Participants shall include only Spinco Employees (and not Former Spinco Employees). 

  
 -20- 

 ARTICLE VI 

DEFINED CONTRIBUTION PLANS 

Section 6.01 U.S. Defined Contribution Plan. 

(a) No Assumption of Defined Contribution Plan Liabilities of the Pluto Savings Plan. As of the Distribution Date, the Pluto Group shall
retain, and no member of the Spinco Group shall assume or retain sponsorship of, or any Assets or Liabilities with respect to, the Pluto Savings Plan, other than with respect to the rollover of account balances described in
Section 6.01(d) or any Liabilities arising from noncompliance by any member of the Spinco Group with the provisions of this Agreement. 

(b) Pluto Savings Plan. Prior to the Distribution Date, Pluto or another member of the Pluto Group shall amend the Pluto Savings Plan
and if applicable, the related trust agreement with The Northern Trust Company and take any other action necessary to provide that: (i) Spinco Employees shall be one hundred percent (100%) vested in their account balances under the Pluto
Savings Plan as of the Distribution Date; (ii) Spinco Employees shall be entitled to receive Matching Contributions and Retirement Savings Contributions (as such terms are defined in the Pluto Savings Plan) with respect to the portion of the
plan year ending immediately prior to the Distribution Time without regard to whether the Distribution Time coincides with the end of a calendar quarter or any requirement to be employed on the last day of the plan year; and (iii) three new
unitized Spinco Share funds shall be established under the Pluto Savings Plan and related trust that will receive the Spinco Shares distributed in connection with the Distribution and the appropriate authorized officer of Pluto shall be further
authorized and directed to amend the Pluto Savings Plan and related trust in such manner as is determined necessary or appropriate to provide for the operation, administration and termination of the Spinco Share funds and such additional actions as
may be required in connection with the Distribution and in respect of other rights in respect of Spinco Shares under the Pluto Savings Plan and related trust. 

(c) Spinco Savings Plan. Spinco shall, or shall cause any member of the Spinco Group, to establish or maintain a qualified defined
contribution plan (the “Spinco Savings Plan”), effective as of the Distribution Date. Spinco shall be responsible for taking all necessary, reasonable and appropriate action to establish, maintain and administer the Spinco Savings
Plan so that it is qualified under Section 401(a) of the Code and that the related trust thereunder is exempt under Section 501(a) of the Code, and as soon as reasonably practicable following the Distribution Date, Spinco shall take all
steps reasonably necessary to obtain a favorable determination from the IRS or obtain an opinion as to such qualification. Immediately prior to the Distribution Date, Spinco Employees shall cease active participation in the Pluto Savings Plan, and
upon the Distribution Date, Spinco Employees shall be eligible to commence participation in the Spinco Savings Plan. Any minimum age or service requirements contained in the Spinco Savings Plan with respect to eligibility to participate generally or
eligibility to share in any employer contributions under such plan shall be waived or deemed satisfied for Spinco Employees to the extent waived or satisfied under the Pluto Savings Plan immediately prior to the Distribution Date. 

  
 -21- 

 (d) Rollover of Account Balances. As soon as practicable after the Distribution Date,
Pluto and Spinco shall take any and all actions as may be required to permit each Spinco Employee to elect to make rollover contributions of “eligible rollover distributions” (within the meaning of Section 402(c)(4) of the Code) in
cash or loan notes in an amount equal to the entire eligible rollover distribution distributable to such Spinco Employee from the Pluto Savings Plan to Spinco Savings Plan. 

(e) Wyeth Union Savings Plan. The provisions of Section 6.01 as applied to the Pluto Savings Plan shall also apply to the Wyeth
Union Savings Plan to the extent applicable. 
 Section 6.02 Puerto Rico Savings Plan. 

(a) Pluto Assumption of the Puerto Rico Savings Plan. As of the Distribution Date, the Pluto Group shall assume, and no member of the
Spinco Group shall retain sponsorship of, or any Assets or Liabilities with respect to, the Puerto Rico Savings Plan, other than with respect to the rollover of account balances described in Section 6.02(c) or any
Liabilities arising from noncompliance by any member of the Spinco Group with the provisions of this Agreement. 
 (b) Treatment of Spinco
Employee Participants. Prior to the Distribution Date, Spinco or another member of the Spinco Group shall amend the Puerto Rico Savings Plan and take any other action necessary to provide that: (i) a member of the Pluto Group shall be the
plan sponsor of the Puerto Rico Savings Plan effective as of the Distribution Date; (ii) Spinco Employees shall be one hundred percent (100%) vested in their account balances under the Puerto Rico Savings Plan as of the Distribution Date;
(iii) Spinco Employees shall be entitled to receive Matching Contributions and Retirement Savings Contributions (as such terms are defined in the Puerto Rico Savings Plan) with respect to the portion of the plan year ending immediately prior to
the Distribution Time without regard to whether the Distribution Time coincides with the end of a calendar quarter or any requirement to be employed on the last day of the plan year; and (iv) two new unitized Spinco Share funds shall be
established, one for each of the existing Pluto Share funds under the Puerto Rico Savings Plan and related trust that will receive the Spinco Shares distributed in connection with the Distribution, and the appropriate authorized officer of Pluto
shall be further authorized and directed to amend the Puerto Rico Savings Plan and related trust in such manner as is determined necessary or appropriate to provide for the operation, administration and termination of the Spinco Share funds and such
additional actions as may be required in connection with the Distribution and in respect of other rights in respect of Spinco Shares under the Puerto Rico Savings Plan and related trust. Upon the Distribution Date, Spinco Employees covered by the
Puerto Rico Savings Plan immediately before the Distribution Date shall be eligible to commence participation in a savings plan maintained by Spinco for employees in Puerto Rico. Any minimum age or service requirements contained in such savings plan
with respect to eligibility to participate generally or eligibility to share in any employer contributions under such plan shall be waived or deemed satisfied for Spinco Employees to the extent waived or satisfied under the Puerto Rico Savings Plan
immediately prior to the Distribution Date. 

  
 -22- 

 (c) Rollover of Account Balances. As soon as practicable after the Distribution Date,
Spinco shall take any and all actions as may be required to permit each Spinco Employee to elect to make rollover contributions in cash or loan notes in an amount equal to the entire eligible rollover distribution distributable to such Spinco
Employee from the Puerto Rico Savings Plan to a plan designated by Spinco and permitted pursuant to the terms of the Puerto Rico Savings Plan or applicable Law. 

Section 6.03 Non-U.S. Defined Contribution Plans. The Pluto Group shall retain, and no
member of the Spinco Group shall assume or retain, sponsorship of, or any Assets or Liabilities with respect to, any defined contribution plan maintained for Spinco Employees or Former Spinco Employees in any
non-U.S. jurisdiction, except as required by applicable Law or with respect to the rollover of account balances of Spinco Employees to the extent permissible in such
non-U.S. jurisdiction or any Liabilities arising from noncompliance by any member of the Spinco Group with the provisions of this Agreement or Liabilities arising from the Transition Benefits, if any. Other
than with respect to any rollover of account balances in accordance with the immediately preceding sentence, Pluto or another member of the Pluto Group shall retain all accounts and all Assets and Liabilities relating to any defined contribution
plan maintained for Spinco Employees or Former Spinco Employees in any non-U.S. jurisdiction with respect to each Spinco Employee and each Former Spinco Employee. 

ARTICLE VII 

NONQUALIFIED PLANS 

Section 7.01 Nonqualified Plans. The Pluto Group shall retain, and no member of the Spinco Group shall assume or retain
sponsorship of, or any Assets or Liabilities with respect to, the Pluto Nonqualified Plans. 
 Section 7.02 Distributions. The
Parties acknowledge that none of the Transactions shall trigger a payment or distribution of compensation under any of the Pluto Nonqualified Plans for any participant and consequently, that the payment or distribution of any compensation to which
such participant is entitled under any such plan shall occur upon such participant’s separation from service from the Spinco Group or the Pluto Group or at such other time as provided in the applicable deferred compensation plan or
participant’s deferral election. Spinco shall notify Pluto in writing of a Spinco Employee’s separation from service with a member of the Spinco Group within thirty (30) days thereafter. The obligations of one Party to provide
Information to the other Party in order to allow the administration of the Pluto Nonqualified Plans pursuant to this Article VII are set forth in Section 14.01. 

ARTICLE VIII 
 HEALTH
AND WELFARE PLANS 
 Section 8.01 Health and Welfare Plan Liabilities. Except as otherwise provided in this
Article VIII, including Section 8.02 regarding life insurance and Section 8.06 regarding long-term disability benefits, effective as of the Distribution Time, the Spinco
Group shall retain or assume, as applicable, all Liabilities relating to, arising out of or resulting from health and welfare 

  
 -23- 

 
coverage or claims incurred by or on behalf of Spinco Employees or Former Spinco Employees under the Pluto Health and Welfare Plans and Spinco Health and Welfare Plans before, at, or after the
Distribution Time, including costs for Transition Benefits (including premiums for medical, disability or life coverage); provided that if, pursuant to the Transition Services Agreement, the Spinco Group bears any Liabilities for Transition
Benefits, the Spinco Group shall not be required to provide duplicative reimbursement of, or otherwise compensate the Pluto Group for, such Liabilities arising from Transition Benefits. Any Liabilities incurred or paid by the Pluto Group shall be
subject to reimbursement by the Spinco Group in accordance with Section 14.05. 
 Section 8.02 Allocation
of Life Insurance Liabilities. Each Pluto Life Insurance Plan shall retain all Liabilities with respect to covered life insurance claims incurred prior to the Distribution Date by Employees and Former Employees and their respective dependents
(and for claims incurred prior to the date set forth on Exhibit 3.01(a) for any Spinco Employee receiving life insurance coverage as a Transition Benefit to the extent covered), other than any Liabilities with respect to claims incurred under
a Spinco Life Insurance Plan by any such Employees or Former Employees and their respective dependents which will be retained by Spinco. The applicable Spinco Life Insurance Plans shall be responsible for all Liabilities with respect to life
insurance claims incurred after the Distribution Date by Spinco Employees and their dependents. For these purposes, a claim shall be deemed to be incurred on the date of the death of the insured person. 

Section 8.03 Post-Separation Transitional Arrangements. 

(a) Coverage and Contribution Elections. As of the Distribution Date, Spinco shall cause the Spinco Health and Welfare Plans (including
the Spinco Flexible Benefits Plan) to recognize and maintain all coverage and contribution elections made by Spinco Employees and Former Spinco Employees under the corresponding Pluto Health and Welfare Plans (including the Pluto Dependent Care
Flexible Benefits Plan) and apply such elections under Spinco Health and Welfare Plans for the remainder of the period or periods for which such elections are, by their terms, applicable. All waiting periods and
pre-existing condition exclusions and actively-at-work requirements shall be waived with respect to Spinco Employees and Former
Spinco Employees who were not subject to any such waiting periods, exclusions or requirements under a Pluto Health and Welfare Plan in which such employees participate immediately prior to the Distribution Date. For the avoidance of doubt, nothing
herein shall prevent Spinco from conducting open enrollment and accepting elections under Spinco Health and Welfare Plans. 
 (b)
Deductibles and Out-of-Pocket Maximums. On and after the Distribution Date, Spinco shall cause the Spinco Health Plans to recognize and give credit for or take
into account all amounts applied to deductibles, out-of-pocket maximums and copayments with respect to which such expenses have been incurred by Spinco Employees and
Former Spinco Employees under the Pluto Health Plans for the remainder of the calendar year in which the Distribution Date occurs. 

Section 8.04 Flexible Benefits Plans. 

(a) Pluto Healthcare Flexible Benefits Plan. Effective as of the Distribution Date, the Spinco Employees shall cease to be participants
in the Pluto Healthcare Flexible Benefits Plan, and the Pluto Group shall retain all Assets and Liabilities in respect of the Pluto Healthcare Flexible Benefits Plan. 

  
 -24- 

 (b) Pluto Dependent Care Flexible Benefits Plan. Effective as of the Distribution
Date, the Spinco Employees shall cease to be participants in the Pluto Dependent Care Flexible Benefits Plan. The Parties shall take all steps necessary or appropriate so that the account balances (whether positive or negative) (the
“Transferred Account Balances”) under the Pluto Dependent Care Flexible Benefits Plan of each Spinco Employee or Former Spinco Employee who has elected to participate therein in the year in which the Distribution Date occurs shall
be transferred, as soon as practicable after the Distribution Date, from the Pluto Dependent Care Flexible Benefits Plan to the corresponding Spinco Flexible Benefits Plan. The Spinco Flexible Benefits Plan shall assume responsibility as of the
Distribution Date for all outstanding claims under the Pluto Dependent Care Flexible Benefits Plan of each Spinco Employee or Former Spinco Employee for the year in which the Distribution Date occurs and shall assume and agree to perform the
obligations of the analogous Pluto Dependent Care Flexible Benefits Plan from and after the Distribution Date. As soon as practicable after the Distribution Date, and in any event within thirty (30) days after the amount of the Transferred
Account Balances is determined or such later date as mutually agreed upon by the Parties, Pluto shall pay Spinco the net aggregate amount of the Transferred Account Balances if such amount is positive, and Spinco shall pay Pluto the net aggregate
amount of the Transferred Account Balances if such amount is negative. 
 Section 8.05 COBRA. Effective as of the Distribution
Time, (a) the Pluto Group shall assume or retain responsibility for complying with, and providing coverage pursuant to, the health care continuation requirements of COBRA, and the corresponding provisions of the Pluto Health Plans (including
the Pluto Healthcare Flexible Benefits Plan), with respect to any Pluto Employees, Spinco Employees or Former Employees (and their covered dependents), but not any Former Spinco Employees receiving severance and benefit continuation as of the
Distribution Time, who incur a qualifying event or loss of coverage under the Pluto Health Plans or the Puerto Rico Health Plan on or prior to the Distribution Time, and (b) the Spinco Group shall assume or retain responsibility for complying
with, and providing coverage pursuant to, the health care continuation requirements of COBRA, and the corresponding provisions of the Spinco Health Plans (including the Puerto Rico Health Plan), with respect to any Spinco Employees (and their
covered dependents) and Former Spinco Employees, including any Former Spinco Employee receiving severance and benefit continuation as of the Distribution Time, who incur a qualifying event or loss of coverage under the Spinco Health Plans following
the Distribution Time; provided that the Spinco Group shall retain or assume, as applicable, all Liabilities relating to, arising out of or resulting from health and welfare claims incurred by or on behalf of Spinco Employees or Former Spinco
Employees (and their covered dependents) under the Pluto Health and Welfare Plans before, at, or after the Distribution Time. Any Liabilities of the Spinco Group incurred or paid by the Pluto Group shall be subject to reimbursement by the Spinco
Group in accordance with Section 14.05, and any Liabilities of the Pluto Group incurred or paid by the Spinco Group shall be subject to reimbursement by the Pluto Group in accordance with
Section 14.05. The Parties agree that the consummation of the transactions contemplated by the Separation Agreement shall not constitute a COBRA qualifying event for any purpose of COBRA. 

  
 -25- 

 Section 8.06 Disability Plans. The Pluto Group shall retain all Liabilities for
long-term disability benefits with respect to (a) all Pluto Employees and Former Employees and (b) any Spinco Employee who, as of the Distribution Time, is on short-term disability leave and who subsequently becomes eligible to receive
long-term disability benefits under such plans but only with respect to disability claims incurred by such Spinco Employee prior to the Distribution Time (and for claims incurred prior to the date set forth on Exhibit 3.01(a) by any Spinco
Employee receiving disability benefits coverage as a Transition Benefit to the extent covered) (other than, in the case of clauses (a) and (b), Liabilities for long-term disability benefits with respect to claims incurred under a Spinco
Long-Term Disability Plan, which will be retained by Spinco). For this purpose, a disability claim shall be considered incurred on the date of the occurrence of the event or condition giving rise to disability. Without limiting the generality of the
foregoing, the Spinco Group shall be responsible for Liabilities related to all other compensation and benefits of such Spinco Employee or Former Spinco Employee that are allocated to the Spinco Group pursuant to this Agreement, including
Liabilities related to severance or group health benefits. 
 Section 8.07 Leave of Absence Programs and FMLA. Effective as of
the Distribution Date, (a) the Spinco Group shall honor all terms and conditions of leaves of absence that have been granted by Pluto to any Spinco Employee under a Pluto Leave of Absence Program or FMLA or other applicable Law regarding leave
of absence before the Distribution Date, including such leaves that are to commence after the Distribution Date; (b) the Spinco Group shall be solely responsible for administering any such leave of absence and complying with FMLA or other
applicable Laws regarding leave of absence with respect to Spinco Employees; and (c) the Spinco Group shall recognize all periods of service of Spinco Employees with the members of the Pluto Group, as applicable, to the extent such service is
recognized by the members of the Pluto Group for the purpose of eligibility for leave entitlement under the Pluto Leave of Absence Programs, FMLA and other applicable Laws. 

Section 8.08 Pluto Workers’ Compensation Program. The treatment of workers’ compensation shall be governed by the
Separation Agreement. 
 ARTICLE IX 

RETIREE MEDICAL PLANS 

Section 9.01 Pluto Canada Retiree Medical Plan. Effective as of no later than the Distribution Time, each Spinco Employee who
participates in or accrues benefits pursuant to the Pluto Canada Retiree Medical Plan, or who would have been eligible to participate in the Pluto Canada Retiree Medical Plan as of the Distribution Time (subject to satisfaction of the age and
service requirements thereof), shall cease actively participating or being eligible to become a participant, or accruing service towards eligibility, in the Pluto Canada Retiree Medical Plan, and the Pluto Group shall have no Liabilities in respect
of the provision of post-retirement medical benefits to such Spinco Employee. As soon as administratively practicable following the Distribution Time, the Spinco Group shall make a cash payment in the amount previously agreed between the Parties,
and sufficient to avoid triggering redundancy, severance, termination or similar payments or benefits, to each Spinco Employee who participated in or accrued benefits pursuant to the Pluto Canada Retiree Medical Plan as of immediately prior to the
Distribution Time. Any Liability related to redundancy, severance, termination or similar payments or benefits arising from the Spinco Group’s failure to provide post-retirement medical benefits to such Spinco Employees shall be a Spinco
Liability. 

  
 -26- 

 Section 9.02 Puerto Rico Retiree Medical Plan. The Spinco Group shall retain,
and no member of the Pluto Group shall assume or retain sponsorship of, or any Liabilities with respect to, all individuals who are eligible to participate in the Puerto Rico Retiree Medical Plan as of immediately prior to the Distribution Date
(without regard to whether he or she is an Employee or Former Employee or has enrolled in or commenced benefits under such plan) (collectively, the “Retiree Medical Plan Participants”). Spinco shall have the right to freeze, amend
or terminate the Puerto Rico Retiree Medical Plan at any time following the Distribution Date; provided, however, that (a) any action with respect to the Puerto Rico Retiree Medical Plan shall not discriminate among the Retiree
Medical Plan Participants and (b) Spinco shall provide the Retiree Medical Plan Participants with a reasonable period of notice prior to any such action. Notwithstanding the right to freeze, amend or terminate the Puerto Rico Retiree Medical
Plan, Spinco shall be required to provide the Retiree Medical Plan Participants with benefits through continued operation of the plan, a cash payment or payments in lieu of benefits or procurement of comparable benefits through a third-party
provider that maximizes the value of any substitute benefit coverage with an aggregate cash cost for such benefits and cash payments to Spinco that is no less than the amount specified on Exhibit 9.02 of this Agreement (the “Total
Cost Amount”). If Spinco elects to satisfy its obligation through a cash payment or payments to the Retiree Medical Plan Participants, the amount of the payment or payments to each Retiree Medical Plan Participant shall equal the allocable
portion of the actuarial value of the benefit that would have otherwise been provided had the plan continued without freeze, amendment or termination (determined based on reasonable actuarial assumptions); provided that, (i) if the Total
Cost Amount would be exceeded (taking into account both the payments and costs incurred by Spinco under the Puerto Rico Retiree Medical Plan with respect to claims paid following the Distribution), the cash payments to each Retiree Medical Plan
Participant shall be reduced on a proportional basis but only to the extent that the Total Cost Amount is not exceeded and (ii) if the Total Cost Amount would not be exceeded (taking into account both the payments and costs incurred by Spinco
under the Puerto Rico Retiree Medical Plan with respect to claims paid following the Distribution), the remaining amount up to the Total Cost Amount shall be allocated on a proportional basis. 

Section 9.03 U.S. Retiree Medical Plan. The Pluto Group shall retain, and no member of the Spinco Group shall assume sponsorship
of, or any Liabilities with respect to, the U.S. Retiree Medical Plan. 
 ARTICLE X 

NON-EQUITY INCENTIVE PRACTICES AND PLANS 

Section 10.01 Corporate Bonus Practices. The Spinco Group shall be responsible for determining all
non-equity bonus awards that would otherwise be payable to Spinco Employees or Former Spinco Employees for any performance periods that are open as of the Distribution Time. The Spinco Group shall also
determine for Spinco Employees or Former Spinco Employees (a) the extent to which established performance criteria (as interpreted by the Spinco Group, in its sole discretion) have been met, and (b) the payment level for each Spinco
Employee 

  
 -27- 

 
or Former Spinco Employee. The Spinco Group shall assume all Liabilities with respect to any such bonus awards payable to Spinco Employees or Former Spinco Employees for any performance periods
that are open as of the Distribution Time and thereafter, and no member of the Pluto Group shall have any obligations with respect thereto. For the avoidance of doubt, the Pluto Group shall assume or retain all Liabilities with respect to any non-equity bonus awards that would otherwise be payable to Pluto Employees or Former Pluto Employees for any performance periods that are open as of the Distribution Time. 

Section 10.02 Spinco Retained Bonus Plans. No later than the Distribution Time, the Spinco Group shall continue to retain (or
assume as necessary) any incentive plan for the exclusive benefit of Spinco Employees and Former Spinco Employees, whether or not sponsored by the Spinco Group, and, from and after the Distribution Time, shall be solely responsible for all
Liabilities thereunder. 
 ARTICLE XI 

EQUITY COMPENSATION AND CERTAIN CASH AWARDS 

Section 11.01 Spinco Stock Plan. Effective as of no later than immediately prior to the Distribution Time, Spinco shall adopt, and
its shareholder shall approve, the Spinco Stock Plan in the form attached as Exhibit 10.1 to Amendment No. 1 to the Registration Statement on Form 10 filed by Spinco with the SEC. 

Section 11.02 Equity Awards and Cash Awards Held by Spinco Employees. 

(a) Vested Awards and Pro Rata Vested Awards. As of immediately prior to the Distribution Time, each Pluto Equity Award and Pluto Cash
Award held by a Spinco Employee (other than any Spinco Delayed Transfer Employee) that is outstanding and unvested shall vest (or, in the case of a performance-based Pluto Equity Award or Pluto Cash Award, the applicable service requirement shall be
deemed satisfied) in respect of a prorated portion of the Pluto Shares or cash subject to such Pluto Equity Award or Pluto Cash Award, as applicable, equal to the product of (i) the total number of Pluto Shares or amount of cash subject
to such Pluto Equity Award or Pluto Cash Award, as applicable, and (ii) a fraction (A) the numerator of which is the number of days elapsed from the applicable date of grant through the day prior to the Distribution Date and
(B) the denominator of which is the total number of days in the vesting period. Each Pluto Equity Award and Pluto Cash Award that is held by a Spinco Employee and that is outstanding and vested immediately prior to the Distribution Time
(including any portion of a Pluto Equity Award or Pluto Cash Award that becomes vested or for which the applicable service requirement is deemed satisfied pursuant to the immediately preceding sentence), shall remain denominated, as of immediately
following the Distribution Time, in Pluto Shares or cash, as applicable, and shall settle according to the existing terms of such Pluto Equity Awards or Pluto Cash Awards, as applicable; provided that Pluto may adjust the terms of Pluto
Equity Awards and Pluto Cash Awards as Pluto determines, in its sole discretion, to be appropriate to preserve the value of such awards as of immediately prior to and immediately following the Distribution Time, which adjustment shall not result in
any Liability to the Spinco Group. Pluto shall retain all Liabilities with respect to each such vested Pluto Equity Award and Pluto Cash Award. 

  
 -28- 

 (b) Unvested Awards. As of immediately prior to the Distribution Time, each Pluto
Equity Award and Pluto Cash Award held by a Spinco Employee (other than any Spinco Delayed Transfer Employee) that is outstanding and unvested and that does not vest pursuant to Section 11.02(a) (or, in the case of a performance-based
Pluto Equity Award or Pluto Cash Award, for which the applicable service requirement is not deemed satisfied), shall be forfeited (the “Forfeited Pluto Equity Awards” and “Forfeited Pluto Cash Awards”). Effective as
of the Distribution Time, Spinco shall grant to each such Spinco Employee a number of restricted stock units pursuant to the Spinco Stock Plan equal to the value of each such Forfeited Pluto Equity Award and Forfeited Pluto Cash Award (each such
award, a “Spinco Make-Whole Award”) pursuant to the terms of the Spinco Stock Plan. For purposes of determining the value of (i) the Forfeited Pluto Equity Awards, the value of a Pluto Share shall be determined based on the
closing price of a Pluto Share at the end of the regular trading session on the principal market for Pluto Shares on the Determination Date and (ii) the Spinco Make-Whole Awards, the value of a Spinco Share shall be determined based on the
closing price of a Utah Ordinary Share at the end of the regular trading session on the principal market for Utah Shares on the Determination Date. Each such Spinco Make-Whole Award generally shall be subject to the same terms and conditions as the
Forfeited Pluto Equity Awards and Forfeited Pluto Cash Awards; provided that (i) the vesting dates of any Spinco Make-Whole Award shall be the same as the vesting dates of the corresponding Forfeited Pluto Equity Award or Forfeited Pluto Cash
Award, as applicable and (ii) the Spinco Make-Whole Award shall vest in full upon a termination of the applicable Spinco Employee’s employment with the Spinco Group based on terms no less favorable than those set forth Section 4.1 of the
Utah Disclosure Schedule to the Business Combination Agreement and with any defined terms to be defined on terms no less favorable than the definitions applicable to the equity awards of similarly situated employees of Utah. Notwithstanding the
foregoing, for purposes of this Section 11.02, with respect to each Spinco Delayed Transfer Employee, references to the Distribution Time (other than for purposes of adjustments to preserve the value of such awards as of immediately prior to
and immediately following the Distribution Time) shall mean the Spinco Delayed Transfer Employee Transfer Date, and any Liability related to any Pluto Equity Award and Pluto Cash Award held by or granted to such Spinco Delayed Transfer Employee
during the Spinco Delayed Employment Period shall be considered a Spinco Liability and be treated in accordance with Section 4.01(d) and the NEB Agreement; provided that if, pursuant to the NEB Agreement or other agreements between the
Parties, the Spinco Group bears any Liabilities contemplated by this sentence, the Spinco Group shall not be required to provide duplicative reimbursement of, or otherwise compensate the Pluto Group for, such Liabilities. 

Section 11.03 Equity Awards Held by Pluto Employees, Former Pluto Employees and Pluto Non-Employee Directors. Each Pluto Equity
Award that is held by a Pluto Employee, Former Pluto Employee or current or former non-employee director of Pluto and that is outstanding immediately prior to the Distribution Time shall remain denominated, as of immediately following the
Distribution Time, in Pluto Shares; provided that Pluto may adjust the terms of Pluto Equity Awards as Pluto determines, in its sole discretion, to be appropriate to preserve the value of such awards as of immediately prior to and immediately
following the Distribution Time, which adjustment shall not result in any Liability to the Spinco Group. Pluto shall retain all Liabilities with respect to each such Pluto Equity Award held by a Pluto Employee, Former Pluto Employee or current or
former non-employee director of Pluto. 

  
 -29- 

 Section 11.04 Necessary Actions. The Parties shall, as soon as practicable after
the date hereof and in no event later than the Business Day immediately prior to the Distribution Date, take all actions as may be necessary to implement the provisions of this Article XI, including adopting any necessary
resolutions. 
 ARTICLE XII 

SEVERANCE, PAID TIME OFF AND HEATING ALLOWANCE 

Section 12.01 Severance. Effective as of no later than the Distribution Time, and except as otherwise provided in
Section 2.03(d), (a) the Spinco Group shall assume and be solely responsible for all Liabilities with respect to redundancy, termination, severance compensation or similar payments or benefits payable or provided to any
Spinco Employee, Spinco Independent Contractor or Former Spinco Service Provider following the Distribution Time, whether arising before, at or after the Distribution Time and (b) the Pluto Group shall retain or assume and be solely responsible
for all Liabilities with respect to redundancy, termination, severance compensation or similar payments or benefits payable or provided to any Pluto Employee, Pluto Independent Contractor or Former Pluto Service Provider, whether arising before, at
or after the Distribution Time. Notwithstanding the foregoing, in the event a Japan Lyrica Employee becomes entitled to severance compensation or benefits as a result of a termination of employment following the Distribution Time, the Spinco Group
shall be responsible for the payment of such compensation or benefits to such Japan Lyrica Employee; provided that, following the date on which Pluto and Utah shall enter into an agreement to unwind the Pluto-Utah Japan Collaboration Agreement, the
Pluto Group shall reimburse the Spinco Group for fifty percent (50%) of such compensation or benefits paid or provided by the Spinco Group to each such Japan Lyrica Employee who is provided written notice of a termination of employment or
eligibility to participate in a voluntary separation program, in each case, at any time between the Distribution Time and the nine (9) month anniversary of the initial entry of generic competition to Lyrica in Japan, in accordance with
Section 14.05 of this Agreement. 
 Section 12.02 Paid Time Off Benefits. Effective as of no later than the Distribution
Time, (a) the Spinco Group shall assume and honor all paid time off of the Spinco Employees and Former Spinco Employees that is accrued as of the Distribution Time and (b) the Pluto Group shall retain or assume and honor all paid time off
of the Pluto Employees and the Former Pluto Employees that is accrued as of the Distribution Time. 
 Section 12.03 Heating
Allowance. Except as otherwise provided in this Section 12.03, effective as of no later than the Distribution Date, the Spinco Group shall assume and be solely responsible for all Liabilities with respect to the heating
allowance for any Spinco Employees or Former Spinco Employees located in China (the “China Heating Allowance”). The Parties may agree to delay all or any portion of the transfer of the China Heating Allowance contemplated by this
Section 12.03 to be effective as of a date coincident with or as soon as practicable following the transfer of a Spinco Delayed Transfer Employee to a member of the Spinco Group or a Delayed Asset with the references to
“Distribution Date” in this Section 12.03 to be the effective date as agreed by the Parties. 

  
 -30- 

 ARTICLE XIII 

RESTRICTIVE COVENANTS 

Section 13.01 Confidentiality and Proprietary Information. No provision of this Agreement, the Separation Agreement or any
Ancillary Agreement shall be deemed to release any individual for any violation of the Pluto non-competition guidelines, non-solicit obligations or any agreement or
policy pertaining to confidential or proprietary information of Pluto or any of its Subsidiaries, or otherwise relieve any individual of his or her obligations under such non-competition guidelines, non-solicit obligations or agreement or policy pertaining to confidential or proprietary information; provided, however, that the employment of any Spinco Employee with Spinco or any member of the
Spinco Group on and following the Distribution Date shall not be a violation of any non-competition guidelines, non-solicit obligations or any agreement or policy
pertaining to confidentiality or proprietary information of any member of the Pluto Group. 
 ARTICLE XIV 

ADMINISTRATIVE PROVISIONS 

Section 14.01 Information Sharing and Access. 

(a) Sharing of Information. Subject to any limitations imposed by applicable Law, each of Pluto and Spinco (acting directly or through
members of the Pluto Group or the Spinco Group, respectively) shall provide to the other Party and its authorized agents and vendors all Information necessary (including Information for purposes of determining benefit eligibility, participation,
vesting, and calculation of benefits) on a timely basis under the circumstances for the Party to perform its duties under this Agreement and applicable Law. Such Information shall include Information relating to equity awards under a Pluto Stock
Plan or the Spinco Stock Plan and Information relating to termination of employment for purposes of distributions under the Pluto Nonqualified Plans. To the extent that such Information is maintained by a third-party vendor, each Party shall use its
commercially reasonable efforts to require the third-party vendor to provide the necessary Information and assist in resolving discrepancies or obtaining missing data. Pluto shall indemnify, defend and hold harmless the Spinco Indemnitees for any
Losses and Liabilities related to or resulting from the failure by any member of the Pluto Group to provide timely and accurate Information prior to, at or after the Distribution Time in accordance with this Agreement, and Spinco shall indemnify,
defend and hold harmless the Pluto Indemnitees for any Losses and Liabilities related to or resulting from the failure of any member of the Spinco Group to provide timely and accurate Information prior to, at or after the Distribution Time in
accordance with this Agreement, in each case, in accordance with Article IV of the Separation Agreement. 

  
 -31- 

 (b) Access to Records. To the extent not inconsistent with this Agreement, the
Separation Agreement or any applicable privacy protection Laws or regulations, reasonable access to Employee-related and benefit plan related records after the Distribution Time shall be provided to members of the Pluto Group and members of the
Spinco Group pursuant to the terms and conditions of Article VI of the Separation Agreement. 
 (c) Maintenance
of Records. With respect to retaining, destroying, transferring, sharing, copying and permitting access to all Employee-related Information, the Pluto Group and the Spinco Group shall comply with all applicable Laws, regulations, the terms of
this Agreement and internal policies, and shall indemnify and hold harmless the other Party and its respective Indemnitees from and against any and all Liability, Actions, and damages that arise from a failure (by the indemnifying Party or its
Subsidiaries or their respective agents) to so comply with all applicable Laws, the terms of this Agreement and internal policies applicable to such Information, in accordance with Article VI of the Separation Agreement.

 (d) Cooperation. Each Party shall use commercially reasonable efforts to cooperate and work together to unify, consolidate and
share (to the extent permissible under applicable privacy/data protection Laws) all relevant documents, resolutions, government filings, data, payroll, employment and benefit plan Information on regular timetables and cooperate as needed with
respect to (i) any claims under or audit of or litigation with respect to any employee benefit plan, policy or arrangement contemplated by this Agreement, (ii) efforts to seek a determination letter, private letter ruling or advisory
opinion from the IRS or U.S. Department of Labor on behalf of any employee benefit plan, policy or arrangement contemplated by this Agreement, (iii) any filings that are required to be made or supplemented to the IRS, U.S. Pension Benefit
Guaranty Corporation, U.S. Department of Labor or any other Governmental Authority, and (iv) any audits by a Governmental Authority or corrective actions, relating to any Benefit Plan, labor or payroll practices; provided,
however, that requests for cooperation must be reasonable and not interfere with daily business operations. 
 (e)
Confidentiality. Notwithstanding anything in this Agreement to the contrary, all confidential records and data relating to Employees to be shared or transferred pursuant to this Agreement shall be subject to Section 6.08 of the
Separation Agreement and the requirements of applicable Law. 
 Section 14.02 Audits Regarding Vendor Contracts. From the period
beginning on the Distribution Date and ending on such date as Pluto and Spinco may mutually agree in writing, Pluto and Spinco and their duly authorized representatives shall have the right to conduct joint audits with respect to any vendor
contracts that relate to both the Pluto Health and Welfare Plans and Spinco Health and Welfare Plans. The scope of such audits shall encompass the review of all correspondence, account records, claim forms, canceled drafts (unless retained by the
bank), provider bills, medical records submitted with claims, billing corrections, vendor’s internal corrections of previous errors and any other documents or instruments relating to the services performed by the vendor under the applicable
vendor contracts. Pluto and Spinco shall agree on the performance standards, audit methodology, auditing policy and quality measures, reporting requirements, and the manner in which costs incurred in connection with such audits will be shared. 

  
 -32- 

 Section 14.03 Fiduciary Matters. Pluto and Spinco each acknowledge that actions
contemplated to be taken pursuant to this Agreement may be subject to fiduciary duties or standards of conduct under ERISA or other applicable Law, and no Party shall be deemed to be in violation of this Agreement if such Party fails to comply with
any provisions hereof based upon such Party’s good faith determination that to do so would violate such a fiduciary duty or standard (as supported by advice from counsel experienced in such matters). Each Party shall be responsible for taking
such actions as are deemed necessary and appropriate to comply with its own fiduciary responsibilities and shall fully release and indemnify the other Party and their respective Indemnitees for any Liabilities caused by the failure to satisfy any
such responsibility, in accordance with Article IV of the Separation Agreement. 
 Section 14.04 Consent
of Third Parties. If any provision of this Agreement is dependent on the consent of any third party (such as a vendor) and such consent is withheld, Pluto and Spinco shall use their commercially reasonable best efforts to implement the
applicable provision. If any provision of this Agreement cannot be implemented due to the failure of such third party to consent, Pluto and Spinco shall negotiate in good faith to implement the provision in a mutually satisfactory manner. 

Section 14.05 Reimbursement of Costs and Expenses. The Parties shall promptly reimburse one another, upon reasonable request of
the Party requesting reimbursement (the “Requesting Party”) as soon as practicable, but in any event within thirty (30) days of receipt of an invoice detailing all costs, expenses and other Liabilities paid or incurred by the
Requesting Party (or any of its Affiliates), and any other substantiating documentation as the other Party shall reasonably request, that are, or have been made pursuant to this Agreement, the responsibility of the other Party (or any of its
Affiliates) including those Liabilities, if any, under Section 6.01(b), Section 6.02(b), Section 8.01, Section 8.05,
Section 15.01 and Section 15.01(b). 
 Section 14.06 Taxes and Filings. The
Parties hereby acknowledge and agree that (a) the members of the Pluto Group shall be solely responsible for all obligations relating to reporting of Employment Taxes to the appropriate Governmental Authority, remitting the amounts of any such
Employment Taxes required to be withheld or paid to the appropriate Governmental Authority and any regulatory filing obligation, in each case, related to any compensation or benefits that are required to be paid or provided by a member of the Pluto
Group pursuant to this Agreement, and (b) the members of the Spinco Group shall be solely responsible for all obligations relating to reporting of Employment Taxes to the appropriate Governmental Authority, remitting the amounts of any such
Employment Taxes required to be withheld or paid to the appropriate Governmental Authority and any regulatory filing obligation, in each case, related to any compensation or benefits that are required to be paid or provided by a member of the Spinco
Group pursuant to this Agreement. Notwithstanding the foregoing, in the event that the Pluto Group or the Spinco Group, as applicable, pays or incurs a cost, expense or other Liability that is, or has been made pursuant to this Agreement, the
responsibility of the other Group, the amount subject to reimbursement in accordance with Section 14.05 shall include the amount of Employment Taxes paid by the first Group in satisfying such obligation. In addition, with
respect to each Spinco Employee and Former Spinco Employee, the Spinco Group shall be responsible for the filing of Form W-2 and Form 1095-C (to the extent applicable to
such Spinco Employee or Former Spinco Employee) in respect of the year in which the Distribution Time occurs. Further, in accordance with and subject to the terms of the Tax Matters Agreement, the Pluto Group shall be entitled to any Tax deduction
available in respect of all Liabilities related to compensation or benefits that it retains or assumes pursuant to this Agreement, and the Spinco Group shall be 

  
 -33- 

 
entitled to any Tax deduction available in respect of all Liabilities related to compensation or benefits that it retains or assumes pursuant to this Agreement. In the event that the treatment
specified in this Section 14.06 does not comply with applicable Law or results in adverse Tax consequences to the Parties or any Employees or Former Employees, the Parties agree to negotiate in good faith alternative
treatment that complies with applicable Law and does not result in adverse Tax consequences to the Parties or any Employees or Former Employees. 

ARTICLE XV 

MISCELLANEOUS 

Section 15.01 Cooperation Relating to Claims. 

(a) Duties of Spinco. Following the Effective Date, Spinco shall cooperate, and shall cause the members of the Spinco Group to cooperate
fully with the members of the Pluto Group in the prosecution, defense and settlement of any claims for which any member of the Pluto Group retains Liability under this Agreement. Such cooperation shall include (i) affording the applicable
member of the Pluto Group, its counsel and its other representatives reasonable access, upon reasonable written notice during normal business hours, to all relevant personnel, properties, books, contracts, commitments and records,
(ii) furnishing promptly to the applicable member of the Pluto Group, its counsel and its other representatives such Information as they reasonably requested, and (iii) providing any other assistance to the applicable member of the Pluto
Group, its counsel and its other representatives as they reasonably request. Pluto shall reimburse Spinco for reasonable costs and expenses incurred in assisting Pluto pursuant to this Section 15.01(a). 

(b) Duties of Pluto. Following the Effective Date, Pluto shall cooperate, and shall cause the members of the Pluto Group to cooperate
fully with the members of the Spinco Group in the prosecution, defense and settlement of any claims for which any member of the Spinco Group assumes Liability under this Agreement. Such cooperation shall include (i) affording the applicable
member of the Spinco Group, its counsel and its other representatives reasonable access, upon reasonable written notice during normal business hours, to all relevant personnel, properties, books, contracts, commitments and records,
(ii) furnishing promptly to the applicable member of the Spinco Group, its counsel and its other representatives such Information as they reasonably request, and (iii) providing any other assistance to the applicable member of the Spinco
Group, its counsel and its other representatives as they reasonably request. Spinco shall reimburse Pluto for reasonable costs and expenses incurred in assisting Spinco pursuant to this Section 15.01(b). 

Section 15.02 No Third-Party Beneficiaries. Nothing expressed or implied in this Agreement is intended or shall be construed to
confer upon or give any Person, other than the Parties, any rights or remedies under or by reason of this Agreement, except for the indemnification rights under the Separation Agreement of any Pluto Indemnitee or Spinco Indemnitee in their
respective capacities as such (which is intended to be for the benefit of the Persons covered thereby and may be enforced by such Persons); provided that Utah shall be a third party beneficiary of the rights of Utah as expressly set forth in
this Agreement. Nothing in this Agreement is intended to amend any employee benefit plan or affect the applicable plan 

  
 -34- 

 
sponsor’s right to amend or terminate any employee benefit plan pursuant to the terms of such plan. The provisions of this Agreement are solely for the benefit of the Parties, and no Service
Provider or Former Service Provider, officer, director, or independent contractor or any other individual associated therewith shall be regarded for any purpose as a third-party beneficiary of this Agreement. 

Section 15.03 Survival of Covenants. Except as expressly set forth in this Agreement, any other Ancillary Agreement, the
Separation Agreement or the Business Combination Agreement, the covenants contained in this Agreement, indemnification obligations and liability for the breach of any obligations contained herein shall survive the Distribution Time and the other
transactions contemplated by the Separation Agreement shall remain in full force and effect in accordance with their terms. 

Section 15.04 Notices. All notices and other communications among the Parties and Utah shall be in writing and shall be deemed to
have been duly given (a) when delivered in person, (b) when delivered after posting in the national mail having been sent registered or certified mail return receipt requested, postage prepaid, (c) when delivered by FedEx or other
internationally recognized overnight delivery service or (d) when delivered by facsimile (solely if receipt is confirmed) or email (so long as the sender of such email does not receive an automatic reply from the recipient’s email server
indicating that the recipient did not receive such email), addressed as follows: 
 If to Pluto, to: 

Pfizer Inc. 
 235 East 42nd
Street 
 New York, New York 10017 

Attention:    Douglas M. Lankler 

        Bryan A. Supran 

Facsimile:   (212) 573-0768 

Email:         douglas.lankler@pfizer.com 

        bryan.supran@pfizer.com 

with a copy (which shall not constitute notice) to: 

Wachtell, Lipton, Rosen & Katz 

51 West 52nd Street 
 New York,
New York 10019 
 Attention:    Edward D. Herlihy 

        David K. Lam 

        Gordon S. Moodie 

        Zachary S. Podolsky 

Facsimile:   (212) 403-2000 

Email:         EDHerlihy@WLRK.com 

        DKLam@WLRK.com 

        GSMoodie@WLRK.com 

        ZSPodolsky@WLRK.com 

  
 -35- 

 If to Spinco, to: Viatris Inc. 

1000 Mylan Boulevard 

Canonsburg, PA 15317 

Attention:     Michael Goettler 

Email:           michael.goettler@viatris.com 

with copies (which shall not constitute notice) to: 

Viatris Inc. 
 1000 Mylan
Boulevard 
 Canonsburg, PA 15317 

Attention: Brian S. Roman, Global General Counsel 

Facsimile:     (724) 514-1871 

Email:           Brian.Roman@viatris.com 

Cravath, Swaine & Moore LLP 

825 8th Ave New York, 
 New York
10019 
 Attention:     Mark I. Greene 

        Thomas E. Dunn 

        Aaron M. Gruber 

Email:          mgreene@cravath.com 

        tdunn@cravath.com 

        agruber@cravath.com 

If to Utah, to: 
 Viatris Inc.

 1000 Mylan Boulevard 

Canonsburg, PA 15317 

Attention:     Michael Goettler 

Email:          michael.goettler@viatris.com 

with copies (which shall not constitute notice) to: 

Viatris Inc. 1000 Mylan Boulevard 

Canonsburg, PA 15317 

Attention:     Brian S. Roman, Global General Counsel 

Facsimile:   (724) 514-1871 

Email:           Brian.Roman@viatris.com

  
 -36- 

 
Cravath, Swaine & Moore LLP 
 825 8th Ave 

New York, New York 10019 

Attention:    Mark I. Greene 

        Thomas E. Dunn 

        Aaron M. Gruber 

Email:         mgreene@cravath.com 

        tdunn@cravath.com 

        agruber@cravath.com 

or to such other address or addresses as the Parties and Utah may from time to time designate in writing by like notice. 

Section 15.05 Amendments and Waivers. No provisions of this Agreement shall be deemed waived, amended, supplemented or modified by
any Party, unless such waiver, amendment, supplement or modification is in writing and signed by the authorized representative of the Party against whom it is sought to enforce such waiver, amendment, supplement or modification. In addition, prior
to the Distribution Date, any such waiver, amendment, supplementation or modification shall be subject to the prior written consent of Utah. 

Section 15.06 Governing Law Jurisdiction; WAIVER OF JURY TRIAL. 

(a) Unless expressly provided by this Agreement, this Agreement and all Actions (whether in contract or tort) that may be based upon, arise out
of or relate to this Agreement or the negotiation, execution or performance hereof or thereof shall be governed by and construed in accordance with the Law of the State of Delaware, without regard to any Laws or the principles thereof that would
result in the application of the Laws of any other jurisdiction. The Parties expressly waive any right they may have, now or in the future, to demand or seek the application of a governing Law other than the Law of the State of Delaware. 

(b) Subject to the provisions of Article VII of the Separation Agreement, each of the Parties hereby irrevocably and unconditionally
submits, to the exclusive jurisdiction of the Court of Chancery of the State of Delaware or, if such court shall not have jurisdiction, the United States District Court for the District of Delaware, or, if such court shall not have jurisdiction, the
other state courts of the State of Delaware, and any appellate court from any appeal thereof, in any Action arising out of or relating to this Agreement or the transactions contemplated hereby, and each of the Parties hereby irrevocably and
unconditionally (i) agrees not to commence any such Action except in such courts, (ii) agrees that any claim in respect of any such Action may be heard and determined in the Court of Chancery of the State of Delaware or, to the extent
permitted by Law, in such other courts, (iii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Action in the Court of Chancery of the State
of Delaware or such other courts, (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such Action in the Court of Chancery of the State of Delaware or such other courts and
(v) consents to service of process in the manner provided for notices in Section 10.02 of the Separation Agreement. Nothing in this Agreement will affect the right of any Party to serve process in any other manner permitted by Law. 

  
 -37- 

 (c) EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS
AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO
THIS AGREEMENT, ANY OF THE ANCILLARY AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING THE SPINCO FINANCING ARRANGEMENTS). EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER
PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS
VOLUNTARILY AND (IV) IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 15.06(c). 

(d) Any controversy, dispute or claim arising out of, in connection with, or in relation to the interpretation, performance, nonperformance,
validity, termination or breach of this Agreement or otherwise arising out of, or in any way related to this Agreement or the transactions contemplated hereby and thereby shall be subject to the dispute resolution procedures set forth in
Article VII of the Separation Agreement. 
 Section 15.07 Assignment; Parties in Interest. No Party may assign its rights
or delegate its duties under this Agreement without the written consent of the other Parties and, prior to the Distribution Date, Spinco may not assign its rights or delegate its duties under this Agreement without the prior written consent of Utah.
Any attempted assignment or delegation in breach of this Section 15.07 shall be null and void. 

Section 15.08 Captions; Counterparts. The captions in this Agreement are for convenience only and shall not be considered a part
of or affect the construction or interpretation of any provision of this Agreement. This Agreement may be executed in two (2) or more counterparts (including by electronic or .pdf transmission), each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument. Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature page. 

Section 15.09 Entire Agreement; Conflicting Agreements. 

(a) The Separation Agreement, this Agreement, the other Ancillary Agreements, and the Business Combination Agreement, including any related
annexes, Exhibits and Schedules, as well as any other agreements and documents referred to herein and therein, shall together constitute the entire agreement between the Parties relating to the transactions contemplated hereby and supersede any
other agreements, whether written or oral, that may have been made or entered into by or among any of the Parties or any of their respective Affiliates relating to the transactions contemplated hereby. 

  
 -38- 

 (b) Severability. If any provision of this Agreement, or the application of any
provision to any Person or circumstance, is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The Parties further agree that if any provision contained
herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent
permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the
Parties. 
 (c) Specific Performance. Subject to the provisions of Article VII of the Separation Agreement, in the event of any actual
or threatened default in, or breach of, any of the terms, conditions and provisions of this Agreement, the Party who is, or is to be, thereby aggrieved shall have the right to specific performance and injunctive or other equitable relief in respect
of its rights under this Agreement or such Ancillary Agreement without the necessity of proving actual damages or the inadequacy of monetary damages as a remedy, in addition to any other remedy to which such Party is entitled hereunder (unless this
Agreement prohibits or otherwise limits any rights to specific performance and injunctive or other equitable relief). The Parties agree that the remedies at law for any breach or threatened breach, including monetary damages, are inadequate
compensation for any loss hereunder or default herein or breach hereof and that any defense in any Action for specific performance that a remedy at law would be adequate is waived. Any requirements for the securing or posting of any bond with such
remedy are waived by each of the Parties. Notwithstanding Section 15.06(d) and the first sentence of this Section 15.09(c), each Party shall have the right to seek specific performance and injunctive or other
equitable relief in respect of its rights under this Agreement without regard to the provisions set forth in Article VII of the Separation Agreement if reasonably necessary to avoid jeopardizing or forfeiting its ability to
obtain such equitable relief. 
 (d) No Set-Off. Except as set forth in the Business
Combination Agreement, this Agreement, any other Ancillary Agreement or as otherwise mutually agreed to in writing by the Parties, neither Party nor any member of its Group shall have any right of set-off or
other similar rights with respect to any amount required to be paid under this Agreement by such Party or such member of its Group, on the one hand, to the other Party or any member of such other Party’s Group, on the other hand. 

(e) Late Payments. Any amounts billed or otherwise invoiced or demanded and properly payable that are not paid within thirty
(30) days of the due date therefor pursuant to this Agreement shall accrue interest from such due date at a rate per annum equal to the Prime Rate. 

(f) Expenses. Except as otherwise specified in the Separation Agreement, the Business Combination Agreement, this Agreement or the
Ancillary Agreements, and except as otherwise agreed in writing between the Parties, each Party and the members of its Group shall each be responsible for their own fees, costs and expenses paid or incurred in connection with the Transactions. The
Parties agree that certain specified costs and expenses shall be allocated between the Parties as set forth on Schedule 10.12 to the Separation Agreement. 

  
 -39- 

 (g) Waivers of Default. Waiver by any Party of any default by the other Party of any
provision of this Agreement shall not be deemed a waiver by the waiving Party of any subsequent or other default, nor shall it prejudice the rights of the other Party. No failure or delay by a Party in exercising any right, power or privilege under
this Agreement shall operate as a waiver thereof, nor shall a single or partial exercise thereof prejudice any other or further exercise thereof or the exercise of any other right, power or privilege. In addition, unless the Business Combination
Agreement shall have been terminated in accordance with its terms, as set forth in the Business Combination Agreement, prior to the Distribution Date, any such waiver by Spinco shall be subject to the written consent of Utah. 

Section 15.10 Interpretation. 

(a) Unless the context of this Agreement otherwise requires: 

(i) (A) words of any gender include each other gender and neuter form; (B) words using the singular or plural number also include the
plural or singular number, respectively; (C) derivative forms of defined terms will have correlative meanings; (D) the terms “hereof,” “herein,” “hereby,” “hereto,” “herewith,”
“hereunder” and derivative or similar words refer to this entire Agreement; (E) the terms “Article,” “Section,” “Annex,” “Exhibit,” “Schedule,” and “Disclosure Schedule”
refer to the specified Article, Section, Annex, Exhibit, Schedule or Disclosure Schedule of this Agreement and references to “paragraphs” or “clauses” shall be to separate paragraphs or clauses of the Section or subsection in
which the reference occurs; (F) the words “include,” “includes” and “including” shall be deemed to be followed by the phrase “without limitation”; (G) the word “or” shall be disjunctive but not
exclusive; and (H) the word “from” (when used in reference to a period of time) means “from and including” and the word “through” (when used in reference to a period of time) means “through and
including”; 
 (ii) references to any federal, state, local, or foreign statute or Law shall (A) include all rules and regulations
promulgated thereunder and (B) be to that statute or Law as amended, modified or supplemented from time to time; and 
 (iii) references
to any Person include references to such Person’s successors and permitted assigns, and in the case of any Governmental Authority, to any Person succeeding to its functions and capacities. 

(b) The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent. The Parties
acknowledge that each Party and its attorney has reviewed and participated in the drafting of this Agreement and that any rule of construction to the effect that any ambiguities are to be resolved against the drafting Party, or any similar rule
operating against the drafter of an agreement, shall not be applicable to the construction or interpretation of this Agreement. 
 (c)
Whenever this Agreement refers to a number of days, such number shall refer to calendar days unless Business Days are specified. If any action is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day,
then such action may be deferred until the next Business Day. 

  
 -40- 

 (d) The phrase “to the extent” shall mean the degree to which a subject or other
thing extends, and such phrase shall not mean simply “if.” 
 (e) The terms “writing,” “written” and comparable
terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. 
 (f) All monetary
figures shall be in United States dollars unless otherwise specified. 
 [Signature Page Follows] 

  
 -41- 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives. 
  

			
	PFIZER INC.
		
	By:	 	 /s/ Douglas E. Giordano

		 	Name: Douglas E. Giordano
		 	 Title: Senior Vice President, Worldwide Business

          Development

	
	UPJOHN INC.
		
	By:	 	 /s/ Sanjeev Narula

		 	Name: Sanjeev Narula
		 	Title: Authorized OfficerEX-10.5

 Exhibit 10.5 

EXECUTION VERSION 

MANUFACTURING AND SUPPLY AGREEMENT 

BY AND BETWEEN 
 PFIZER
INC. 
 AND 

UPJOHN INC. 
 DATED AS
OF NOVEMBER 16, 2020 
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	 1. DEFINITIONS
	  	 	1	 
		
	 2. SUPPLY OF PRODUCT
	  	 	13	 
			
	 2.1
	  	Agreement to Supply	  	 	13	 
	 2.2
	  	Use of Facility, Equipment, Molds and Tooling	  	 	15	 
	 2.3
	  	Capacity	  	 	16	 
	 2.4
	  	Forecasts and Purchase Orders	  	 	16	 
	 2.5
	  	Failure to Supply	  	 	19	 
	 2.6
	  	Delivery; Risk of Loss	  	 	21	 
	 2.7
	  	Procurement of Materials	  	 	22	 
	 2.8
	  	Product Samples	  	 	23	 
	 2.9
	  	Storage	  	 	23	 
	 2.10
	  	Transitional Support	  	 	24	 
		
	 3. PRICE; PAYMENT; PRICE
ADJUSTMENTS; TAXES
	  	 	26	 
			
	 3.1
	  	Price	  	 	26	 
	 3.2
	  	Price Adjustment	  	 	27	 
	 3.3
	  	Cost Improvement	  	 	31	 
	 3.4
	  	Price Review and Audit Procedure	  	 	31	 
	 3.5
	  	Invoices and Payment	  	 	32	 
	 3.6
	  	Taxes	  	 	33	 
	 3.7
	  	No Duplicative Payments	  	 	35	 
		
	 4. MANUFACTURING STANDARDS AND
QUALITY ASSURANCE
	  	 	35	 
			
	 4.1
	  	Quality Agreement	  	 	35	 
	 4.2
	  	Manufacturing Standards	  	 	35	 
	 4.3
	  	Manufacturing Changes	  	 	36	 
	 4.4
	  	Pest Control	  	 	36	 
	 4.5
	  	Legal and Regulatory Filings and Requests	  	 	37	 
	 4.6
	  	Quality Tests and Checks	  	 	37	 
	 4.7
	  	Responsibility for Non-Complying Product	  	 	38	 
	 4.8
	  	Rejection of Non-Complying Product	  	 	38	 
	 4.9
	  	Disposal of Rejected and Non-Complying Product	  	 	40	 
	 4.10
	  	Maintenance and Retention of Records	  	 	40	 
	 4.11
	  	Government Inspections, Seizures and Recalls	  	 	40	 
	 4.12
	  	Inspections	  	 	41	 
	 4.13
	  	Segregation of Restricted Compounds	  	 	42	 
	 4.14
	  	Packaging Material	  	 	43	 
		
	 5. COVENANTS
	  	 	43	 
			
	 5.1
	  	Mutual Covenants	  	 	43	 
	 5.2
	  	Manufacturer Covenants	  	 	44	 
	 5.3
	  	Manufacturer’s Social Responsibility	  	 	46	 

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	 5.4
	  	Notice of Material Events	  	 	47	 
	 5.5
	  	Disclaimer of Warranties	  	 	47	 
		
	 6. ENVIRONMENTAL COVENANTS
	  	 	47	 
			
	 6.1
	  	Compliance with Environmental Laws	  	 	47	 
	 6.2
	  	Permits, Licenses and Authorization	  	 	47	 
	 6.3
	  	Generation of Hazardous Wastes	  	 	48	 
	 6.4
	  	Environmental Sustainability Information	  	 	48	 
	 6.5
	  	Environmental and Health and Safety Reviews	  	 	49	 
		
	 7. TERM; TERMINATION
	  	 	49	 
			
	 7.1
	  	Term of Agreement	  	 	49	 
	 7.2
	  	Term of Facility Addendum	  	 	50	 
	 7.3
	  	Termination for Cause	  	 	50	 
	 7.4
	  	Termination for Disposition of Facility	  	 	50	 
	 7.5
	  	Termination in Event of Insolvency	  	 	51	 
	 7.6
	  	Termination for Breach of Anti-Bribery Representation	  	 	51	 
	 7.7
	  	Termination for Convenience by Customer	  	 	52	 
	 7.8
	  	Effect of Termination or Expiration	  	 	52	 
	 7.9
	  	Unused Materials	  	 	53	 
	 7.10
	  	Return of Materials, Tools and Equipment	  	 	54	 
		
	 8. INTELLECTUAL PROPERTY
	  	 	55	 
			
	 8.1
	  	Customer’s Intellectual Property	  	 	55	 
	 8.2
	  	Improvements and Developments	  	 	55	 
	 8.3
	  	Ownership of Other Property	  	 	56	 
	 8.4
	  	Limited Right to Use	  	 	56	 
		
	 9. JOINT ADVISORY COMMITTEE
	  	 	56	 
			
	 9.1
	  	Formation and Role	  	 	56	 
	 9.2
	  	Membership; Chairs	  	 	57	 
	 9.3
	  	Meetings	  	 	57	 
	 9.4
	  	Areas of Responsibility	  	 	58	 
	 9.5
	  	Advisory Role; No Decision-Making Authority	  	 	58	 
		
	 10. INDEMNIFICATION; LIMITATIONS OF
LIABILITY
	  	 	58	 
			
	 10.1
	  	Indemnification of Customer	  	 	58	 
	 10.2
	  	Indemnification of Manufacturer	  	 	59	 
	 10.3
	  	Indemnification Procedures	  	 	60	 
	 10.4
	  	Limitations on Liability	  	 	62	 
	 10.5
	  	Indemnification Obligations Net of Insurance Proceeds and Other Amounts	  	 	63	 
	 10.6
	  	Additional Matters	  	 	64	 

  
 -ii- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
		
	 11. INSURANCE
	  	 	65	 
			
	 11.1
	  	Requirements to Maintain	  	 	65	 
	 11.2
	  	Amounts and Limits	  	 	65	 
		
	 12. CUSTOMER-SUPPLIED MATERIALS;
BUY-SELL MATERIALS; TRANSITION
	  	 	66	 
			
	 12.1
	  	Supply; Rejection; Transition	  	 	66	 
	 12.2
	  	Title and Risk of Loss	  	 	68	 
	 12.3
	  	Reimbursement for Loss of Customer-Supplied Materials	  	 	68	 
		
	 13. CONFIDENTIALITY
	  	 	69	 
		
	 14. SUPPLY CHAIN SECURITY
	  	 	69	 
			
	 14.1
	  	Supply Chain Representations	  	 	69	 
	 14.2
	  	C-TPAT	  	 	69	 
		
	 15. RECORDS AND AUDITS
	  	 	70	 
			
	 15.1
	  	Records	  	 	70	 
	 15.2
	  	Audits	  	 	70	 
		
	 16. AG AND BRANDED PRODUCT
SUPPLY AGREEMENT
	  	 	71	 
		
	 17. NOTICES
	  	 	71	 
		
	 18. MISCELLANEOUS
	  	 	73	 
			
	 18.1
	  	Negotiations of Dispute	  	 	73	 
	 18.2
	  	Publicity	  	 	73	 
	 18.3
	  	Governing Law and Venue	  	 	73	 
	 18.4
	  	Relationship of the Parties	  	 	74	 
	 18.5
	  	Assignment; Binding Effect	  	 	75	 
	 18.6
	  	Force Majeure	  	 	76	 
	 18.7
	  	Severability	  	 	76	 
	 18.8
	  	Non-Waiver; Remedies	  	 	76	 
	 18.9
	  	Further Documents	  	 	77	 
	 18.10
	  	Forms	  	 	77	 
	 18.11
	  	Headings; Interpretation	  	 	77	 
	 18.12
	  	Rules of Construction	  	 	78	 
	 18.13
	  	Counterparts	  	 	78	 
	 18.14
	  	Amendments	  	 	78	 
	 18.15
	  	Entire Agreement	  	 	79	 
	 18.16
	  	Non-Disturbance	  	 	79	 

  

			
	Attachment A	  	Form of Facility Addendum
	Attachment B	  	Quality Agreement
	Attachment C	  	Monthly Inventory Report
	Attachment D	  	Anti-Bribery and Anti-Corruption Principles
	Attachment E	  	Policies
	Attachment F	  	Example Product Materials Adjustment Calculation
	Attachment G	  	Example Price Calculation of Volume Change Pricing Adjustment

  
 -iii- 

 MANUFACTURING AND SUPPLY AGREEMENT 

THIS MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated as of November 16, 2020 (the “Effective
Date”), is by and between Pfizer Inc., a Delaware corporation (hereinafter “Manufacturer”), and Upjohn Inc., a Delaware corporation (hereinafter “Customer”). Manufacturer and Customer may be referred to
herein individually as a “Party” or collectively as the “Parties”. 
 W I T N E S S E T H: 

WHEREAS, Pfizer Inc. (“Pluto”) and Upjohn Inc. (“Spinco”) have entered into a Separation and Distribution
Agreement, dated as of July 29, 2019 (as amended, modified or supplemented from time to time in accordance with its terms, the “Separation Agreement”), pursuant to which Pluto and Spinco have agreed to separate the Spinco
Business from the Pluto Business so that, as of the Distribution Date, the Spinco Business shall be held by members of the Spinco Group and the Pluto Business is held by members of the Pluto Group (the “Separation”); 

WHEREAS, after the Separation, Spinco shall become a standalone publicly traded company, pursuant to the terms of the Separation Agreement and
a Business Combination Agreement, dated as of July 29, 2019 (the “Business Combination Agreement”), by and among Pluto, Spinco, Mylan N.V., a public company with limited liability incorporated under the laws of the Netherlands,
and certain of their Affiliates; 
 WHEREAS, in connection with the Separation, the Parties are entering into an Authorized Generic and
Branded Product Supply and Distribution Agreement (the “AG and Branded Product Supply Agreement”), pursuant to which Manufacturer shall manufacture and supply certain authorized generic and branded pharmaceutical products to
Customer and Customer may commercialize such products on the terms and subject to the conditions set forth therein; and 
 WHEREAS, in
connection with the Separation, the Parties are entering into this Agreement, pursuant to which Customer desires to procure from Manufacturer, and Manufacturer desires to supply or cause one of its Affiliates to supply to Customer, Products for sale
by Customer or its Affiliates in the Territory during the Term, upon the terms and subject to the conditions set forth herein. 
 NOW,
THEREFORE, in consideration of these premises and the covenants and agreements set forth herein, and intending to be legally bound thereby, the Parties hereby agree as follows: 

 

	1.	 Definitions. 

As used in this Agreement, the following capitalized terms shall have the meanings set forth below. Capitalized terms not otherwise defined in
this Agreement shall have the meanings ascribed to such terms in the Separation Agreement. 
  

	 	1.1	 “Accounting Method” means U.S. Generally Accepted Accounting Principles (GAAP) or, if
otherwise agreed by the Parties, an alternative accounting method used in the ordinary course of business.

	 	1.2	 “Act” means the U.S. Federal Food, Drug, and Cosmetic Act, as amended. 

 

	 	1.3	 “Action” means any demand, action, claim, dispute, suit, countersuit, arbitration, inquiry,
subpoena, proceeding or investigation of any nature (whether criminal, civil, legislative, administrative, regulatory, prosecutorial or otherwise) by or before any federal, state, local, foreign or international Governmental Authority or any
arbitration or mediation tribunal. 

  

	 	1.4	 “Additional Quantities” shall have the meaning set forth in
Section 2.4(c). 

  

	 	1.5	 “Affected Products” shall have the meaning set forth in
Section 10.4(a). 

  

	 	1.6	 “Affiliate(s)” means, when used with respect to a specified Person, a Person that controls, is
controlled by, or is under common control with such specified Person. As used herein, “control” (including, with correlative meanings, “controlled by” and “under common control with”), when used with respect to
any specified Person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or other interests, by contract,
agreement, obligation, indenture, instrument, lease, promise, arrangement, release, warranty, commitment, undertaking or otherwise. It is expressly agreed that, from and after the Effective Date, solely for purposes of this Agreement (a) each
member of the Spinco Group shall be deemed to not be an Affiliate of any member of the Pluto Group and (b) each member of the Pluto Group shall be deemed to not be an Affiliate of any member of the Spinco Group. 

 

	 	1.7	 “AG and Branded Product Supply Agreement” shall have the meaning set forth in the Recitals.

  

	 	1.8	 “Agreement” shall have the meaning set forth in the Preamble. 

 

	 	1.9	 “API” means active pharmaceutical ingredient. 

 

	 	1.10	 “Batch Size” shall have the meaning set forth in Section 2.4(e)(ii).

  

	 	1.11	 “Binding Forecast Period” shall have the meaning set forth in
Section 2.4(b). 

  

	 	1.12	 “Bulk Drug Product” means Product that has been manufactured into a final pharmaceutical
product following a specific formulation and set of specifications, including drug substance (e.g., tablets or granules) for administration to humans but has not been packaged for use or for commercialization. 

 

	 	1.13	 “Business Combination Agreement” shall have the meaning set forth in the Recitals.

  

	 	1.14	 “Business Day” means (a) any day other than a Saturday, Sunday or a day on which banking
institutions are authorized or obligated by Law to be closed in New York, New York or (b) with respect to those activities specific to a Facility, any day other than any day on which banks located in the city and country in which the Facility
is located are authorized or obligated to be closed. 

  
 -2- 

	 	1.15	 “Buy-Sell Materials” means the materials that Customer
sells to Manufacturer for use in manufacturing Product for Customer under the terms of this Agreement and as set forth in the applicable Facility Addendum. For the avoidance of doubt, Buy-Sell Materials are
distinguishable from and exclusive of both Product Materials and Customer-Supplied Materials. 

  

	 	1.16	 “Conflict Minerals” shall have the meaning set forth in
Section 5.3(c). 

  

	 	1.17	 “Conversion Cost Markup” shall have the meaning set forth in
Section 2.5(e). 

  

	 	1.18	 “Conversion Costs” means, with respect to a given Product, (a) direct and indirect labor
costs, (b) equipment costs, including depreciation, (c) laboratory and quality control costs at the applicable Facility, including Product testing and on-going stability studies, (d) quality
assurance costs, (e) general site and manufacturing support costs for resources that support the manufacture of the applicable Product (including utilities, warehousing, consumables, maintenance, engineering, safety, human resources, finance,
information technology, plant management and other similar activities, capital improvements in the form of depreciation, an allocation of costs for above site services provided to the applicable Facility for resources that support the manufacture of
the applicable Product and an allowance for inventory loss, in each case, at the Facility-level), (f) costs paid to Third Party manufacturers for the manufacture and supply of such Product (or components thereof), (g) all costs associated with the
performance of Manufacturer’s obligations under Section 4.6, including all activities, tests and checks set forth therein, and (h) costs paid to Third Party contractors for services provided in connection with the
manufacture and supply of such Product, in each case associated with such Product. 

  

	 	1.19	 “CPP” shall have the meaning set forth in Section 4.5(a).

  

	 	1.20	 “C-TPAT” means the Customs-Trade Partnership Against
Terrorism program of the U.S. Bureau of Customs and Border Protection. 

  

	 	1.21	 “C-TPAT Benefits” means the expected benefit afforded
to importers that have joined C-TPAT related to substantially fewer of their imports being inspected and, hence, fewer supply chain delays. 

 

	 	1.22	 “Current Good Manufacturing Practices” or “cGMP” means all applicable
standards and applicable Laws (as defined below) relating to manufacturing practices for products (including ingredients, testing, storage, handling, intermediates, bulk and finished products) promulgated by the FDA or any other applicable
Governmental Authority (including, without limitation, EU or member state level) having jurisdiction, including, but not limited to, standards in the form of applicable Laws, guidelines, advisory opinions and compliance policy guides and current
interpretations of the applicable authority or agency thereof (as applicable to pharmaceutical and biological products and ingredients), as the same may be updated, supplemented or amended from time to time. 

  
 -3- 

	 	1.23	 “Customer” shall have the meaning set forth in the Preamble. 

 

	 	1.24	 “Customer Indemnified Party” shall have the meaning set forth in
Section 10.1(a). 

  

	 	1.25	 “Customer-Owned Improvements and Developments” shall have the meaning set forth in
Section 8.2(b). 

  

	 	1.26	 “Customer Property” means all Intellectual Property, together with all materials, data,
writings and other property in any form whatsoever, which is (a) owned or controlled by Customer or its Affiliates as of and following the Effective Date and (b) provided to Manufacturer by or on behalf of Customer or its Personnel under
this Agreement. 

  

	 	1.27	 “Customer-Supplied Materials” means the materials supplied by Customer to Manufacturer under
the terms of this Agreement and as set forth in the applicable Facility Addendum. For the avoidance of doubt, Customer-Supplied Materials are distinguishable from and exclusive of both Product Materials and
Buy-Sell Materials. 

  

	 	1.28	 “Delivery” shall have the meaning set forth in Section 2.6(a).

  

	 	1.29	 “Developments” shall have the meaning set forth in Section 8.2(a).

  

	 	1.30	 “Effective Date” shall have the meaning set forth in the Preamble. 

 

	 	1.31	 “Environmental Laws” means any Laws relating to (a) human or occupational health and
safety; (b) pollution or protection of the environment (including ambient air, indoor air, water vapor, surface water, groundwater, wetlands, drinking water supply, land surface or subsurface strata, biota and other natural resources); or
(c) exposure to, or use, generation, manufacture, processing, management, treatment, recycling, storage, disposal, emission, discharge, transport, distribution, labeling, presence, possession, handling, Release or threatened Release of, any
hazardous or toxic material, substance or waste and any Laws relating to recordkeeping, notification, disclosure, registration and reporting requirements respecting hazardous or toxic materials, substances or wastes. 

 

	 	1.32	 “Environmental Liability” means any Liability arising under Environmental Laws.

  

	 	1.33	 “Exclusive Purchase Requirement” means, on a Product SKU-by-Product SKU and country-by country basis within the applicable Territory, (a) in the first two (2) years of the Initial Term, one hundred percent
(100%) of Customer’s total requirements for such Product SKU and (b) in the third (3rd) year of the Initial Term, fifty percent (50%) of Customer’s total requirements for such Product SKU; provided, however, that
(x) such quantities of Product reasonably procured by Customer to qualify a back-up supplier for such Product shall be excluded from the Exclusive Purchase Requirement, and (y) for the avoidance of
doubt, Customer may commercialize such quantities of Product procured under (x) above without violating the applicable Exclusive Purchase Requirement or related provisions in Section 2.1(e). 

  
 -4- 

	 	1.34	 “Exclusive Purchase Requirement Suspension Period” shall have the meaning set forth in
Section 2.5(b). 

  

	 	1.35	 “Exclusivity Period” means the three (3) year period immediately following the Effective
Date, as such period may be earlier terminated pursuant to this Agreement. 

  

	 	1.36	 “Extension Period” shall have the meaning (a) with respect to this Agreement, as set
forth in Section 7.1 and (b) with respect to a Facility Addendum, as set forth in Section 7.2. 

  

	 	1.37	 “Facility” means, with respect to a given Product, Manufacturer’s manufacturing facility
located at the address set forth in the applicable Facility Addendum for such Product and such other facilities permitted pursuant to this Agreement and any applicable Facility Addendum to be used by Manufacturer in the manufacture, packaging or
storage of (a) such Product or (b) materials utilized in the manufacture or storage of such Product hereunder. 

  

	 	1.38	 “Facility Addendum” means a document executed by the Parties or their respective Affiliates
for one or more Products to be manufactured in a Facility pursuant to this Agreement, which shall be substantially in the form of Attachment A to this Agreement. 

 

	 	1.39	 “Facility Conversion Cost” means, with respect to a given Facility and Fiscal Year, the sum of
all Product Conversion Costs for Products manufactured for Customer or the applicable Affiliate of Customer at such Facility during such Fiscal Year. 

  

	 	1.40	 “Facility Conversion Cost Adjustment Fiscal Year” shall have the meaning set forth in
Section 3.2(b)(i). 

  

	 	1.41	 “Facility Conversion Cost Baseline Fiscal Year” shall have the meaning set forth in
Section 3.2(b)(i). 

  

	 	1.42	 “Facility Conversion Cost Threshold” shall have the meaning set forth in
Section 3.2(b)(i). 

  

	 	1.43	 “Facility Disposition” shall have the meaning set forth in
Section 7.4. 

  

	 	1.44	 “Facility Actual Product Materials Cost” means, with respect to a given Facility and Fiscal
Year, the sum of all actual costs of Product Materials for Products manufactured for Customer or the applicable Affiliate of Customer at such Facility during such Fiscal Year. 

  
 -5- 

	 	1.45	 “Facility Estimated Product Materials Cost” means, with respect to a given Facility and Fiscal
Year, the sum of all estimated costs, as determined in good faith by Manufacturer and notified to Customer prior to the beginning of such Fiscal Year, of Product Materials for Products manufactured for Customer or the applicable Affiliate of
Customer at such Facility during such Fiscal Year. 

  

	 	1.46	 “Familial Relative(s)” means a parent, spouse, child or sibling (including any such
relationships formed by marriage). 

  

	 	1.47	 “FDA” means the U.S. Food and Drug Administration or any successor agency.

  

	 	1.48	 “Finished Product” means Product that has been packaged for commercialization and distribution
to patients incorporating Bulk Drug Product. 

  

	 	1.49	 “Firm Order” shall have the meaning set forth in Section 2.4(b).

  

	 	1.50	 “Fiscal Year” means each twelve-month fiscal period commencing on January 1 with respect
to Facilities located in the United States and December 1 for all other facilities, in each case, during the Term. 

  

	 	1.51	 “Force Majeure Event” shall have the meaning set forth in
Section 18.6. 

  

	 	1.52	 “Forecast” shall have the meaning set forth in Section 2.4(b).

  

	 	1.53	 “Forms” shall have the meaning set forth in Section 18.10.

  

	 	1.54	 “Global Trade Control Laws” means all applicable economic sanctions, export and import control
laws, regulations and orders. 

  

	 	1.55	 “Government” means all levels and subdivisions of U.S. and
non-U.S. governments (i.e., local, regional or national and administrative, legislative or executive). 

  

	 	1.56	 “Government Official” means (a) any elected or appointed governmental official
(e.g., a member of a ministry of health), (b) any employee or person acting for or on behalf of a governmental official, agency or enterprise performing a governmental function, (c) any candidate for public office, political party
officer, employee or person acting for or on behalf of a political party or candidate for public office or (d) any person otherwise categorized as a Government Official under local Law. As used in this definition, “government”
is meant to include all levels and subdivisions of U.S. and non-U.S. governments (i.e., local, regional or national and administrative, legislative or executive). 

 

	 	1.57	 “Governmental Authority” means any nation or government, any state, municipality or other
political subdivision thereof, and any entity, body, agency, commission, department, board, bureau, court, tribunal or other instrumentality, whether federal, state, local, domestic, foreign or multinational, exercising executive, legislative,
judicial, taxing, regulatory, administrative or other similar functions of, or pertaining to, government and any executive official thereof. 

  
 -6- 

	 	1.58	 “Hazardous Materials” means (a) any petroleum or petroleum products, radioactive
materials, toxic mold, radon, asbestos or asbestos-containing materials in any form, lead-based paint, urea formaldehyde foam insulation or polychlorinated biphenyls; and (b) any chemicals, materials, substances, compounds, mixtures, products
or byproducts, biological agents, living or genetically modified materials, pollutants, contaminants or wastes that are now or hereafter become defined, regulated or characterized as or included in the definition of “hazardous substances,”
“hazardous wastes,” “hazardous materials,” “extremely hazardous wastes,” “restricted hazardous wastes,” “special waste,” “toxic substances,” “pollutants,”
“contaminants,” “toxic,” “dangerous,” “corrosive,” “flammable,” “reactive,” “radioactive,” or words of similar import, under any Environmental Law. 

 

	 	1.59	 “Improvements” shall have the meaning set forth in Section 8.2(a).

  

	 	1.60	 “Increments” shall have the meaning set forth in Section 2.4(e)(ii).

  

	 	1.61	 “Indemnifying Party” shall have the meaning set forth in
Section 10.3(a). 

  

	 	1.62	 “Indemnitee” shall have the meaning set forth in Section 10.3(a).

  

	 	1.63	 “Indemnity Payment” shall have the meaning set forth in
Section 10.5(a). 

  

	 	1.64	 “In-Flight or Shared Volume Product” means those
Products identified as such in a Facility Addendum. 

  

	 	1.65	 “Initial Price” shall have the meaning set forth in Section 3.1(a).

  

	 	1.66	 “Initial Price Term” means, with respect to a Product set forth in a Facility Addendum, the
period of time beginning on the Effective Date and ending on the last day of the first full Fiscal Year of the Term of such Facility Addendum. 

  

	 	1.67	 “Initial Term” shall have the meaning (a) with respect to this Agreement, set forth in
Section 7.1 and (b) with respect to a Facility Addendum, set forth in Section 7.2. 

  

	 	1.68	 “Insolvent Party” shall have the meaning set forth in Section 7.5.

  

	 	1.69	 “Insurance Proceeds” means those monies (a) received by an insured from an insurance
carrier; (b) paid by an insurance carrier on behalf of the insured; or (c) received (including by way of setoff) from any Person in the nature of insurance, contribution or indemnification in respect of any Liability, in each of cases (a),
(b) and (c), net of any applicable premium adjustments (including reserves or retentions and retrospectively rated premium adjustments) and net of any costs or expenses incurred in the collection thereof. 

 

	 	1.70	 “Intellectual Property” means all intellectual property rights throughout the world,
including: (a) patents and patent applications and all related provisionals, divisionals, continuations, continuations-in-part, reissues, reexaminations, extensions
and substitutions of any of the foregoing; (b) trademarks, service marks, 

  
 -7- 

	 	
names, corporate names, trade names, domain names, social media names, tags or handles, logos, slogans, trade dress, design rights, and other similar designations of source or origin, together
with the goodwill symbolized by any of the foregoing, whether or not registered or applied for registration, including common law trademark rights; (c) copyrights and copyrightable subject matter, whether or not registered or applied for
registration; (d) technical, scientific, regulatory and other information, designs, ideas, inventions (whether patentable or unpatentable and whether or not reduced to practice), research and development, discoveries, results, creations,
improvements, know-how, techniques and data (including biological, chemical, pharmacological, toxicological, pharmaceutical, physical and analytical, safety, quality control, manufacturing and preclinical and
clinical data), technology, algorithms, procedures, plans, processes, practices, methods, trade secrets, instructions, formulae, formulations, compositions, specifications, and marketing, pricing, distribution, cost and sales information, tools,
materials, apparatus, creations, improvements, works of authorship in any media, confidential, proprietary or nonpublic information, and other similar materials, and all recordings, graphs, drawings, reports, analyses and other writings, and other
tangible embodiments of the foregoing in any form whether or not listed herein, in each case, other than Software; (e) Software; and (f) applications, registrations and common law rights for the foregoing. 

 

	 	1.71	 “JAC Chair” shall have the meaning set forth in Section 9.2(b).

  

	 	1.72	 “JAC Meeting” shall have the meaning set forth in Section 9.3(a).

  

	 	1.73	 “JAC Member” shall have the meaning set forth in Section 9.2(a).

  

	 	1.74	 “Joint Advisory Committee” or “JAC” shall have the meaning set forth in
Section 9.1. 

  

	 	1.75	 “Late Payment Date” shall have the meaning set forth in Section 3.5.

  

	 	1.76	 “Latent Defects” shall have the meaning set forth in Section 4.8(a).

  

	 	1.77	 “Laws” means any U.S. and non-U.S. federal, national,
international, multinational, supranational, state, provincial, local or similar law (including common law and privacy and data protection laws), statute, ordinance, regulation, rule, code, order, treaty (including any tax treaty on income or
capital), binding judicial or administrative interpretation or other requirement or rule of law or legal process, in each case, enacted, promulgated, issued, entered or otherwise put into effect by a Governmental Authority or any rule or requirement
of any securities exchange. 

  

	 	1.78	 “Losses” means any and all damages, losses, deficiencies, Liabilities, Taxes, obligations,
penalties, judgments, settlements, claims, payments, fines, charges, interest, costs and expenses, whether or not resulting from Third-Party Claims, including the costs and expenses of any and all Actions and demands, assessments, judgments,
settlements and compromises relating thereto and the reasonable costs and expenses of attorneys’, accountants’, consultants’ and other professionals’ fees and expenses incurred in the investigation or defense thereof or the
enforcement of rights hereunder. 

  
 -8- 

	 	1.79	 “Make to Order Products” means all Products that are identified as “Make to Order
Products” in the applicable Facility Addendum. 

  

	 	1.80	 “Manufacturer” shall have the meaning set forth in the Preamble. 

 

	 	1.81	 “Manufacturer Indemnified Party” shall have the meaning set forth in
Section 10.2(a). 

  

	 	1.82	 “Manufacturer-Owned Improvements and Developments” shall have the meaning set forth in
Section 8.2(c). 

  

	 	1.83	 “Manufacturer Third Party Suppliers” shall have the meaning set forth in
Section 2.7(a). 

  

	 	1.84	 “Manufacturing Change” shall have the meaning set forth in
Section 4.3(a). 

  

	 	1.85	 “Minimum Order Quantity” shall have the meaning set forth in the applicable Facility Addendum
with respect to each Product. 

  

	 	1.86	 “Non-Complying Buy-Sell
Materials” means any Buy-Sell Material that, as of or prior to its delivery by or on behalf of Customer or its Affiliate to Manufacturer or its Affiliate or designee pursuant to this Agreement, does
not comply in all material respects with, or has not been used, handled or stored in all material respects in accordance with, the specifications for such Buy-Sell Material, all applicable Laws, cGMP, the
Quality Agreement, this Agreement or the applicable Facility Addendum. 

  

	 	1.87	 “Non-Complying Customer-Supplied Materials” means any Customer-Supplied Material that, as of or prior to its delivery by or on behalf of Customer or its Affiliate to Manufacturer or its Affiliate or designee pursuant to this Agreement, does not comply in all material
respects with, or has not been used, handled or stored in all material respects in accordance with, the specifications for such Customer-Supplied Material, all applicable Laws, cGMP, the Quality Agreement,
this Agreement or the applicable Facility Addendum. 

  

	 	1.88	 “Non-Complying Product” shall have the meaning set
forth in Section 4.7. 

  

	 	1.89	 “Party” or “Parties” shall have the meaning set forth in the Preamble.

  

	 	1.90	 “Person” means an individual, a general or limited partnership, a corporation, a trust, a
joint venture, an unincorporated organization, a limited liability entity, any other entity and any Governmental Authority. 

  
 -9- 

	 	1.91	 “Personnel” means, with respect to a Party, such Party’s Affiliates, contractors and
agents together with such Party’s and its Affiliates’, contractors’ and agents’ respective individual employees, contractors and other agents. 

 

	 	1.92	 “Pluto” shall have the meaning set forth in the Recitals. 

 

	 	1.93	 “Price” means, with respect to a Product: 

 

	 	(a)	 during the Initial Price Term, the Initial Price of such Product; and 

 

	 	(b)	 after the Initial Price Term, the adjusted price for such Product, as calculated on a Fiscal Year basis, in
accordance with Section 3.2. 

  

	 	1.94	 “Product” means a product specified in the applicable Facility Addendum which, for the
avoidance of doubt, includes all applicable SKUs of such product, in each case, as the same may be amended from time to time by the mutual written agreement of the Parties; provided that, upon Customer’s request, the Parties shall
discuss in good faith any amendments to the applicable Facility Addendum to add Product SKUs and any related information thereto. 

  

	 	1.95	 “Product Conversion Cost” means, with respect to a given Product, the total units of such
Product anticipated to be shipped or actually shipped, as applicable, during a given Fiscal Year (determined in a manner consistent with Manufacturer’s customary practices) multiplied by the per-unit
Conversion Cost for such Product for such Fiscal Year. 

  

	 	1.96	 “Product Materials” means all raw materials (including, without limitation, active
pharmaceutical ingredients and excipients), labeling or packaging materials and components needed for the manufacture and supply of a given Product. For the avoidance of doubt, Product Materials are distinguishable from and exclusive of both Buy-Sell Materials and Customer-Supplied Materials. 

  

	 	1.97	 “Product SKU” means the specific Stock Keeping Unit (SKU) number for a given Product supplied
for sale in a given country or region in the applicable Territory, in each case, as such SKU number may be updated from time to time. 

  

	 	1.98	 “Purchase Order” means a written or electronic order form submitted by Customer in accordance
with the terms of this Agreement to Manufacturer authorizing the manufacture and supply of a given Product. 

  

	 	1.99	 “Quality Agreement” means those supplemental quality provisions set forth in any Quality
Agreement between Manufacturer and Customer relating to a Facility, as the same may be amended or modified from time to time by mutual written agreement of the Parties. The form of Quality Agreement for each Facility is attached hereto as
Attachment B. 

  

	 	1.100	 “Recall” means a “recall”, “correction” or “market withdrawal”
and shall include any post-sale warning or mailing of information. 

  
 -10- 

	 	1.101	 “Receiving Site” shall have the meaning set forth in
Section 2.10(a). 

  

	 	1.102	 “Record Retention Period” shall have the meaning set forth in
Section 15.1. 

  

	 	1.103	 “Records” means any books, documents, accounting procedures and practices and other data,
regardless of type or form, of all matters relating to Manufacturer’s performance of its obligations under this Agreement that enable Manufacturer to demonstrate compliance with such obligations, including, without limitation,
Manufacturer’s compliance with applicable Laws. 

  

	 	1.104	 “Regulatory Approvals” means the permit, approval, consent, registration, license,
authorization or certificate of a Governmental Authority necessary for the manufacturing, distribution, use, promotion and sale of a Product for one or more indications in a country or other regulatory jurisdiction, including approval of New Drug
Applications and Biologics License Applications (each as defined by applicable Law) in the United States and Marketing Authorizations (as such term is defined by applicable Law) in the European Union. 

 

	 	1.105	 “Release” means any release, spill, emission, leaking, dumping, pumping, injection, pouring,
deposit, disposal, discharge, dispersal, leaching or migration into or through the indoor or outdoor environment (including ambient air, surface water, groundwater, land surface or subsurface strata, soil and sediments) or into, through or within
any property, building, structure, fixture or equipment. 

  

	 	1.106	 “Restricted Markets” means, as applicable and as may be updated from time to time, in each
case, under Global Trade Control Laws, the Crimean Peninsula, Cuba, the Donbass Region, Iran, North Korea, and Syria. 

  

	 	1.107	 “Restricted Party” means any: (a) individual or entity placed on lists maintained by an
applicable Governmental Authority, including those established under the Act, the List of Excluded Individuals / Entities published by the U.S. Health and Human Services Office of Inspector General, the regulations administered by the U.S.
Department of the Treasury Office of Foreign Assets Control, the U.S. Department of Commerce Bureau of Industry and Security, or similar lists of restricted parties maintained by the Governmental Authorities of the countries that have jurisdiction
over the activities conducted under this Agreement; (b) individual or entity suspended or debarred from contracting with the U.S. government; or (c) any entity in the aggregate owned or controlled, directly or indirectly, fifty percent
(50%) or greater by one or more such individuals or entities described in clause (a). 

  

	 	1.108	 “Separation” shall have the meaning set forth in the Recitals. 

 

	 	1.109	 “Separation Agreement” shall have the meaning set forth in the Recitals.

  

	 	1.110	 “Serialization” means the assigning of a unique identification code on a given Product unit or
Product units of sale at the primary, secondary and/or tertiary level for the purpose assuring authenticity and/or tracking and tracing of the movement of a given Product through the entire supply chain. 

  
 -11- 

	 	1.111	 “Service Taxes” shall have the meaning set forth in Section 3.6(b).

  

	 	1.112	 “Specifications” means the specifications for the manufacture, processing, packaging,
labeling, testing and testing procedures, shipping, storage and supply of a given Product, including all formulae, know-how, raw materials requirements, analytical procedures and standards of quality control,
quality assurance and sanitation, set forth with respect to such Product in the applicable Regulatory Approval(s) and provided by Customer to Manufacturer. 

  

	 	1.113	 “Spinco” shall have the meaning set forth in the Recitals. 

 

	 	1.114	 “Standard Cost” means, with respect to a given Product in a given Fiscal Year, an amount equal
to: 

  

	 	(a)	 the cost of Product Materials (including the cost of active ingredients, intermediates, semi-finished
materials, excipients and primary and secondary packaging) associated with such Product (“Standard Product Materials Cost”); and 

  

	 	(b)	 the Conversion Costs for such Product (“Standard Conversion Cost”), 

in each case of clauses (a) and (b), calculated in accordance with Manufacturer’s accounting policies in effect as of
the Effective Date and applied consistently across Manufacturer’s entire manufacturing operations for the full applicable Facility. Depreciation will be based on original acquisition cost of fixed assets, and not impacted by fair value
accounting for business transactions. 
  

	 	1.115	 “Technical Support” shall have the meaning set forth in
Section 2.10(a). 

  

	 	1.116	 “Term” shall have the meaning (a) with respect to this Agreement, as set forth in
Section 7.1 and (b) with respect to a Facility Addendum, as set forth in Section 7.2. 

  

	 	1.117	 “Territory” means, with respect to a given Product, the countries set forth in the applicable
Facility Addendum for such Product. 

  

	 	1.118	 “Third Party” means a Person other than Manufacturer, Customer or their respective Affiliates.

  

	 	1.119	 “Third-Party Claim” shall have the meaning set forth in
Section 10.3(a). 

  

	 	1.120	 “Triggering Event” shall have the meaning set forth in
Section 2.5(a). 

  

	 	1.121	 “VAT” means (A) any Tax imposed in compliance with the council directive of
28 November 2006 on the common system of value added tax (EC Directive 2006/112); and (B) any other Tax of a similar nature, however denominated, to the Taxes referred to in clause (A) above, whether imposed in a member state of the
European Union in substitution for, or levied in addition to, the Taxes referred to in clause (A) above, or imposed elsewhere (including goods and services Taxes, but excluding transfer Tax, stamp duty and other similar Taxes).

  
 -12- 

	 	1.122	 “VMR Products” means all Products that are identified as “VMR Products” in the
applicable Facility Addendum. 

  

	 	1.123	 “Waste” means all wastes that arise from the manufacture, handling or storage of Product
hereunder, or which is otherwise produced through the implementation of this Agreement, including Hazardous Materials. 

  

	2.	 Supply of Product. 

 

	 	2.1	 Agreement to Supply. 

 

	 	(a)	 Affiliates and Facility Addenda. Either the entity designated above as Customer or any Affiliate of
Customer and either the entity designated above as Manufacturer or any Affiliate of Manufacturer may enter into Facility Addenda under this Agreement. The entities that execute a Facility Addendum are also deemed to be “Customer” and
“Manufacturer” (respectively) for all purposes of the Facility Addendum and this Agreement (with respect to the applicable Facility Addendum). 

  

	 	(b)	 Supply Pursuant to Facility Addenda. During the Term of each Facility Addendum, Manufacturer shall
manufacture and supply Product to Customer for the Territory applicable to such Product on the terms and subject to the conditions of this Agreement and the applicable Facility Addendum. The terms of this Agreement shall be incorporated by reference
into each Facility Addendum that may be executed by the Parties or, as described in Section 2.1(a), their respective Affiliates. During the term of this Agreement, Customer may request that Manufacturer manufacture and
supply to Customer clinical trial material, and the Parties shall negotiate in good faith the terms and conditions of such manufacturing and supply arrangement applying the terms and conditions of this Agreement to the extent mutually agreeable.

  

	 	(c)	 Hierarchy of Terms; Effect of Amendments. In the event of a conflict between the terms of any Facility
Addendum and the terms of this Agreement, the terms of this Agreement shall govern and control, except to the extent that the applicable Facility Addendum expressly and specifically states an intent to supersede a specific section of this Agreement
on a specific matter. Any amendment to the terms of this Agreement contained in a Facility Addendum shall be effective solely with respect to such Facility Addendum, and not with respect to this Agreement or any other Facility Addendum. Any
amendment to the terms of this Agreement shall be effective with respect to all Facility Addenda. Except to the extent otherwise expressly stated in this Agreement, in the event of a conflict between the terms of this Agreement and the terms of the
Separation Agreement, the terms of the Separation Agreement shall govern and control. 

  
 -13- 

	 	(d)	 Use of Subcontractors. Subject to Section 2.2(a), Manufacturer shall
manufacture and supply Product itself or through its Affiliates, in each case, at the applicable Facilities (and such other facilities as may be specified in the applicable Facility Addendum with respect to applicable Products). With respect to
those Third-Party contractors, subcontractors or service providers used by Manufacturer or its Affiliates in the manufacturing or supply of a given Product immediately prior to the Effective Date, Manufacturer may engage such Third-Party
contractors, subcontractors or service providers to perform the same activities for such Product under this Agreement without first obtaining Customer’s prior written consent. For the avoidance of doubt, the use of any Third-Party contractors,
subcontractors or service providers other than in the manner expressly permitted pursuant to this Section 2.1(d) must be approved in advance in writing by Customer, such approval not to be unreasonably withheld, conditioned
or delayed. Manufacturer shall be liable for all actions and omissions of its contractors, subcontractors and service providers, and any breach of the terms and conditions of this Agreement by such contractors, subcontractors or service providers
shall be deemed a breach of the terms and conditions by Manufacturer under this Agreement. For the avoidance of doubt, as of the Effective Date, as between Manufacturer and Customer, Manufacturer will be solely responsible for maintaining and
establishing relationships with the Third-Party contractors, subcontractors or service providers used in the manufacturing or supply of Product (other than the manufacturing or supply of Buy-Sell Materials or
Customer-Supplied Materials). 

  

	 	(e)	 Exclusivity. 

  

	 	(i)	 Customer Exclusivity. During the Exclusivity Period, on a Product SKU-by-Product SKU and country-by-country basis within the applicable Territory, Customer shall purchase from Manufacturer, in
accordance with the terms and conditions of this Agreement, at least the Exclusive Purchase Requirement of its requirements for such Product SKU in such country; provided, however, that In-Flight
or Shared Volume Products shall be excluded from the exclusivity requirements set forth in this Section 2.1(e)(i). Following the Exclusivity Period (and during the Exclusivity Period, with respect to Product SKU quantities
in excess of the Exclusive Purchase Requirement in accordance with the preceding sentence), nothing in this Agreement shall prevent Customer or any of its Affiliates from manufacturing Product for itself, or having Product manufactured by a Third
Party, including in amounts in addition to the Purchase Orders for Product issued to Manufacturer in accordance with this Agreement. For clarity and notwithstanding 

  
 -14- 

	 	
anything contained herein, nothing in this Section 2.1(e)(i) (A) is intended to be inconsistent with Section 2.4(e)(i) or to otherwise
indicate that Customer is subject to any requirement to purchase Product under this Agreement or (B) is intended to prevent Customer from qualifying a back-up supplier for any Product during the
Exclusivity Period. 

  

	 	(ii)	 Upon request by Manufacturer, which Manufacturer may make from time to time during the Term but not more than
once during any quarter of a Fiscal Year, Customer shall provide to Manufacturer within thirty (30) days of such request a certification attesting to Customer’s compliance with its Exclusive Purchase Requirement obligations pursuant to
Section 2.1(e)(i) and signed by a representative of Customer with a title of Vice President or more senior. 

  

	 	2.2	 Use of Facility, Equipment, Molds and Tooling.  

 

	 	(a)	 Facilities. For each Product, Manufacturer shall perform all manufacturing activities and all storage
activities at the Facilities set forth in the Facility Addendum applicable to such Product. Manufacturer may use any other facility for the manufacture and storage of Products if (i) such facility has been approved for such manufacture by all
applicable Governmental Authorities and (ii) Manufacturer obtains Customer’s prior written consent with respect to the use of such other facility as set forth in Section 4.3(a) (such approval not to be
unreasonably withheld, conditioned or delayed). The Parties shall agree to either execute a new Facility Addendum or amend an existing Facility Addendum in order to include such facility. Manufacturer shall notify Customer of its intent to use any
alternate facility as soon as reasonably practicable. 

  

	 	(b)	 Purchase and Installation of Equipment, Dedicated Change Parts and Tooling. Subject to this
Section 2.2(b), Manufacturer shall be responsible for (i) purchasing, installing and validating at the Facilities all new equipment, dedicated change parts and tooling; (ii) modifications to existing equipment,
dedicated change parts and tooling necessary for the manufacture, packaging, labeling and Delivery of Product hereunder; and (iii) maintenance of all such equipment, dedicated change parts and tooling, and all costs and expenses associated
therewith; provided that in no event shall Manufacturer be required to purchase any new equipment, install any equipment purchased or requested by Customer or add (or, for clarity, allocate or dedicate) any additional manufacturing or storage
capacity in connection with Customer’s requests for additional capacity for manufacturing or for other activities to be carried out by Manufacturer hereunder not otherwise expressly provided for hereunder or in an applicable Facility Addendum.
If Customer makes such a request for additional equipment or capacity, then the Parties shall promptly meet and discuss Customer’s request in good faith, including an appropriate allocation of costs between the Parties with respect thereto.

  
 -15- 

	 	2.3	 Capacity.  

Subject to Section 2.2(b), Manufacturer shall devote adequate manufacturing capacity to be capable of manufacturing
and supplying Product to Customer in accordance with the provisions of this Agreement and the Facility Addenda. Manufacturer shall promptly notify Customer if Manufacturer reasonably believes its existing capacity and demands thereon would prevent
it from meeting Customer’s anticipated Product requirements as set forth in any Forecast that conforms to the requirements set forth in Section 2.4. 

 

	 	2.4	 Forecasts and Purchase Orders. 

 

	 	(a)	 VMR Products Forecasting and Purchase Orders. With respect to the VMR Products, the processes and
mechanisms by which Forecasts are prepared and Purchase Orders are issued shall be as set forth in the applicable Facility Addenda and the remainder of this Section 2.4 shall not apply with respect to such VMR Products as
applicable. 

  

	 	(b)	 Make to Order Product Forecasts. Except as otherwise set forth in a Facility Addendum, in each calendar
month during the Term of a Facility Addendum, Customer shall provide to Manufacturer a rolling Product SKU-level forecast of its estimated requirements of Make to Order Products for the eighteen (18)-month
period commencing with the month in which such forecast is provided (each, a “Forecast”). In the event Customer delivers a Forecast where the allocation of Product requirements over the time period of the Forecast are not consistent
with historical trends, at Manufacturer’s request, the Parties will meet to discuss the Forecast in good faith in the context of previous allocations of Product requirements. Such Forecasts represent Customer’s reasonable estimates of the
quantity of Products it will require during the applicable period covered by each such Forecast. Except as otherwise set forth in a Facility Addendum, each Forecast shall be a non-binding forecast and for
informational purposes only, except that: (i) the portion of such Forecast covering the first three (3) calendar months reflected therein (the “Binding Forecast Period”) shall be binding and shall constitute a firm order
for the quantity of each Product specified therein (each, a “Firm Order”), (ii) each of months four (4) through six (6) of a given Forecast may not differ by more than twenty-five percent (25%) (whether positive or
negative) from the quantity of such Product set forth in those months in the previous Forecast, and (iii) each of months seven (7) through twelve (12) of a given Forecast may not differ by more than fifty percent (50%) (whether
positive or negative) from the quantity of such Product set forth in those months in the previous Forecast. For the avoidance of doubt, (1) this subsection (b) applies to Forecasts for API and Bulk Drug Product and (2) the
Forecast with respect to Finished Product shall apply to the roll-up level of the Bulk Drug Product that is incorporated into the Finished Product. 

  
 -16- 

	 	(c)	 Make to Order Purchase Orders. Manufacturer shall provide Product to Customer pursuant to Purchase
Orders issued by Customer to Manufacturer, which Purchase Orders will be issued on a Product SKU-by-Product SKU basis, not to exceed one (1) Purchase Order per
Product SKU per calendar month unless otherwise agreed between the Parties in advance in writing. No verbal communications or e-mail shall be construed to mean a commitment to purchase Product. Customer shall
be required to order pursuant to a Purchase Order at least the amount of Product set forth in the Firm Order for such Product in the applicable calendar month. Manufacturer shall provide to Customer such quantities of Product as may be ordered by
Customer pursuant to such Purchase Orders, up to one hundred ten percent (110%) of the quantity set forth in the most recent Forecast for the applicable period. In the event that Customer orders quantities of Product above one hundred ten percent
(110%) of the quantity set forth in the most recent Forecast for the applicable period (such quantities above one hundred ten percent (110%) referred to as “Additional Quantities”), Manufacturer shall use its commercially reasonable
efforts, but shall not be obligated, to supply such Additional Quantities. For purposes of this paragraph, the most recent Forecast for any given month shall mean the Forecast submitted by Customer in the month prior to the month in which the
applicable Purchase Order is issued. All Purchase Orders shall specify the quantity and description of Products ordered, the applicable Facility where such Products will be Delivered, the required delivery date (subject to the provisions of
Section 2.4(d)), and the manner of Delivery (including the carrier to be used). 

  

	 	(d)	 Delivery Date. Unless expressly set forth to the contrary in a Facility Addendum, Customer will issue
Purchase Orders for Product no later than a period equal to the Binding Forecast Period prior to the required delivery date. By way of example only, if the Binding Forecast Period is the first three (3) months of a Forecast with respect
to a Product, then Customer will issue Purchase Order for such Product no later than three (3) months prior to the required delivery date. 

  

	 	(e)	 No Minimum Purchase Obligation; Minimum Order Quantities. 

 

	 	(i)	 No Obligation. Without limiting Customer’s obligations under
Section 2.1(e), 2.4(b), 2.4(c), 2.4(d) or 2.4(e)(ii), Manufacturer hereby acknowledges and agrees that Customer is not otherwise obligated to purchase any minimum or specific quantity, volume or
dollar amount of Product under any Facility Addendum unless expressly set forth in the applicable Facility Addendum. 

  
 -17- 

	 	(ii)	 Minimum Order Quantities. Notwithstanding Section 2.4(e)(i), Customer
acknowledges and agrees that (A) each Purchase Order Customer places hereunder for Product that is either API or Bulk Drug Product shall be equal to, or a whole multiple of, the Batch Size for such applicable Product as set forth in the
applicable Facility Addendum and (B) each Purchase Order that Customer places hereunder for Product that is Finished Product shall be equal to or greater than the Minimum Order Quantity for such applicable Product as set forth in the applicable
Facility Addendum; provided that, where Customer places Purchase Orders under (B) above that exceed the applicable Minimum Order Quantity, Customer shall place such Purchase Orders for such excess quantities in Increments above the
Minimum Order Quantity as specified in the applicable Facility Addendum. As used herein, “Batch Size” means the production quantity for a given run of a Product SKU and “Increments” means the quantity step change
above the applicable Minimum Order Quantity, in each case, as specified in the applicable Facility Addendum. 

  

	 	(f)	 Acceptance and Rejection of Orders. Within ten (10) Business Days of receipt of a Purchase Order,
Manufacturer may reject such Purchase Order by written notice to Customer only on the basis that it is inconsistent with the terms of this Agreement, including a Purchase Order containing (i) a delivery schedule that is inconsistent with
Section 2.4(d), (ii) a Product quantity that is inconsistent with Section 2.4(e)(ii), (iii) a Product quantity that is less than the Firm Order for the applicable period or (iv) subject to
Section 2.4(c), a Product quantity that is more than one hundred ten percent (110%) of the Forecast for the applicable period. Manufacturer shall be deemed to have accepted Customer’s Purchase Order for Products in the
event it either (a) indicates its acceptance of Customer’s Purchase Order in writing or (b) does not indicate its rejection of a Purchase Order within ten (10) Business Days of receipt pursuant to this
Section 2.4(f). 

  

	 	(g)	 Changes to Purchase Orders. Purchase Orders, once submitted to Manufacturer, may be amended only by
mutual written agreement of the Parties; provided that Manufacturer shall exercise its commercially reasonable efforts to comply with proposed amendments to Purchase Orders that Customer may request after sending a Purchase Order to
Manufacturer. 

  

	 	(h)	 Cancellations. In the event that Customer cancels all or part of a Purchase Order (provided that
a cancellation shall be deemed to have occurred to the extent that Customer fails to issue a Purchase Order with respect to the full amount of Product contemplated by any portion of a Forecast with respect to the Binding Forecast Period) and such
cancellation is not due to Manufacturer’s breach of this Agreement or any Facility Addendum, Manufacturer will use good faith efforts to reallocate capacity and mitigate any resultant costs of such cancellation and, unless otherwise set forth
with 

  
 -18- 

	 	
respect to the relevant cancelled Product under the applicable Facility Addendum, Customer will be charged for one hundred percent (100%) of any and all
non-cancellable Third-Party costs actually and reasonably incurred by Manufacturer in accordance with this Agreement prior to cancellation for materials or services related to the cancelled portion of the
Purchase Order for which reasonably acceptable documentation is submitted by Manufacturer to Customer. 

  

	 	(i)	 Conflicts. In the event of any conflict between the provisions of this Agreement and any Customer
Purchase Order, Manufacturer’s acceptance form or Manufacturer’s invoice form or any similar such forms, the provisions of this Agreement shall govern and control. 

 

	 	(j)	 Product Inventory as of Effective Date. Promptly following the Effective Date, Manufacturer shall
provide Customer with a Product inventory report organized by Facility, lot number, remaining shelf life, and such other data points with respect to such Product inventory as Customer may request. For the avoidance of doubt, (i) Manufacturer
shall be entitled to fill Purchase Orders with such inventory that complies with the terms and conditions of this Agreement, including Section 5.2, and (ii) the Parties shall meet to discuss in good faith the
disposition of all such Product inventory that does not meet the criteria set forth in (i) above. 

  

	 	2.5	 Failure to Supply. 

 

	 	(a)	 Capacity Allocation. In the event that Manufacturer fails to manufacture and deliver Product in
accordance with accepted Purchase Orders or applicable Specifications, Manufacturer shall notify Customer promptly, including details of the reasons for the failure and Manufacturer’s estimated timeline of when the failure will be corrected.
Manufacturer shall be solely responsible for undertaking commercially reasonable measures to minimize any shortage of Product delivered to Customer as a result of such manufacturing issues. If Manufacturer fails to manufacture and deliver Product in
accordance with accepted Purchase Orders or applicable Specifications by the delivery date specified in the applicable Purchase Order(s) in accordance with Section 2.4(d), other than due to a Force Majeure Event,
(i) for a period of two (2) or more months past such delivery date four (4) or more times in any rolling twelve (12) month period, or (ii) for a period of four (4) or more months past such delivery date on one occasion
(each of (i) and (ii), a “Triggering Event”), then Manufacturer shall use its best efforts to allocate on a quarterly basis its manufacturing capacity and Product Materials to the manufacture and supply of Products for Customer
on a ratable basis based on the use of each during the twelve (12)-month period immediately preceding such Triggering Event (or either (1) the Term of the applicable Facility Addendum, if the Term is less than twelve (12) months, or
(2) such other period set forth in the applicable Facility Addendum); provided that (A) if Customer’s Minimum Order 

  
 -19- 

	 	
Quantity for the applicable Product(s) exceeds its ratable allocation of manufacturing capacity or Product Materials (as applicable) for the applicable quarter, Customer shall continue to accrue
its allocation of capacity until such quarter when Customer’s allocation of capacity is equal to or greater than its accrued allocation of capacity and (B) this Section 2.5(a) shall not apply to the extent that
Customer fails to timely provide adequate Customer-Supplied Materials or Buy-Sell Materials to Manufacturer in accordance with Section 12. For the avoidance of doubt, Manufacturer
shall notify Customer promptly in writing of any anticipated Triggering Event when Manufacturer has reason to believe that such Triggering Event is likely to occur and provide such information with respect to such anticipated Triggering Event as
Customer may reasonably request. 

  

	 	(b)	 Suspension of the Exclusive Purchase Requirement. In the event of a Triggering Event, Customer’s
Exclusive Purchase Requirement with respect to each and every Product that is the subject of the Triggering Event shall be temporarily suspended until such time as Manufacturer notifies Customer that Manufacturer is able to resume the manufacture
and supply of the subject Product(s) on the terms and conditions of this Agreement (such period referred to as the “Exclusive Purchase Requirement Suspension Period”); provided that, (i) during such Exclusive Purchase
Requirement Suspension Period, Customer shall use commercially reasonable efforts to limit its orders for the subject Product(s) to the quantities specified in the last Forecast that preceded the Triggering Event for the applicable period(s) and
promptly notify Manufacturer in the event and to the extent that Customer’s orders exceed such quantities specified in such Forecast and (ii) Customer shall be entitled to take delivery of Product(s) ordered during the Exclusive Purchase
Requirement Suspension Period even if such delivery is scheduled for or actually occurs subsequent to the Exclusive Purchase Requirement Suspension Period. 

  

	 	(c)	 Modification of the Exclusive Purchase Requirement. Upon the expiration of the Exclusive Purchase
Requirement Suspension Period, Customer shall use commercially reasonable efforts to resume ordering from Manufacturer, on a Product-by-Product basis, the subject
Product(s) in accordance with Customer’s Exclusive Purchase Requirement during the Exclusivity Period. 

  

	 	(d)	 Business Continuity. Manufacturer shall maintain a written business continuity plan to be able to assure
supply of Product to Customer in the event of a disruption to supply from the primary location or Facility of manufacture, including any disruption resulting from a Force Majeure Event and make such plan available from time to time upon
Customer’s request. 

  
 -20- 

	 	(e)	 Remedies. Customer shall have the right to terminate this Agreement on an affected Product-by-affected Product basis immediately upon written notice to Manufacturer in the event a Triggering Event (under clause (ii) thereof) continues for more than one
hundred and eighty (180) days. Customer shall also have the right to cancel orders for any quantities of Product affected by any Triggering Event effective upon notice to Manufacturer, and Customer shall have no further obligations to purchase
any such cancelled quantities of Product. In the event a Triggering Event occurs during the Exclusivity Period, Manufacturer shall, at Manufacturer’s cost and expense, provide such assistance as is reasonably requested by Customer to assist any
alternate manufacturer in meeting Customer’s requirements for the Product until Manufacturer has remedied the cause of such Triggering Event and is able to supply Product to Customer in its requested quantities. Such assistance shall include
providing, subject in all cases to Section 2.10(h), Technical Support in respect of the affected Product(s). In the event of a Triggering Event, Manufacturer shall be liable for any actual amounts that Customer is
contractually required to pay to any Third-Party customer of Customer that result from Customer’s inability to supply the affected Product to such Third-Party customer as a direct result of such Triggering Event; provided that
(1) Customer shall provide to Manufacturer appropriate evidence of such amounts (including invoices from the applicable customers) and the applicable contractual requirements (redacted, in each case, of information pertaining to pricing and
other commercial terms that are not directly related to the claimed amounts), it being understood and agreed that, upon request, Manufacturer will enter into customary confidentiality arrangements prior to such information being shared and
(2) Manufacturer shall not be liable for any such amounts in the aggregate in any Fiscal Year in excess of the aggregate Conversion Cost Markup during such Fiscal Year with respect to all Products manufactured at the Facility that is the
subject of the applicable Triggering Event. “Conversion Cost Markup” means, for a Product for any Fiscal Year, ten percent (10%) of the product of (A) Manufacturer’s Standard Conversion Cost for such Product for such Fiscal Year
and (B) the quantity of such Product ordered by Customer for delivery during such Fiscal Year. The rights of Customer set forth in this paragraph are in addition to any other rights set forth in this Agreement. 

 

	 	2.6	 Delivery; Risk of Loss. 

 

	 	(a)	 Delivery. Unless otherwise set forth in the applicable Facility Addendum, Manufacturer shall deliver
Product to Customer FCA (Incoterms 2010) at the applicable Facility, and all Purchase Orders will be deemed to have been completed when the quantity of Product made available to Customer at the applicable Facility is between ninety percent (90%) and
one hundred and ten percent (110%) of the quantity of Product set forth in any accepted Purchase Order (each such event, a “Delivery”). Delivery shall occur by or within the delivery date(s) set forth in the applicable Purchase
Order or such other date as may be agreed to in writing by the Parties from time to time. Without limiting Customer’s rights and remedies under Section 4.8, Manufacturer acknowledges and agrees that, unless such early
Delivery was agreed upon by the Parties in writing, Manufacturer shall provide Customer with such data as Customer may reasonably request from time to time for measures of key performance indicators (KPI). 

  
 -21- 

	 	(b)	 Certificates of Compliance. Manufacturer shall include certificates of compliance and certificates of
analysis with all Delivery of Product or prior to Delivery upon reasonable request of Customer. 

  

	 	(c)	 Title. Unless otherwise set forth in the applicable Facility Addendum, title to Product and risk of loss
or damage shall pass to Customer upon Delivery to Customer pursuant to Section 2.6(a). 

  

	 	2.7	 Procurement of Materials. 

 

	 	(a)	 Manufacturer shall order and maintain sufficient quantities of all Product Materials, including safety stock as
required by the applicable Facility Addendum, to enable Manufacturer to manufacture and Deliver Product in accordance with its Delivery obligations under this Agreement and the applicable Facility Addendum. With respect to those Third Party
suppliers of Product Materials used by Manufacturer or its Affiliates in the ordinary course in the manufacturing or supply of a given Product immediately prior to the Effective Date (“Manufacturer Third Party Suppliers”),
Manufacturer shall be permitted to purchase solely the same Product Materials from such Manufacturer Third Party Suppliers in connection with its activities under this Agreement without first obtaining Customer’s prior written consent. Any
other Third-Party supplier for Product Materials (or procurement of a different Product Material from any Third-Party supplier) must be approved in advance in writing by Customer (such approval not to be unreasonably withheld, conditioned or
delayed). For the avoidance of doubt, as of the Effective Date, as between Manufacturer and Customer, Manufacturer will be solely responsible for maintaining and establishing relationships with the Third-Party suppliers of Product Materials.
The costs of all such Product Materials shall be included in the Price of the applicable Product. 

  

	 	(b)	 Unless otherwise set forth in the applicable Facility Addendum for a specific Product, Customer shall have no
liability for excess or obsolete Product Materials purchased by Manufacturer, (x) except as set forth in Section 2.4(h) or Section 7.9 or (y) unless the excess or obsolescence is caused
by a change to the specifications for such Product Materials or the Specifications of a given Product in accordance with this Agreement after such Product Materials have been purchased by Manufacturer based upon a Firm Order or accepted Purchase
Order). 

  
 -22- 

	 	(c)	 Customer understands and acknowledges that (i) certain Product Materials have a limited shelf-life, are
long lead time items, and are subject to minimum order quantities specified by the applicable supplier and (ii) Manufacturer will rely on the Firm Orders and Forecasts to order Product Materials required to meet the Firm Orders (plus safety stock
for certain Product Materials of a Product as reasonably determined by Manufacturer). In addition, Customer understands that, to ensure an orderly supply of the Product Materials, Manufacturer may elect to purchase the Product Materials in
sufficient volumes to meet the production requirements for Products during part or all of the forecasted periods; provided, however, that Customer shall not have any liability with respect to any purchase by Manufacturer or any of its
Affiliates of labeling or packaging materials (including labels, cartons and leaflets) in excess of the amount required to meet the Firm Order applicable at such time plus the amount of applicable Product forecasted to be ordered in months four
(4) through six (6) of the Forecast applicable at such time. 

  

	 	(d)	 Manufacturer must review with Customer any assessment made (or related action proposed to be taken) by
Manufacturer related to rejection or destruction of any Customer-Supplied Materials, Buy-Sell Materials, Product, or Product Materials intended for Customer’s Product to discuss viability for commercial
use. 

  

	 	2.8	 Product Samples. 

If representative lot samples of production batches of Product are requested by Customer in order to satisfy its obligations under applicable
Law, including any regulatory requirements, or to any Governmental Authority, then Manufacturer shall provide Customer (or any such Third Party as Customer shall designate) with representative lot samples of each production batch of Product promptly
upon Customer’s request. Customer shall be entitled to review, upon reasonable prior written notice, all manufacturing Records relating to such samples, including all analytical procedures and cleaning validation relating to the equipment used
in connection with the manufacture of the samples. Such Product samples shall be Delivered to Customer (or such Third Party as Customer shall designate) in accordance with the provisions set forth in Section 2.6(a) and at
the Price as determined in accordance with the terms of Section 3. Customer shall pay for such samples when invoiced in accordance with Section 3.5. 

 

	 	2.9	 Storage. 

Manufacturer will store Products, Buy-Sell Materials, Product Materials, and Customer-Supplied
Materials in accordance with the requirements of the Quality Agreement. With respect to those Third-Party warehouses used by Manufacturer or its Affiliates in the ordinary course for the storage of a given Product,
Buy-Sell Materials, Product Materials, or Customer-Supplied Materials immediately prior to the Effective Date, Manufacturer may engage such Third-Party warehouse to perform the solely same activities for such
Product, Buy-Sell Materials, Product Materials, and Customer-Supplied Materials under this Agreement without first obtaining Customer’s prior written consent. The use of any Third Party warehouse

  
 -23- 

 
for the storage of any Product, Buy-Sell Materials, Product Materials, or Customer-Supplied Materials other than in the manner expressly permitted pursuant
to this Section 2.9 must be approved in advance in writing by Customer, such approval not to be unreasonably withheld, conditioned or delayed. Manufacturer shall obtain the right for Customer to audit, at Customer’s
expense, any such Third-Party warehouse upon reasonable prior advance written notice and during normal business hours. Manufacturer has no obligation to store Product more than fifteen (15) Business Days following the requested
delivery date for such Product; provided that (a) Manufacturer shall be obligated to store Product for such longer period as may be reasonably necessary for Customer to arrange transportation for such Product in the event that
Manufacturer experiences delays in the manufacture, release, or supply of a particular Product that results in the delivery of a quantity of Product that exceeds historical or Forecast quantities of Product for the applicable period and;
(b) with respect to any Product that Customer reasonably believes should not be released by Manufacturer, Manufacturer shall store such Product until the Parties’ definitive resolution pursuant to this Agreement and the Quality Agreement
as to whether such Product should be released. At the expiration of the applicable time frame in the preceding sentence, notwithstanding any provision of this Section 2.9 to the contrary, Manufacturer may transport and
store the subject Product at a Third-Party warehouse at Customer’s expense. 
  

	 	2.10	 Transitional Support. 

 

	 	(a)	 On a Product-by-Product basis,
Customer may elect, upon written notice to Manufacturer, for Manufacturer to provide Customer with reasonable technical support, as more fully set forth in this Section 2.10, to transfer production of a given Product or
Products to a Customer facility or a facility of an alternative source of supply as designated by Customer (such support, “Technical Support” and such facility, the “Receiving Site”). Customer may make such election
for Technical Support at any time during the Term (including in the event of a Triggering Event under Section 2.5(a) or in advance of any expiration of this Agreement) or promptly after the termination or expiration of this
Agreement but in no event more than ninety (90) days following the effective date of such termination or expiration. Such reasonable Technical Support shall consist of: 

 

	 	(i)	 supply of a technical package to facilitate the transfer of all relevant manufacturing information for such
Product(s) to the Receiving Site, including formulation descriptions, manufacturing instructions, Specifications, methods, data required for applicable regulatory submissions and facility qualification, and material supplier information, as
applicable, except for any information that is subject to confidentiality obligations owing to a Third Party; provided that the technical package will not include any manufacturing information, including formulation descriptions,
manufacturing instructions, Specifications, methods and material supplier information, that is generally available to or known by the public, can be obtained on reasonable terms from Third Parties or is already available or being utilized by
Customer or its Affiliate at one of Customer’s or its Affiliate’s facilities; 

  
 -24- 

	 	(ii)	 host site visits to the Manufacturer’s Facility by Customer to observe production of the applicable
Product or Products, in each case, at a mutually agreed date and subject to confidentiality procedures or requirements as may be requested or implemented by Manufacturer; provided that the request for each such visit shall be made so as to
allow for sufficient advance preparation time and can be accommodated in the requested timeframe without interruption to Manufacturer’s routine production or operations; 

 

	 	(iii)	 performance of high-level consultation and answering reasonable queries for Customer through the transfer
process; and 

  

	 	(iv)	 provision of reasonable Product samples required under applicable Law for transfer activities.

  

	 	(b)	 Customer shall be responsible for identifying and requesting any and all Technical Support that is required
from Manufacturer to assure such technology transfer is successful. 

  

	 	(c)	 The Parties shall reasonably cooperate and mutually agree to facilitate the provision of any additional
reasonable Technical Support with respect to the applicable Product or Products to Customer, including assistance through the transfer process, Manufacturer Personnel visits to the Receiving Site and training and troubleshooting during the Receiving
Site’s first production run of the applicable Product or Products, in each case, as and to the extent reasonably agreed by Manufacturer in each instance (and subject to Sections 2.10(d), 2.10(e) and 2.10(f)).

  

	 	(d)	 The Parties will work together in good faith to plan for upcoming and ongoing Technical Support needs and to
accommodate such plans in order to maintain ongoing business continuity. In addition, Manufacturer shall have no obligation to hire or retain any individuals or make any capital expenditures in connection with Technical Support, and
Manufacturer’s obligation to provide Technical Support is contingent upon the continued employment by Manufacturer of those individuals capable of providing such Technical Support. Manufacturer may terminate its obligation to provide any
Technical Support with respect to the applicable Product under this Agreement if Customer or any of its Affiliates hires any Manufacturer Personnel involved in providing Technical Support to Customer hereunder (without limiting any applicable non-solicitation obligations of Customer pursuant to the Business Combination Agreement). 

  
 -25- 

	 	(e)	 Customer shall be solely responsible for any and all regulatory or other Governmental Authority requirements,
activities and related costs and expenses that arise in conjunction with any Technical Support, technology transfer of production or production of each Product to or at the Receiving Site. These activities may also include, but are not limited to,
creation of additional data or technical information, analytical method modifications or other work of a technical nature required to support regulatory queries or contemporary standards and guidelines driven by the manufacturing transfer (subject
to Section 8.2). 

  

	 	(f)	 Subject to Section 2.5(e), Customer is responsible for, and shall promptly reimburse
Manufacturer for, any and all reasonable out-of-pocket costs and expenses incurred by or on behalf of Manufacturer in connection with any Technical Support provided to
Customer under this Agreement, including employee costs to be charged at a rate that reasonably approximates the cost of providing the Technical Support, without any intent to cause Manufacturer to make profit or incur loss. 

 

	 	(g)	 With respect to each Product for which Manufacturer provides Technical Support under this Agreement,
Manufacturer shall provide to Customer any analytical materials and methods in Manufacturer’s possession or control that are required in connection with disclosures to any applicable Governmental Authority to qualify the applicable Product
Materials, Buy-Sell Materials, or Customer-Supplied Materials for such Product or such Product itself for release testing to meet the then-current applicable marketing
authorization, in each case, subject to Section 13. 

  

	 	(h)	 Nothing in this Agreement shall require Manufacturer to provide more than 75 hours per calendar year per
Product in connection with any Technical Support. Notwithstanding anything to the contrary herein, except as expressly provided in Section 2.10(g), Manufacturer shall have no obligation to disclose, license or otherwise
provide confidential or proprietary information of Manufacturer, its Affiliates or any Third Party in connection with this Agreement or any Technical Support or technology transfer therein. 

 

	3.	 Price; Payment; Price Adjustments; Taxes. 

 

	 	3.1	 Price. 

 

	 	(a)	 Initial Price. On a Fiscal
Year-by-Fiscal Year basis, Customer shall purchase each Product from Manufacturer at the Price for such Product for such Fiscal Year, as determined in accordance with
the terms of this Section 3. The Price for each Product during the Initial Price Term (such Price, the “Initial Price” for such Product) is set forth in the Facility Addendum for such Product. Following the
Initial Price Term, the Price of such Product may be adjusted only as set forth in Section 3.1(b) and Section 3.2. 

  
 -26- 

	 	(b)	 Price in Extension Periods. In the event that Customer elects to extend the Initial Term of the
Agreement or of a Facility Addendum, the Price for each applicable Product in any Extension Period shall be one hundred percent (100%) of Manufacturer’s Standard Product Materials Cost plus one hundred and ten percent (110%) of
Manufacturer’s Standard Conversion Cost of such Product, each for the initial Fiscal Year of the first Extension Period with respect to such Product. During each Extension Period, the Price of such Product may be adjusted as set forth in
Section 3.2; provided that the initial Fiscal Year of the first Extension Period shall operate as the Facility Conversion Cost Baseline Fiscal Year (as defined below). 

 

	 	(c)	 Subject to the limitations and conditions set forth in this Agreement, it is the intention of the Parties that
the Price of each Product reflects one hundred percent (100%) of Manufacturer’s Standard Product Materials Cost plus one hundred and ten percent (110%) of Manufacturer’s Standard Conversion Cost of such Product. The Price for each
Product will be set forth in the currency specified in the applicable Facility Addendum. 

  

	 	(d)	 Changes to the Standard Cost Methodology. Manufacturer shall have the right to change the Standard Cost
methodology once per Fiscal Year; provided that any change shall be consistent with the Accounting Method and applied across all products manufactured at the applicable Facility. If Manufacturer elects to change the Standard Cost
methodology, Manufacturer shall calculate both (i) the revised Standard Cost using the methodology effective during the then-current Fiscal Year of the Term of the applicable Facility Addendum and (ii) the percentage change in Standard
Cost caused by the change in methodology relative to the former methodology. If such Standard Cost methodology change results in an increase of Facility Conversion Cost for Products manufactured for Customer of more than two percent (2%), then
Manufacturer shall revert to the former methodology for purposes of the calculation of Price during such Fiscal Year. 

  

	 	3.2	 Price Adjustment. 

 

	 	(a)	 Product Materials Adjustment. 

 

	 	(i)	 On a Facility-by-Facility
basis, with respect to each full Fiscal Year of the Term of the applicable Facility Addendum, the Price of each Product manufactured at the applicable Facility will be updated to reflect one hundred percent (100%) of the full estimated amount of the
increase or decrease in the cost of Product Materials for each such Product. 

  
 -27- 

	 	(ii)	 In each Fiscal Year of the Term of this Agreement, Manufacturer shall submit a report to Customer by no later
than the end of the first quarter of such Fiscal Year setting out the Facility Actual Product Materials Cost with respect to each Facility for the prior Fiscal Year. In the event that the Facility Actual Product Materials Cost differs from the
Facility Estimated Product Materials Cost, when adjusted to reflect actual volume, then Manufacturer shall issue either (A) an invoice to Customer for any amounts owed by Customer to Manufacturer or (B) a credit memo for amounts owed by
Manufacturer to Customer reflecting the difference between the Price as invoiced and an adjusted Price for such Fiscal Year; provided, however, that any such adjustment made in accordance with the foregoing shall be subject in all
cases to the provisions of Section 3.2(e). Customer shall pay all undisputed amounts due in the currency specified in the applicable Facility Addendum within forty-five (45) calendar days from the date of the invoice. If Customer disputes
all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall notify Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice
shall not result in a waiver of any of Customer’s rights under this Agreement. 

  

	 	(b)	 Conversion Cost Adjustments. 

 

	 	(i)	 Subject to the remainder of this Section 3.2(b), on a
Facility-by-Facility basis, if the Facility Conversion Costs of a Facility during any Fiscal Year following the first full Fiscal Year of the Term of the applicable
Facility Addendum (such Fiscal Year, a “Facility Conversion Cost Adjustment Fiscal Year”) are estimated to be (a) less than seventy-five percent (75%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline
Fiscal Year (as defined below) or (b) greater than one hundred and twenty-five percent (125%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year (clauses (a) and (b) referred to
collectively as the “Facility Conversion Cost Threshold”), when adjusted to reflect a constant volume between the Facility Conversion Cost Adjustment Fiscal Year and the Facility Conversion Cost Baseline Fiscal Year, then the Price
for such Product will be updated beginning with such Facility Conversion Cost Adjustment Fiscal Year to reflect one hundred and ten percent (110%) of the increase or decrease in Facility Conversion Costs. An example calculation of the foregoing
Price adjustment is attached hereto as Attachment G. Subject to the last sentence of Section 3.1(b), the “Facility Conversion Cost Baseline Fiscal Year” shall be, as of the Effective Date, 2019
budget volumes and costs as summarized in the applicable Facility Addenda; provided that in each instance in which the Price is adjusted in accordance with the immediately preceding sentence of this
Section 3.2(b)(i), the Facility Conversion Cost Baseline Fiscal Year shall be the applicable Facility Conversion Cost Adjustment Fiscal Year. 

  
 -28- 

	 	(ii)	 In the event that Price is adjusted as a result of a change to Facility Conversion Cost under
Section 3.2(b)(i), the Facility Conversion Cost Threshold for all remaining Fiscal Years in the Initial Term (or Extension Periods as appropriate) will be reduced such that if Facility Conversion Costs of a Facility during
any Facility Conversion Cost Adjustment Fiscal Year are estimated to be (a) less than eighty percent (80%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year or (b) greater than one hundred and twenty
percent (120%) of the Facility Conversion Costs for the Facility Conversion Cost Baseline Fiscal Year, then the Price for such Product will be updated beginning with such Facility Conversion Cost Adjustment Fiscal Year to reflect the full estimated
amount of the increase or decrease in Conversion Cost. 

  

	 	(iii)	 Notwithstanding anything to the contrary in this Section 3.2(b), Manufacturer shall
not have the ability to adjust the Price to reflect actual volume for Products in a Facility to the extent that Customer has reduced its demand for one or more Products in such Facility due to Manufacturer’s breach of or other failure to supply
under this Agreement or the applicable Facility Addendum. 

  

	 	(iv)	 In each Fiscal Year following the first full Fiscal Year of the Term of this Agreement, Manufacturer shall
submit a report to Customer by no later than the end of the first quarter of such Fiscal Year setting out the actual volume of Product for each Facility for the prior Fiscal Year. In the event that the actual Facility Conversion Costs demonstrate
that the then applicable Facility Conversion Cost Threshold has been exceeded, and Manufacturer had not previously adjusted the applicable Price in accordance with this Section 3.2(b) to account for such adjustment, then
Manufacturer shall either issue (A) an invoice to Customer for any amounts owed by Customer to Manufacturer or (B) a credit memo for amounts owed by Manufacturer to Customer reflecting the difference between the Price as invoiced and the
adjusted Price for such Fiscal Year; provided, however, that any such adjustment made in accordance with the foregoing shall be subject in all cases to the provisions of Section 3.2(b)(iii). For clarity, any
amount owed by Customer to Manufacturer or owed by Manufacturer to Customer shall be one hundred and ten percent (110%) of Manufacturer’s Conversion Cost, reduced by a 20% allowance for variable costs. Customer shall pay all undisputed amounts
due in the currency specified in the applicable Facility Addendum within forty-five (45) calendar days 

  
 -29- 

	 	
from the date of the invoice. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall notify
Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice shall not result in a waiver of any of Customer’s rights under this Agreement. 

 

	 	(c)	 Notwithstanding the above, the price for Buy-Sell Materials will be
updated annually in each year following the first Fiscal Year to reflect one hundred percent (100%) of the full estimated amount of the cost of Buy-Sell Materials to Manufacturer. Customer may not change the
price of Buy-Sell materials during any Fiscal Year. Upon any notification by Customer to Manufacturer of any reduction in the price of Buy-Sell Materials for the
upcoming Fiscal Year, Manufacturer shall submit to Customer an inventory of such Buy-Sell Materials on hand and a calculation of the positive difference between the aggregate price for such Buy-Sell Materials applying the price for the current Fiscal Year and the aggregate price for such Buy-Sell Materials applying the price for the upcoming Fiscal Year. Customer
shall promptly and in no event later than forty-five (45) days issue to Manufacturer a credit memo in the amount of such positive difference reflected in Manufacturer’s notice. 

 

	 	(d)	 The increases or decreases described in this Section 3.2 shall be determined by
Manufacturer in a manner consistent with the accounting methodologies used by Manufacturer as of the Effective Date and shall be based on the applicable Forecasts provided by Customer in July of the applicable Fiscal Year and applied consistently
across Manufacturer’s entire manufacturing operations for the full Facility. 

  

	 	(e)	 Manufacturer shall notify Customer of any estimated expected changes to Prices for the upcoming Fiscal Year by
no later than June 1 of the then-current Fiscal Year and shall notify Customer of any actual changes to Prices for the upcoming Fiscal Year by no later than October 30 of the then-current Fiscal Year. Between June 1 and
October 30, the Parties will engage in ongoing discussions to ensure that any final changes to Prices for the applicable Fiscal Year conform to the terms and conditions of this Agreement. Manufacturer will promptly respond to Customer’s
inquiries regarding any proposed changes to the Price of Products and provide reasonable documentation to Customer supporting the estimated or actual change in such Prices. Any actual, adjusted Price of each Product shall become effective on the
first day of the first month of such upcoming Fiscal Year. 

  

	 	(f)	 Any disputes relating to changes in Price for a given Product will be resolved pursuant to
Section 3.4. 

  
 -30- 

	 	3.3	 Cost Improvement.  

At Customer’s reasonable request, Manufacturer and Customer agree to discuss in good faith the implementation of possible cost reduction
opportunities with the objective to reduce the net Price of Product. Without limiting the generality of the foregoing, Manufacturer shall use commercially reasonable efforts to reduce the price of Product Materials. 

 

	 	3.4	 Price Review and Audit Procedure.  

 

	 	(a)	 Manufacturer shall maintain complete and accurate Records that fairly reflect the relevant costs and
calculations used to determine the Price of each Product and shall retain such Records for a period of not less than three (3) years after the applicable Product was manufactured and delivered hereunder. With respect to a Price change under
Section 3.2 for any Product in an upcoming Fiscal Year, if Customer requests such a review in writing within thirty (30) days following notice to Customer of such change, then: (i) the Parties shall reasonably
discuss and attempt to resolve any disagreement with respect thereto and (ii) if such disagreement is not resolved within thirty (30) days following commencement of such discussions, Customer shall have the right, no more than one
(1) time per Fiscal Year each for the subject of (1) and (2) below and on no less than thirty (30) days’ notice to Manufacturer, to appoint a reputable and internationally recognized independent Third-Party audit firm reasonably
acceptable to Manufacturer (and which agrees to be bound by Manufacturer’s customary confidentiality agreement) to audit such relevant Records, during normal business hours and on a confidential basis, to verify that, either (1) the change
in the relevant Products’ Price for an applicable Facility for the upcoming Fiscal Year, as applicable, or (2) the true-up determination with respect to (x) the estimated and actual Facility
Conversion Costs of a Facility with respect to any Fiscal Year or (y) the Facility Estimated Product Materials Cost and the Facility Actual Product Materials Cost with respect to any Fiscal Year, was accurately and equitably calculated by
Manufacturer in accordance with this Agreement; provided that Customer shall be deemed to have waived its right for such a review if Customer does not make such request within thirty (30) days following delivery of Manufacturer’s
notice to Customer of such increase. For the avoidance of doubt, any such audit initiated by Customer in accordance with clause (ii) above shall include in the scope of audit all of the Products manufactured at the applicable Facility,
and not be limited in scope to the discrete Product(s) in question. Subject to Section 3.4(b)(2), Customer shall bear all costs and expenses of conducting such an audit, and such accounting firm shall work on an hourly or
flat fee basis without a contingency fee or other performance or bonus fee. Such accounting firm shall, as promptly as practicable, provide in writing (I) a detailed report of such audit to Manufacturer and (II) a separate report limited
to the Price for the subject Products in the relevant Fiscal Year as calculated by such accounting firm 

  
 -31- 

	 	
in accordance with this Agreement to Manufacturer and Customer. The Price for the Products during a Fiscal Year, as calculated by such accounting firm, absent any manifest error, shall be binding
upon the Parties with respect to such increase or required payment, as applicable; provided that, within fifteen (15) days of receipt of the audit report, Manufacturer shall have the right to dispute such Price or calculation thereof by
submitting written notice to Customer and the accounting firm accompanied by information supporting Manufacturer’s position. Within thirty (30) days of receipt of Manufacturer’s notice of dispute, the accounting firm shall issue its
final findings with respect to the Price for the relevant Product in the relevant Fiscal Year and such decision, absent manifest error, shall be binding upon the Parties. 

 

	 	(b)	 If, as a result of any audit by Customer pursuant to Section 3.4(a), the aggregate
Price calculated by the accounting firm with respect to all Products manufactured at the applicable Facility for a Fiscal Year is: 

  

	 	(i)	 less than ninety-five percent (95%) of the aggregate Price for all such Products established by Manufacturer
pursuant to Section 3.2 for such Products during such Fiscal Year, then, if Customer has made payments to Manufacturer for such Products at the higher Price established by Manufacturer during such Fiscal Year, Manufacturer
shall refund to Customer the overpayment made by Customer; or 

  

	 	(ii)	 more than one hundred and five percent (105%) of the aggregate Price for all such Products established by
Manufacturer pursuant to Section 3.2 for such Products during such Fiscal Year, then, if Customer has made payments to Manufacturer for such Products at the lower Price established by Manufacturer for such period, Customer
shall promptly pay Manufacturer for the amount of the underpayment that should have been paid by Customer; 

 in each case
of clauses (i) and (ii), (1) such payment to be made within forty-five (45) days of the owing Party’s receipt of the relevant detailed report and final Price pursuant to
Section 3.4(a) and (2) Manufacturer shall be responsible for payment of the applicable accounting firm’s reasonable and actual fees in connection with such audit. 

 

	 	3.5	 Invoices and Payment. 

Manufacturer shall submit invoices to Customer upon Delivery of Product. All invoices for Products will be in functional currency unless
otherwise specified in the applicable Facility Addendum, and all undisputed payments hereunder shall be in full and be made without any withholding, offset or any other deductions. Manufacturer shall include the following information on all
invoices: (a) the applicable Purchase Order number and billing address; (b) the quantity of Product 

  
 -32- 

 
delivered (and where applicable, the type, description or part number, if any); (c) the required delivery date specified in the applicable Purchase Order; (d) the actual date of Delivery;
(e) the Price; (f) any applicable Taxes, transportation charges or other charges provided for in the applicable Purchase Order; (g) the applicable invoice number; and (h) the Delivery Facility, unless otherwise
specified in the Facility Addendum. Subject to Customer’s rights under Section 4.8 to reject Non-Complying Product or Product that is not otherwise Delivered in
accordance with the terms of and conditions of this Agreement, Manufacturer shall invoice Customer for Product upon Delivery of the applicable Product in accordance with Section 2.6(a). Customer shall be obligated to pay
only for actual quantities of Product delivered. Unless otherwise set forth in the applicable Facility Addendum with respect to a particular Product or Products, Customer shall pay all undisputed amounts due in the currency specified in the
applicable Facility Addendum within forty-five (45) calendar days from the date of the invoice. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute, and in such event Customer shall
notify Manufacturer of the amount and nature of the dispute. Payment by Customer of any amount reflected in any invoice shall not result in a waiver of any of Customer’s rights under this Agreement. If any payment required to be made under this
Agreement is not made within twenty (20) days of the applicable date when such payment is due (the “Late Payment Date”), interest shall accrue on such past due amount from the Late Payment Date until the date payment is
actually made at a quarterly rate equal to the lesser of (i) the Three-Month U.S. dollar LIBOR (Reuters Page LIBOR01) on the Late Payment Date (or the next Business Day if such Late Payment Date is not a Business Day), and (ii) the maximum
rate permitted by applicable Law. Time for any payments hereunder shall be of the essence. 
  

	 	3.6	 Taxes. 

 

	 	(a)	 All sums payable under this Agreement are exclusive of any amount in respect of VAT. If any action of one Party
(the “Supplier”) under this Agreement constitutes, for VAT purposes, the making of a supply to another Party (or a member of that Party’s Group) (the “Recipient”) and VAT is or becomes chargeable on that supply, the
Recipient shall pay to the Supplier, in addition to any amounts otherwise payable under this Agreement by the Recipient, a sum equal to the amount of the VAT chargeable on that supply against delivery to the Recipient of a valid VAT invoice issued
in accordance with the laws and regulations of the applicable jurisdiction. 

  

	 	(b)	 Without duplication of amounts covered by Section 3.6(a), Customer (or the applicable
Affiliate) shall be responsible for all VAT, sales, goods and services, use, gross receipts, transfer, consumption and other similar Taxes (excluding, for clarity, Taxes imposed on net income, profits and gains and franchise Taxes), together with
interest, penalties and additions thereto (“Service Taxes”), imposed by applicable taxing authorities on the direct sale of Products to Customer or any of its Affiliates or any payment hereunder; provided that such Service
Taxes are shown on a valid invoice. 

  
 -33- 

	 	
If Manufacturer or any of its Affiliates is required to pay any part of such Service Taxes, Manufacturer shall provide Customer with evidence that such Service Taxes have been paid, and Customer
(or its applicable Affiliate) shall reimburse Manufacturer for such Service Taxes. Manufacturer shall, upon the reasonable request of Customer, promptly revise any invoice to the extent such invoice was erroneously itemized or categorized. Each
Party shall, and shall cause its Affiliates to, use commercially reasonable efforts to (i) minimize the amount of any Service Taxes imposed on the provision of Services hereunder, including by availing itself of any available exemptions from or
reductions to any such Service Taxes, and (ii) cooperate with the other Party in providing any information or documentation that may be reasonably necessary to minimize such Service Taxes or obtain such exemptions or reductions. If at any time
Manufacturer (or any of its Affiliates) receives a refund (or credit or offset in lieu of a refund) of any Service Taxes borne by Customer (or any of its Affiliates), then Manufacturer or its Affiliate receiving such refund or utilizing such credit
or offset shall promptly pay over the amount of such refund, credit or offset (net of all reasonable related out-of-pocket costs, expenses and Taxes incurred in respect
thereof) to Customer or its applicable Affiliate, it being understood that Customer and its applicable Affiliate shall be liable for (x) any subsequent disallowance of such refund, credit or offset and any related interest, penalties or
additions thereto and (y) any reasonable out-of-pocket costs and expenses related to such disallowance. 

 

	 	(c)	 The Parties and their Affiliates shall reasonably cooperate to determine whether any Tax withholding applies to
any amounts paid under this Agreement and, if so, shall further reasonably cooperate in (i) minimizing the amount of any such withholding Taxes, including by availing itself of any available exemptions from or reductions to any such withholding
Taxes, (ii) providing any information or documentation that may be reasonably necessary to minimize such withholding Taxes or obtain such exemptions (including, without limitation, pursuant to any applicable double taxation or similar treaty)
or (iii) receiving a refund of such withholding Taxes or claiming a Tax credit therefor. If any such withholding is required by applicable Law, the paying Party (or its applicable Affiliate) shall properly and timely withhold and remit such
Taxes to the applicable taxing authority and use reasonable efforts to provide the other Party with a copy of any receipt (where it is common practice for the applicable taxing authority to provide such a receipt) or other documentation confirming
such payment, and such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the receiving Party (or its applicable Affiliate). The paying Party (or its applicable Affiliate) shall not be required to “gross
up” any amounts invoiced to the paying Party to account for, or otherwise compensate the receiving Party (or its applicable Affiliate) for, any Taxes that are required to be withheld under applicable Law. 

  
 -34- 

	 	(d)	 Where a Party or any member of its Group is required by this Agreement to reimburse or indemnify the other
Party or any member of its Group for any cost or expense, the reimbursing or indemnifying Party (or the applicable member of its Group) shall reimburse or indemnify the other Party (or the applicable member of its Group) for the full amount of the
cost or expense, inclusive of any amounts in respect of VAT imposed on that amount to the extent properly reflected on a valid invoice, except to the extent that the reimbursed or indemnified Party reasonably determines that it (or such member of
its Group), or a member of the same group as it (or such member of its Group) for VAT purposes, is entitled to credit for or repayment of that VAT from any relevant taxing authority. 

 

	 	(e)	 For purposes of this Agreement, and except as otherwise specifically provided in this Agreement, Tax matters
shall be exclusively governed by the Tax Matters Agreement, and in the event of any inconsistency between the Tax Matters Agreement and this Agreement with respect to Tax matters, the Tax Matters Agreement shall control. 

 

	 	3.7	 No Duplicative Payments. Notwithstanding anything to the contrary in this
Agreement, no Party (or Affiliate thereof) shall enjoy a duplicative right, entitlement, obligation, or recovery with respect to any matter arising out of the same facts and circumstances. 

 

	4.	 Manufacturing Standards and Quality Assurance. 

 

	 	4.1	 Quality Agreement. 

On a Facility-by-Facility and
Product-by-Product basis, the Parties will comply with the requirements and provisions set forth in the Quality Agreement applicable to the applicable Facility and
Product, the form of which has been attached hereto as Attachment B and, through such attachment, made a part hereof. In the event of a conflict between the terms of the applicable Quality Agreement and the terms of this Agreement, the terms
of the Quality Agreement shall govern and control for all quality and regulatory compliance matters and the terms of this Agreement shall govern and control for all other matters. 

 

	 	4.2	 Manufacturing Standards. 

Manufacturer shall manufacture and supply each Product (including disposing of all Waste and other materials) in accordance with all
applicable Specifications, applicable Laws, requirements under the applicable Quality Agreement, and this Agreement. 

  
 -35- 

	 	4.3	 Manufacturing Changes. 

 

	 	(a)	 Discretionary Changes. Subject to Section 4.3(b), in the event that either
Party desires to change, revise, modify or otherwise alter the Specifications, manufacturing processes, Product Materials, Buy-Sell Materials, Customer-Supplied Materials, or Facilities with respect to a given
Product in any manner (each, a “Manufacturing Change”), the Party desiring the Manufacturing Change shall notify the other Party in writing of the proposed Manufacturing Change and the Parties will promptly meet to discuss, in good
faith, the feasibility of implementing such Manufacturing Change and the allocation of costs between the Parties for such Manufacturing Change; provided that the requested Manufacturing Change will not be implemented unless and until the
Parties mutually agree in writing to implement such Manufacturing Change. Unless otherwise agreed upon by the Parties, the Party requesting the Manufacturing Change will be responsible for, and will bear the costs of, any filings or other actions
that either Party must take with the applicable Governmental Authority as a result of such Manufacturing Change. 

  

	 	(b)	 Required Changes. If, at any time, a Manufacturing Change is required by a Governmental Authority in a
country in which Regulatory Approval for a given Product has been granted, a Governmental Authority in a country in which Customer seeks to obtain Regulatory Approval for a given Product, or a Governmental Authority in the country in which the
Facility that manufactures a given Product is located, then the Party that first has knowledge of the required Manufacturing Change shall notify the other Party in writing of such required Manufacturing Change, and Manufacturer will review such
Manufacturing Change with Customer. Manufacturer will bear all costs and expenses associated with implementing the Manufacturing Change, unless such Manufacturing Change relates solely to a Product or Products manufactured for Customer (including
any required labeling changes), in which case Customer will bear all costs and expenses associated with implementing such Manufacturing Change for such Product, including any changes to labeling or packaging, but only to the extent such costs are
reasonable and documented. 

  

	 	4.4	 Pest Control. 

Manufacturer shall manufacture all Products, and Manufacturer shall store all Product Materials,
Buy-Sell Materials, Customer-Supplied Materials, and all Products, in a clean, dry area, free from insects and rodents, in a manner to prevent entry of foreign materials and contamination of Product.
Manufacturer’s pest control measures shall include the adequate cleaning of the Facility, control of food and drink, protection of Product from the environment, monitoring of flying and crawling pests and logs detailing findings and actions
taken. Manufacturer’s pest control program shall be detailed in a written procedure which complies with applicable Laws, including cGMPs, and which shall be subject to review and approval by Customer. If Customer has specific concerns about
procedures in place at any Facility, Customer will present such issues in its audit findings and the Parties will discuss in good faith a mutually agreeable plan for resolution of such issues. Failure of Manufacturer to comply with this
Section 4.4 shall be deemed a material breach of this Agreement. 

  
 -36- 

	 	4.5	 Legal and Regulatory Filings and Requests. 

 

	 	(a)	 Manufacturer shall reasonably cooperate with Customer in responding to all requests for information from, and
in making all legally required filings with, Governmental Authorities in the Territory having jurisdiction to make such requests or require such filings. Manufacturer shall: (a) obtain and comply with all licenses, consents and permits required
under applicable Laws in the Territory (and Manufacturer shall provide Customer with a copy of all such licenses, consents and permits that are material upon Customer’s reasonable request); and (b) comply with all applicable Laws in the
Territory with respect to its manufacturing and packaging processes, the Facility or otherwise, to permit the performance of its obligations hereunder. Upon Customer’s request, Manufacturer shall apply for and obtain Certificates of
Pharmaceutical Production (“CPP”) from the Governmental Authorities of the country where the Facility is located, such CPPs to be issued to countries where CPPs according to Customer’s opinion are required. Manufacturer shall
pay all reasonable costs necessary to obtain such CPPs and be entitled to be reimbursed against invoice by Customer at cost; provided that Manufacturer shall make good faith efforts to consolidate its invoices for such reimbursement for CPPs
and submit to Customer on a Fiscal Year quarterly basis. 

  

	 	(b)	 In the event that Customer wishes to extend the Territory with respect to a certain Product, Customer shall
notify Manufacturer of such request and Manufacturer shall consider Customer’s request in good faith. For the avoidance of doubt, in the event that the Parties agree to extend the Territory with respect to a certain Product, any resulting
Manufacturing Change shall be treated as a discretionary Manufacturing Change and governed by Section 4.3(a). 

  

	 	4.6	 Quality Tests and Checks. 

Manufacturer shall perform all bulk holding stability, manufacturing trials, validation (including, but not limited to, method, process and
equipment cleaning validation), raw material, in-process, bulk finished product and stability (chemical and/or microbial) tests or checks required to assure the quality of a given Product and any tests or
checks required by the Specifications, the Quality Agreement, applicable Facility Addendum or applicable Laws. With respect to any Product manufactured prior to Closing or located at a Facility as of Closing, Manufacturer shall maintain, continue
and complete any and all such activities, tests and checks, including, without limitation, all ongoing stability testing. All costs associated with the performance of Manufacturer’s obligations under this Section 4.6
(including with respect to any Product manufactured prior to Closing or located at a Facility as of Closing) are included in the Price of each Product and, accordingly, Manufacturer shall perform the foregoing at its cost and expense, without
further reimbursement from Customer. Manufacturer shall obtain Product for these tests from batches of Product manufactured under this Agreement, and Manufacturer is 

  
 -37- 

 
responsible for providing all necessary technical, quality and operational resources. All tests and test results shall be performed, documented and summarized by Manufacturer in accordance with
the Specifications, Quality Agreement, applicable Facility Addendum, applicable Laws and reasonable quality assurance requirements provided by Customer to Manufacturer in writing. Manufacturer shall maintain all production Records and disposition of
each batch of Product. 
  

	 	4.7	 Responsibility for Non-Complying Product.

 Manufacturer shall not release any Product for Delivery to Customer that does not conform to the covenants set
forth in Section 5.2(e) (such non-conforming Product, “Non-Complying Product”), without the prior written approval of
Customer. Manufacturer shall quarantine all such Non-Complying Products and shall promptly submit to Customer a report detailing the nature of such non-compliance and
Manufacturer’s recommended disposition, including the investigation and testing done. Manufacturer shall also provide any additional information regarding such Non-Complying Product as may reasonably be
requested by Customer. Customer shall not be required to pay for any Non-Complying Product or for the destruction or other disposition thereof (unless an investigation determines that the root cause for such
Product being Non-Complying Product is Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Material). 
  

	 	4.8	 Rejection of Non-Complying Product.

  

	 	(a)	 Customer’s Ability to Reject. Customer may reject any
Non-Complying Product or Product that is not delivered to Customer in accordance with this Agreement by providing written notice of such rejection to Manufacturer within seventy-five (75) days following
Customer’s receipt of any Delivery of Product hereunder; provided, however, that Customer may, until the expiry date for a Product, provide notice of rejection of any Delivery of such Product having (i) latent defects,
(ii) any defects that are not reasonably discoverable by Customer through standard inspection and testing of Products or (iii) defects caused by the breach by Manufacturer of any of its representations or warranties under this Agreement
(collectively, “Latent Defects”); provided, further, that, and notwithstanding the foregoing, Customer shall notify Manufacturer within sixty (60) days after Customer first becomes aware of any such Latent Defect.

  

	 	(b)	 Manufacturer’s Ability to Reject. Manufacturer may reject any
Non-Complying Product by (i) providing Customer with no less than sixty (60) days’ prior written notice of Manufacturer’s intention to reject such
Non-Complying Product along with the documentation set forth in Section 4.7, (ii) meeting with Customer at Customer’s request to discuss the basis for the proposed rejection of
the subject Non-Complying Product, and (iii) providing Customer with notice of rejection in the event that Manufacturer rejects the subject Non-Complying Product at
the end of such sixty (60) day period (or such other time frame as the parties may agree upon). 

  
 -38- 

	 	(c)	 Manufacturer’s Obligation; Replacement. Manufacturer shall respond to any rejection,
defect notice or any quality-related complaint from Customer pursuant to Section 4.8(a) in a timely manner or such other time frame as may be specified in the applicable Quality Agreement. Manufacturer shall conduct an
analysis of the causes of any such complaint, shall report to Customer on any corrective action taken and shall reasonably consider Customer’s suggestions related to such corrective action or other quality-related matters. Customer shall
promptly return any Product (or portions thereof) rejected pursuant to Section 4.8(a) to Manufacturer at Manufacturer’s expense. With respect to any Non-Complying Product
rejected by Customer, in addition to any other rights or remedies of Customer hereunder, Customer may elect, in its sole discretion, upon written notice to Manufacturer to either (i) have Manufacturer replace any
Non-Complying Product as soon as practicable at no additional charge to Customer; provided that (A) the Manufacturer shall replace such Non-Complying Product
within a period of ninety (90) days beginning on the date that the Manufacturer confirms or a Third-Party laboratory determines that the subject Product is a Non-Complying Product, and (B) if
Manufacturer fails to replace such Non-Complying Product within such ninety (90) day period, then a Triggering Event shall be deemed to have occurred and the provisions of
Section 2.5 shall apply; or (ii) be reimbursed for the Price of the Non-Complying Product actually paid. Manufacturer shall reimburse Customer for the cost of all
Customer-Supplied Materials used to manufacture any Non-Complying Product (unless such Product is a Non-Complying Product due to any
Non-Complying Customer-Supplied Material, as applicable). 

  

	 	(d)	 Independent Testing. If the Parties are unable to agree on whether Product rejected by Customer is Non-Complying Product, then Manufacturer may hire an independent Third-Party laboratory, subject to Customer’s prior written approval of such laboratory, not to be unreasonably withheld, conditioned or delayed,
to perform testing on such rejected Product in accordance with the Specifications, applicable Laws and the Quality Agreement, which Third Party laboratory shall promptly provide the results thereof to Customer and Manufacturer. Manufacturer must
engage such Third-Party laboratory within the thirty (30) day period following Manufacturer’s receipt of Customer’s rejection notice. If Manufacturer fails to engage such Third-Party laboratory during such thirty (30) day period,
then Manufacturer will be deemed to have waived its right to engage such Third-Party laboratory. The determination of such tests shall be binding upon the Parties for all purposes hereunder; provided that, if such tests are unable to
determine whether or not such rejected Product is Non-Complying Product, or if Manufacturer does not engage such Third-Party laboratory within the thirty (30) day period, then such Product shall be deemed
to be Non-Complying Product. If such tests determine that the rejected Product is, or such Product is so deemed to be, Non-Complying Product, then Manufacturer shall
bear the costs of such tests and Customer’s 

  
 -39- 

	 	
remedies with respect to Non-Complying Product as set forth in this Agreement shall apply to such Non-Complying
Product. Otherwise, Customer shall (i) bear the costs of such tests and shall remain obligated to pay Manufacturer the Price for such Product in accordance with Section 3 and (ii) reimburse Manufacturer for any
shipping charges paid by Manufacturer pursuant to Section 4.8(c) with respect to the return of such Product to Manufacturer. Without limiting the foregoing obligations, if Customer reasonably requests in writing, then
Manufacturer shall use commercially reasonable efforts to re-deliver such Product to Customer at Customer’s expense. For the avoidance of doubt, provided that the Product conforms to the minimum
shelf-life dating set forth in Section 5.2(e)(v) upon initial Delivery, such minimum shelf-life dating requirement shall not apply to the subject Product upon re-delivery in
accordance with the immediately preceding sentence. 

  

	 	(e)	 Survival. The provisions of this Section 4.8 shall survive termination or
expiration of this Agreement or the applicable Facility Addendum. 

  

	 	4.9	 Disposal of Rejected and Non-Complying Product.

 All Non-Complying Product and Product rejected pursuant to this Agreement
shall be removed (if applicable) and disposed of by Manufacturer in accordance with all applicable Laws, and as approved in advance by Customer in writing (such disposal cost to be at Manufacturer’s expense, unless it is subsequently determined
that Customer wrongly rejected such Product pursuant to Section 4.8). Manufacturer shall make documentation relating to such disposition available to Customer upon Customer’s reasonable request. Manufacturer shall not
sell for salvage or for any other purpose any rejected or Non-Complying Product, without the prior written approval of Customer. Manufacturer shall destroy all
Non-Complying Product prior to disposal and Manufacturer shall deface and render unreadable all words or symbols that identify Customer, including Customer’s trademarks and logotypes that adorn any
packaging containing such Product, prior to disposal of such Product. 
  

	 	4.10	 Maintenance and Retention of Records.  

Manufacturer shall maintain detailed Records with respect to Product Materials, Buy-Sell Materials,
and Customer-Supplied Materials usage and finished Product production in accordance with the Quality Agreement. 
  

	 	4.11	 Government Inspections, Seizures and Recalls. 

 

	 	(a)	 Notification; Initiation of Recalls. If (i) Manufacturer determines or comes to learn that a
Product distributed to the market contains a latent defect or (ii) the FDA or any other Governmental Authority conducts an inspection at Manufacturer’s Facility, seizes any Product, Buy-Sell
Materials, Customer-Supplied Materials, or Product Materials, requests a Recall of 

  
 -40- 

	 	
any Product, Buy-Sell Materials, Customer-Supplied Materials, or Product Materials, or otherwise notifies Manufacturer of any violation or potential
violation of any applicable Law at the Facility, or (iii) Customer notifies Manufacturer of its intent to initiate a Recall, then, with respect to each ((i)-(iii)), Manufacturer shall promptly notify Customer (as applicable) and shall take such
actions as may be required under the Specifications or Quality Agreement. As applicable, Manufacturer shall promptly send any reports relating to such inspections, Recalls, violations or potential violations of applicable Law to Customer;
provided that Manufacturer may reasonably redact any such reports to protect its confidential and proprietary Information that does not relate to Products. In the event that any such Governmental Authority requests, but does not seize, a
given Product in connection with any such inspection, Manufacturer shall, to the extent reasonably practicable and permitted by applicable Law (1) promptly notify Customer of such request, (2) satisfy such request only after receiving
Customer’s approval, (3) follow any reasonable procedures instructed by Customer in responding to such request and (4) promptly send any samples of the applicable Product requested by the Governmental Authority to Customer.
Manufacturer shall give and permit full and unrestricted access to all or any of its premises at any time to any authorized representative of any Governmental Authority or any of its agents or advisers and shall cooperate fully with any such
representatives, in each case, relating to any such inspection. Manufacturer shall not initiate any Recall of Product, except as provided in the Quality Agreement, without the prior written agreement by Customer. 

 

	 	(b)	 Costs. In the event a Recall results from any breach by Manufacturer of this Agreement, including
Recalls on account of a given Product containing a latent defect, in addition to any other rights or remedies available to Customer under this Agreement, Manufacturer shall reimburse Customer for Customer’s costs and expenses associated with
such Recall, including costs of materials supplied by Customer (including Customer-Supplied Materials), shipping costs, administrative costs associated with arranging and coordinating the Recall and all actual Third Party costs associated with the
distribution of replacement Product; provided that Customer shall be solely responsible for all, and shall reimburse Manufacturer for Manufacturer’s costs and expenses associated with any Recall to the extent such Recall does not result
from a breach by Manufacturer of this Agreement (e.g., is due to any Non-Complying Customer-Supplied Material or
Non-Complying Buy-Sell Material). 

  

	 	4.12	 Inspections. 

Subject to the remainder of this Section 4.12, no more than once per calendar year, upon thirty (30) days’
advance written notice to Manufacturer, Customer may physically inspect or audit (consistent with Section 15.2) the Facilities under this Section 4.12; provided that Customer will use good
faith efforts to choose dates of 

  
 -41- 

 
inspection or audit that do not unreasonably interfere with the operation of Manufacturer’s business; provided, further, that Customer shall consider in good faith any
alternative dates of inspection or audit proposed by Manufacturer within five (5) days of Manufacturer’s receipt of such notice (it being understood that nothing in this Section 4.12 shall require Customer to
accept any such proposed alternative dates of inspection or audit). Notwithstanding the limits set forth in the foregoing sentence, Customer may more frequently conduct “for cause” physical inspections or audits of a Facility with five
(5) days’ advance written notice to Manufacturer if Customer has reasonable cause to believe that an inspection or audit of such Facility is warranted because Manufacturer’s activities with respect to such Facility are in breach of
this Agreement, applicable Laws, the Quality Agreement or the applicable Facility Addendum. Any such inspection or audit shall include access to relevant Records (subject to the terms of Section 15.2) and Personnel and
being present during, as applicable, start-up manufacturing operations, validation, cleaning, sampling, laboratory testing, warehouse receiving and storage, pack out and shipping. Manufacturer shall provide
technical assistance and direction to Customer and its representatives at the Facility. Subject to the terms and conditions set forth herein, Customer may conduct, at its own expense, periodic quality audits, to ensure Manufacturer’s compliance
with the terms of this Agreement. Manufacturer shall cooperate with Customer’s representatives for all of these purposes, and shall promptly correct any deficiencies noted during the audits. Any Records or information accessed or otherwise
obtained by Customer or its representatives during any such inspection or audit or any visit at any Facility shall be deemed Manufacturer’s confidential and proprietary Information and each representative of Customer will be subject to non-use and other confidentiality obligations substantially comparable to those set forth herein for Customer. 
  

	 	4.13	 Segregation of Restricted Compounds. 

Unless otherwise set forth in a Facility Addendum with respect to a Product, Manufacturer shall not manufacture a Product using facilities or
equipment shared with the following classes of product without prior consultation and agreement with Customer: (a) steroids, hormones, or otherwise highly active or toxic products that carry a likelihood of a serious adverse effect
(e.g., carcinogenicity; anaphylaxis; reproductive and/or developmental toxicity; serious target organ toxicity) following a potential product cross-contamination or carry-over scenario, particularly at low exposure concentrations
(i.e., with reference to an acceptable daily exposure (ADE) value or permitted daily exposure (PDE) value < 10 μg/day); (b) immunosuppressors where the ADE or PDE value < 10 μg/day; (c) live or infectious biological
agents; (d) live or attenuated vaccines; (e) biotherapeutics where the ADE or PDE value < 10 μg/day and sufficient deactivation cannot be demonstrated; (f) products exclusive for animal use;
(g) non-medicinal products; or (h) radiopharmaceuticals. Manufacturer shall not manufacture any highly sensitizing products, including beta-lactam antibiotics, as well as certain non-beta-lactam antibiotics, or otherwise highly sensitizing products that can elicit an immediate hypersensitivity reaction (Type I hypersensitivity; immunoglobulin
E-mediated) in the same Facility as a Product. 

  
 -42- 

	 	4.14	 Packaging Material. 

Unless otherwise provided in the applicable Facility Addendum, Customer shall determine and be responsible for the text (including any logos
or other graphics) for all packaging material used in connection with Product. Manufacturer shall assure that all packaging materials are accurate and consistent with Customer’s specifications for such text or graphics, including such matters
as placement, size and colors. Manufacturer shall promptly notify Customer of any errors or deficiencies in such provided packaging materials. 
  

	5.	 Covenants. 

 

	 	5.1	 Mutual Covenants. Each Party hereby covenants to the other Party that it will perform its
activities under this Agreement in full compliance with all applicable Global Trade Control Laws, including as follows: 

  

	 	(a)	 unless a license or other authorization is first obtained, the issuance of which is not guaranteed, neither
Party will knowingly transfer to the other Party any goods, software, technology or services that are (1) controlled at a level other than EAR99 under the U.S. Export Administration Regulations; (2) controlled under the U.S. International
Traffic in Arms Regulations; (3) specifically identified as an E.U. Dual Use Item; or (4) on an applicable export control list of a foreign country; 

 

	 	(b)	 prior to engaging in any activities in a Restricted Market, involving individuals ordinarily resident in a
Restricted Market or including companies, organizations, or Governmental Authorities from or located in a Restricted Market in each case in connection with this Agreement, each Party must first notify the other Party (which notice, notwithstanding
Section 18, shall be addressed to (a) Pluto at gtc@pfizer.com and (b) Spinco at an email address designated by Spinco to Pluto), who will review and, if compliant with Global Trade Control Laws, approve (subject
to any appropriate conditions) such activities (such approval not to be unreasonably withheld or delayed), within five (5) Business Days of such notification; provided that (1) to the extent relating to U.S. sanctions or export
controls, such notification and approval shall not be required if the activity contemplated would be permissible for U.S. persons subject to U.S. sanctions (including without limitation under a U.S. Department of the Treasury Office of Foreign
Assets Control general license), and (2) once notification is made and approval is granted with respect to a specific counterparty in a Restricted Market, further notification and approval will not be required for future transactions or
activities with the same counterparty (unless there is a change in circumstances, processes or intermediate parties, including, but not limited to, carriers, or otherwise a change to Global Trade Control Laws relevant to that Restricted Market or
counterparty); provided that, notwithstanding the foregoing, neither Party shall undertake any of the activities described in this clause (2) without the prior written approval of the other Party; and 

  
 -43- 

	 	(c)	 notwithstanding anything set forth in Section 4.14 to the contrary, for the purposes
of any and all packaging and shipping of any goods, software, technology or services pursuant to the activities contemplated under this Agreement, Manufacturer will determine: 

 

	 	(i)	 a classification under relevant import and export laws; 

 

	 	(ii)	 the country of origin; and 

 

	 	(iii)	 a value for customs; 

provided, however, that the Party acting as the importer of record (IOR) or exporter of record (EOR) shall have the right to
request a review of any determination contemplated by clause (i), (ii) or (iii) above; provided, further, that if the IOR or EOR (as applicable) disagrees with such determination, then such Party shall
maintain the right to refuse to export or import the applicable goods, software, technology or services. 
  

	 	5.2	 Manufacturer Covenants. Manufacturer hereby covenants to Customer that:

  

	 	(a)	 The Facility and all equipment, tooling and molds utilized in the manufacture and supply of Product hereunder
by or on behalf of Manufacturer shall, during the Term of this Agreement, be maintained in good operating condition and shall be maintained and operated in accordance with all applicable Laws. The manufacturing and storage operations, procedures and
processes utilized in manufacture and supply of Product hereunder (including the Facility) shall be in full compliance with all applicable Laws, including cGMP and health and safety laws. 

 

	 	(b)	 Manufacturer shall perform all of its obligations under this Agreement in compliance with the applicable Laws
in the Territory. Manufacturer is in compliance and shall continue to comply, and shall cause its Personnel to comply, with all applicable Laws, including Laws requiring Serialization; provided that, with respect to compliance with Laws
requiring Serialization, Customer shall reimburse Manufacturer for all investments made or costs incurred by Manufacturer in connection with any Serialization requirements specific to a given Product or Products (which, for clarity, shall not
include Serialization requirements applicable to both Products and other products produced by Manufacturer in the Facility), but only to the extent such costs are reasonable and documented and are directed specifically with respect to a Product or
Products. Manufacturer has and shall continue to have, and shall cause its Personnel to have, all professional licenses, consents, authorizations, permits, and certificates, and shall have and shall cause its Personnel to have completed all
registrations and made such notifications as required by applicable Law for its performance of the services under this Agreement. 

  
 -44- 

	 	(c)	 Manufacturer shall hold during the Term of this Agreement all licenses, permits and similar authorizations
required by any Governmental Authority in the Territory for Manufacturer to perform its obligations under this Agreement. 

  

	 	(d)	 Manufacturer shall have good title to all Product supplied to Customer pursuant to this Agreement and shall
pass such title to Customer (or its designee) free and clear of any security interests, liens, or other encumbrances. 

  

	 	(e)	 Products furnished by Manufacturer to Customer under this Agreement: 

 

	 	(i)	 shall be manufactured, packaged, labeled, handled, stored and Delivered in accordance with, shall be of the
quality specified in, and shall conform upon Delivery to Customer (or its designee) to, the Specifications; 

  

	 	(ii)	 shall be manufactured, packaged, labeled, handled, stored and Delivered in compliance with all applicable Laws
including, without limitation, cGMPs, and in accordance with the Quality Agreement, this Agreement and the applicable Facility Addendum; 

  

	 	(iii)	 shall not contain any Product Material that has not been used, handled or stored by or on behalf of
Manufacturer in accordance with the Specifications, all applicable Laws, the Quality Agreement, this Agreement and the applicable Facility Addendum; 

  

	 	(iv)	 shall not be adulterated or misbranded within the meaning of Sections 501 and 502, respectively, of the Act or
any other applicable Law; and 

  

	 	(v)	 shall, at the time Delivered, have at least a remaining shelf-life as specified in the applicable Facility
Addendum. 

 Notwithstanding the foregoing clauses (i) through (v) of this
Section 5.2(e) or anything else contained in this Agreement or any Facility Addendum or Quality Agreement, Manufacturer shall have no liability under this Agreement (including under Section 4.11(b)
or Section 10.1) or any Facility Addendum or Quality Agreement for any Non-Complying Product which is non-complying due to any Non-Complying Customer-Supplied Materials or Non-Complying Buy-Sell Materials. 

  
 -45- 

	 	(f)	 Manufacturer has not and will not directly or indirectly offer or pay, or authorize such offer or payment, of
any money or anything of value or improperly or corruptly seek to influence any Government Official or any other Person in order to gain an improper business advantage, and, has not accepted, and will not accept in the future, such a payment.
Manufacturer will comply with the Anti-Bribery and Anti-Corruption Principles set forth in Attachment D. 

  

	 	(g)	 Manufacturer shall ensure that it and its Personnel comply with the standard policies, regulations and
directives listed on Attachment E and incorporated herein. 

  

	 	5.3	 Manufacturer’s Social Responsibility. 

 

	 	(a)	 Manufacturer covenants that it shall not, during the Term of this Agreement (i) use involuntary or
underage labor (defined in accordance with applicable Laws) at the Facilities where its performance under this Agreement will occur or (ii) maintain unsafe or unhealthy conditions in any dormitories or lodging that it provides for its
employees. Manufacturer agrees that during the Term of this Agreement, it shall promptly correct unsafe or unhealthy conditions in any dormitories or lodging that it provides for its employees. 

 

	 	(b)	 Manufacturer covenants that it will perform its obligations under this Agreement in a manner consistent with
all of the Pharmaceutical Industry Principles for Responsible Supply Chain Management, as codified as of the Effective Date at http://www.pharmaceuticalsupplychain.org. 

 

	 	(c)	 Manufacturer shall not use, and shall not allow to be used, any (i) cassiterite, columbite-tantalite,
gold, wolframite, or the derivatives tantalum, tin or tungsten that originated in the Democratic Republic of Congo or an adjoining country or (ii) any other mineral or its derivatives determined by the Secretary of State to be financing
conflict pursuant to Section 13(p) of the Securities Exchange Act of 1934 ((i)-(ii) collectively, “Conflict Minerals”), in the production of any Product. Notwithstanding the foregoing, if Manufacturer uses, or determines that
it has used, a Conflict Mineral in the production of any Product, Manufacturer shall immediately notify Customer, which notice shall contain a written description of the use of the Conflict Mineral, including, without limitation, whether the
Conflict Mineral appears in any amount in the applicable Product (including trace amounts) and a valid and verifiable certificate of origin of the Conflict Mineral used. Manufacturer must be able to demonstrate that it undertook a reasonable country
of origin inquiry and due diligence process in connection with its preparation and delivery of the certificate of origin. 

  

	 	(d)	 Manufacturer will provide Customer with periodic access, upon reasonable notice, to any of its Facilities where
it is performing under this Agreement, to its employees and Records and to any associated dormitories or lodging that Manufacturer provides to its employees, to permit Customer to determine Manufacturer’s compliance with this
Section 5.3. Customer may exercise its inspection rights under this Section 5.3(d) upon receipt of any information that would suggest to a reasonable Person that Manufacturer is not fulfilling its
obligations under this Section 5.3. 

  
 -46- 

	 	5.4	 Notice of Material Events.  

Manufacturer will promptly notify Customer of any actual or anticipated events of which Manufacturer is aware that have or would be reasonably
expected to have a material effect on any Product or on its ability to manufacture or supply any Product in accordance with the provisions set forth herein, including any labor difficulties, strikes, shortages in materials, plant closings,
interruptions in activity and the like. 
  

	 	5.5	 Disclaimer of Warranties. 

EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, NEITHER PARTY MAKES NOR RECEIVES ANY WARRANTY OF ANY KIND, EXPRESS, IMPLIED, STATUTORY OR
OTHERWISE, INCLUDING WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE, TITLE AND NON-INFRINGEMENT OF ANY FIRMWARE, SOFTWARE OR HARDWARE PROVIDED OR USED HEREUNDER, AND ANY
REPRESENTATIONS OR WARRANTIES ARISING FROM COURSE OF DEALING, COURSE OF PERFORMANCE OR TRADE USAGE, AND ALL SUCH REPRESENTATIONS AND WARRANTIES ARE HEREBY EXPRESSLY DISCLAIMED. 

 

	6.	 Environmental Covenants. 

 

	 	6.1	 Compliance with Environmental Laws.  

 

	 	(a)	 Manufacturer shall perform all of its obligations herein in compliance with all Environmental Laws and all
licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws. 

  

	 	(b)	 Manufacturer shall be solely responsible for all Environmental Liabilities arising from its performance of this
Agreement. 

  

	 	6.2	 Permits, Licenses and Authorization. 

 

	 	(a)	 Manufacturer shall be solely responsible for obtaining, and shall obtain in a timely manner, and maintain in
good standing, all licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws, whether de novo documents or modifications to existing documents, which are necessary to perform
the services hereunder, and shall bear all costs and expenses associated therewith. 

  

	 	(b)	 Manufacturer shall provide copies of all material items referenced in Section 6.2(a)
to Customer upon request by Customer and shall operate in compliance therewith. 

  
 -47- 

	 	(c)	 Manufacturer shall provide Customer with reasonably prompt verbal notice, confirmed in writing within
twenty-four (24) hours, in the event of any major incident, which shall include any event, occurrence, or circumstance, including any governmental or private action, which materially impacts or could materially impact Manufacturer’s
ability to fulfill its obligations under this Agreement. These include, but are not limited to: (i) material revocation or modification of any of the documents described in Section 6.2(a), (ii) any action by
Governmental Authorities that may reasonably lead to the material revocation or modification of Manufacturer’s required permits, licenses, or authorizations, as listed above, (iii) any Third Party Claim against the management or ownership
of the Facility that could reasonably materially impact Manufacturer’s obligations under this Agreement, (iv) any fire, explosion, significant accident, or catastrophic Release of Hazardous Materials, or significant “near miss”
incident, (v) any significant non-compliance with Environmental Laws and (vi) any environmental condition or operating practice that may reasonably be believed to present a significant threat to
human health, safety or the environment. 

  

	 	(d)	 Notwithstanding the requirements noted above, each Party, whether Customer or Manufacturer, is required to
create and maintain: 

  

	 	(i)	 required licenses, permits and agreements, including those necessary to affect imports, exports, and activities
covered by economic sanctions regulations, including annual agreements for activities involving Restricted Markets; 

  

	 	(ii)	 policies, procedures, controls, and systems to support compliance with Global Trade Control Laws; and

  

	 	(iii)	 agreements with Customs Brokers, freight forwarders, financial institutions, and other third parties, as
necessary. 

  

	 	6.3	 Generation of Hazardous Wastes. 

Without limiting other legally applicable requirements, Manufacturer shall prepare, execute and maintain, as the generator of Waste, all
registrations, notices, shipping documents and manifests required under applicable Environmental Laws and in accordance therewith. Manufacturer shall utilize only reputable and lawful Waste transportation and disposal vendors, and shall not
knowingly utilize any such vendor whose operations endanger human health or the environment. 
  

	 	6.4	 Environmental Sustainability Information. 

Manufacturer will disclose to Customer, on an annual basis, its results with respect to any efforts to reduce greenhouse gas emissions, water
consumption or the generation of waste associated with the performance of this Agreement, to the extent Manufacturer otherwise prepares such results. 

  
 -48- 

	 	6.5	 Environmental and Health and Safety Reviews. 

 

	 	(a)	 Manufacturer covenants that it will, to the Manufacturer’s knowledge, completely and accurately disclose
to Customer all material environmental and health and safety information regarding its Products (including an obligation to supplement this information, as necessary) during the Term of this Agreement, as reasonably requested by Customer.

  

	 	(b)	 Manufacturer shall permit Customer (at Customer’s expense) to conduct reasonable annual reviews of the
environmental and health and safety practices and performance of the Facilities with respect to the Products where Manufacturer’s performance under this Agreement is occurring; provided that such review shall not include any invasive
sampling at such Facilities and shall not unreasonably interfere with Manufacturer’s operation of such Facilities. In connection with such reviews, Manufacturer shall reasonably assist in the completion of an environmental health and safety
survey of Manufacturer or the scheduling of an environmental health and safety audit of the Facility, as applicable, in each case with respect to the Products. Customer shall share its findings (including any deficiencies) with Manufacturer as soon
as practicable, Manufacturer shall have the sole right to report any such deficiencies to third parties and Manufacturer shall use commercially reasonable efforts to correct, at no expense to Customer, such deficiencies in its environmental and
health and safety management practices with respect to the Products that are not in compliance with applicable Law or create significant risk to human health or the environment. Manufacturer acknowledges that such reviews conducted by Customer are
for the benefit of Customer only; they are not a substitute for Manufacturer’s own environmental and health and safety management obligations under this Agreement and accordingly, Manufacturer may not rely upon them. 

 

	7.	 Term; Termination.  

 

	 	7.1	 Term of Agreement. 

Unless otherwise provided in the applicable Facility Addendum, this Agreement (a) shall commence on the Effective Date and shall continue
for a period of four (4) years from such date (the “Initial Term” of this Agreement), unless sooner terminated pursuant to Section 7.3, 7.4, 7.5, 7.6 or 7.7, and
(b) may be extended for up to three (3) additional periods of twelve (12) months (each, an “Extension Period”) by written notice given by Customer to Manufacturer not less than twelve (12) months prior to the
expiration of the Initial Term or the applicable Extension Period, as the case may be. The Initial Term and all Extension Periods shall be referred to collectively as the “Term” of this Agreement. For the avoidance of doubt, the
Term of this Agreement shall continue until all Facility Addenda hereunder expire or otherwise terminate, unless this Agreement or such Facility Addenda are sooner terminated pursuant to Section 7.3, 7.4, 7.5,
7.6 or 7.7. 

  
 -49- 

	 	7.2	 Term of Facility Addendum. 

Unless otherwise provided in the applicable Facility Addendum, each Facility Addendum shall commence on the Effective Date and shall continue
for a period of four (4) years from such date (the “Initial Term” of the Facility Addendum), unless extended or terminated pursuant to Section 7.3, 7.4, 7.5, 7.6 or 7.7. A
Facility Addendum may be extended for up to three (3) additional periods of twelve (12) months (each, an “Extension Period”) by written notice given by Customer to Manufacturer not less than twelve (12) months prior
to the expiration of the Initial Term or the applicable Extension Period, as the case may be. The Initial Term and all Extension Periods shall be referred to collectively as the “Term” of the Facility Addendum. 

 

	 	7.3	 Termination for Cause.  

 

	 	(a)	 Either Party may terminate this Agreement and the applicable Facility Addendum, on a Product-by-Product basis, with respect to a particular Product, upon written notice to the other Party in the event of a material breach by the other Party of any term of this
Agreement or Facility Addendum with respect to such Product, which breach remains uncured for ninety (90) calendar days following written notice to such breaching Party of such material breach. 

 

	 	(b)	 Either Party may terminate this Agreement and the applicable Facility Addendum, on a Facility Addendum-by-Facility Addendum basis, with respect to a particular Facility, upon written notice to the other Party in the event of a material breach by the other Party of any
term of this Agreement or Facility Addendum with respect to such Facility, which breach remains uncured for ninety (90) calendar days following written notice to such breaching Party of such material breach. 

 

	 	(c)	 For clarity, in the event that multiple Products are manufactured by or on behalf of Manufacturer under this
Agreement in the same Facility, a material breach by Manufacturer of this Agreement or Facility Addendum that is an act or omission specific to one or more Products in a Facility, but not all Products in such Facility, shall give rise to an ability
of Customer to terminate this Agreement solely with respect to the affected Product(s) under Section 7.3(a) but shall not give rise to an ability of Customer to terminate the relevant Facility Addendum under
Section 7.3(b). 

  

	 	7.4	 Termination for Disposition of Facility. 

In the event that Manufacturer or any of its Affiliates, directly or indirectly, sells, assigns, leases, conveys, transfers or otherwise
disposes of any Facility (a “Facility Disposition”), then Manufacturer shall immediately notify Customer of such event and Customer shall be entitled for a period of six (6) months after the receipt of such notice to terminate
any Facility Addendum with respect to such Facility for 

  
 -50- 

 cause immediately upon written notice to Manufacturer and, in the event Customer decides
not to terminate the Facility Addendum for cause, Customer shall be entitled for a period of two (2) years (or such longer period in order to obtain approval for manufacture from all applicable Governmental Authorities) after receipt of such
notice to receive Technical Support at Manufacturer’s sole cost to enable Customer to orderly transfer production of affected Product or Products to a Customer facility or an alternative facility as designated by Customer; provided that
Manufacturer shall notify Customer of any proposed or planned Facility Disposition by Manufacturer or any of its Affiliates as soon as reasonably practicable and in any event no later than the date that is three (3) months prior to the
effective date of such Facility Disposition. 
  

	 	7.5	 Termination in Event of Insolvency. 

In the event that a Party hereto (a) becomes insolvent, or institutes or has instituted against it a petition for bankruptcy or is
adjudicated bankrupt, (b) executes a bill of sale, deed of trust, or a general assignment for the benefit of creditors, (c) is dissolved or liquidated or (d) has a receiver appointed for the benefit of its creditors, or has a receiver
appointed on account of insolvency (in the case of clauses (a)–(d), such Party shall be referred to as the “Insolvent Party”), then the Insolvent Party shall immediately notify the other Party of such event and such other Party
shall be entitled to (i) terminate this Agreement or any and all Facility Addenda for cause immediately upon written notice to the Insolvent Party or (ii) request that the Insolvent Party or its successor provide adequate assurances of
continued and future performance in form and substance acceptable to such other Party, which shall be provided by the Insolvent Party within ten (10) calendar days of such request, and the other Party may terminate this Agreement and any or all
Facility Addenda for cause immediately upon written notice to the Insolvent Party in the event that the Insolvent Party fails to provide such assurances acceptable to the other Party within such ten (10) day period. 

 

	 	7.6	 Termination for Breach of Anti-Bribery Representation. 

Customer may terminate this Agreement and any and all Facility Addenda effective immediately upon notice to Manufacturer, if Manufacturer
(a) breaches any of the representations and warranties set forth in Section 5.2(f) or (b) Customer learns (i) that improper payments are being or have been made or offered to any Government Official or any
other Person by Manufacturer or those acting on behalf of Manufacturer with respect to any obligations performed hereunder or (ii) that Manufacturer or those acting on behalf of Manufacturer with respect to the performance of any obligations
hereunder has accepted any payment, item, or benefit, regardless of value, as an improper inducement to award, obtain or retain business or otherwise gain or grant an improper business advantage from or to any other Person or entity. Further, in the
event of such termination, Manufacturer shall not be entitled to any further payment, regardless of any activities undertaken or agreements with additional Third Parties entered into by Manufacturer prior to such termination, and Manufacturer shall
be liable for damages or remedies as provided by this Agreement, at Law or in equity. 

  
 -51- 

	 	7.7	 Termination for Convenience by Customer. 

 

	 	(a)	 This Agreement and/or any or all Facility Addendum (unless otherwise specified in the applicable Facility
Addendum) may be terminated on a Product-by-Product basis by Customer immediately upon written notice to Manufacturer, if Customer cannot continue to distribute, use,
market or sell such Product supplied under this Agreement or the relevant Facility Addendum without violating any then-current Laws. 

  

	 	(b)	 This Agreement and/or any or all Facility Addenda shall be deemed to be terminated by Customer on a Product-by-Product basis without any further action of either Customer or Manufacturer in the event that Customer fails to order a Product during any rolling eighteen
(18) month period; provided that this subsection (b) shall not apply with respect to API as Product. 

  

	 	7.8	 Effect of Termination or Expiration.  

 

	 	(a)	 The termination or expiration of this Agreement (whether in its entirety or with respect to any Product or
Facility) or any Facility Addendum for any reason shall not release any Party hereto of any liability which at the time of termination or expiration had already accrued to the other Party in respect to any act or omission prior thereto.

  

	 	(b)	 Upon termination of this Agreement by Customer in whole or in part or upon the termination of any Facility
Addendum, in each case, pursuant to Section 7.3, 7.4, 7.5 or 7.6, and on a terminated-Product-by-terminated-Product basis,
at Customer’s option and pursuant to Customer’s instructions, Manufacturer shall provide Customer with sufficient inventory of such terminated Product to ensure business continuity according to then-current terms and pricing (subject to
Section 3) until the earlier of: (i) Customer’s identification of, and securing of Regulatory Approval for, another supplier of such terminated Product or (ii) unless otherwise set forth in the applicable
Facility Addendum as the “Inventory Tail Period” for such Product, a time period that reflects Customer’s reasonable needs of such Product as mutually agreed upon by the Parties in good faith. Manufacturer shall take such further
action, at Manufacturer’s expense, that Customer may reasonably request to minimize delay and expense arising from termination or expiration of this Agreement. For the avoidance of doubt, Manufacturer’s obligation to supply Product
pursuant to this Section 7.8(b) shall be subject to and governed by the terms of this Agreement, including terms pertaining to Forecasts and Purchase Orders and payment terms. 

  
 -52- 

	 	(c)	 Upon Customer’s request at any time during the Term, Manufacturer shall promptly notify Customer of any
material contracts, licenses, permits, and other material documents, in each case, that are specific to, and are used solely in connection with, a Product or Facility Addendum and provide copies or access thereto subject to any restrictions on the
provision of copies or access. Upon termination or expiration of this Agreement in whole or in part or any Facility Addendum, if requested by Customer within ninety (90) days immediately following the effective date of such expiration or
termination of this Agreement and pursuant to Customer’s reasonable request and instructions, Manufacturer shall use commercially reasonable efforts to, as applicable, make assignments or partial assignments of such material contracts,
licenses, permits, and other material documents, as applicable, in each case subject to any restrictions on assignment, or as may otherwise be set forth in any Contract relating thereto. Customer shall reimburse Manufacturer for all out-of-pocket costs reasonably incurred by Manufacturer in activities conducted pursuant to this Section 7.8(c), unless this Agreement has been
terminated by Customer pursuant to Section 7.3, 7.4, 7.5 or 7.6, in which case Manufacturer shall bear all such reasonable expenses. 

 

	 	(d)	 The termination or expiration of this Agreement shall not affect the survival and continuing validity of
Section 2.10 (Transitional Support) (with respect to Manufacturer’s obligations and to the extent Technical Support has been requested prior to, or within ninety (90) days following, the effective date of
termination or expiration), Section 3.5 (Invoices and Payment), Sections 4.1, 4.5, 4.6, 4.8, 4.10, 4.11, 4.12 and 4.13 (Manufacturing Standards and Quality Assurance),
Section 5 (Covenants), Section 6 (Environmental Covenants), Section 7.8 (Effect of Termination or Expiration), Section 7.9 (Unused Materials),
Section 7.10 (Return of Materials, Tools and Equipment), Section 8 (Intellectual Property), Section 10 (Indemnification; Limitations of Liability),
Section 11 (Insurance), Section 13 (Confidentiality), Section 15 (Records and Audits), Section 17 (Notices), Section 18
(Miscellaneous), or of any other provision which is expressly intended to continue in force after such termination or expiration. 

  

	 	7.9	 Unused Materials.  

In the event of the expiration of this Agreement or termination of this Agreement in whole or in part (including the termination of any
Facility Addendum) by Customer in accordance with Section 7.3, 7.4, 7.5 or 7.6, Customer may, at its option within ninety (90) days immediately following the effective date of the expiration or
termination of this Agreement, purchase any work in process and/or Product Materials that Manufacturer has purchased exclusively for Customer in accordance with this Agreement for the production of any terminated Product. Customer shall pay
Manufacturer’s direct cost for works in process, and Manufacturer’s purchase price from its suppliers for Product Materials. In the event of the termination of this Agreement by Customer in accordance with
Section 7.7 or the termination of this Agreement by Manufacturer in accordance with Section 7.3, 7.4, 7.5 or 7.6, Customer shall purchase at cost all Product Materials
purchased 

  
 -53- 

 
in accordance with Customer’s Purchase Orders and on reasonable reliance upon Customer’s Forecast; provided that Manufacturer uses its reasonable commercial efforts to exhaust
existing stocks of such Product Materials prior to the date of termination. In the event of the termination or expiration of this Agreement for any other reason, Customer shall have no obligation to purchase any Product Materials. Any Product
Materials that are not purchased or required to be purchased by Customer pursuant to this Section 7.9 shall be disposed of or destroyed in accordance with Customer’s instructions, which costs shall be borne by
Manufacturer. 
  

	 	7.10	 Return of Materials, Tools and Equipment.  

 

	 	(a)	 Upon termination or expiration of this Agreement in whole or in part or, with respect to any Product, Facility
or any Facility Addendum for any reason whatsoever, at Customer’s request, Manufacturer shall, as promptly as practicable given relevant circumstances, deliver to Customer in accordance with Customer’s reasonable instructions all
Specifications (and copies thereof), artwork, labels, bottles, all premiums and packaging materials purchased by Customer and all Product Materials, Buy-Sell Materials, Customer-Supplied Materials, and
equipment, molds, tablet press tooling or proprietary materials in Manufacturer’s possession and control that during the Term had, pursuant to this Agreement or a Facility Addendum, either (i) been provided by Customer to Manufacturer, or
(ii) purchased by Manufacturer (and reimbursed by Customer), in each case, that are used and held for use exclusively for the manufacture for Customer of Product or Products impacted by such termination or expiration; provided that
Manufacturer shall not be so required to deliver any materials, tools or equipment that are fixtures or fittings or any items the removal of which from the Facility using good faith diligent efforts would be reasonably likely to disrupt in any
material respect, or cause damage to, the Facility or its operations or any materials, tools or equipment owned, leased or otherwise controlled by Manufacturer or any of its Affiliates or any material expense. At Customer’s request,
Manufacturer shall, as promptly as reasonably practicable given relevant circumstances and in accordance with Customer’s reasonable instructions, remove all such equipment, molds and tablet press tooling from the Facility and make such
equipment, molds and tooling available for pickup at the Facility by a carrier designated by Customer. All delivery, removal and transportation costs reasonably incurred in connection with this Section 7.10(a) shall be
borne by Customer, except in the event Customer terminates this Agreement pursuant to Section 7.3, 7.4, 7.5 or 7.6, in which case all such reasonable costs shall be borne by Manufacturer.

  
 -54- 

	 	(b)	 Any Product quarantined at the time of expiration or termination of this Agreement shall be disposed of or
destroyed by Manufacturer in accordance with Customer’s instructions and at Customer’s cost; provided that, to the extent (i) such quarantine is the result of Manufacturer’s gross negligence, fraud, willful misconduct or
breach of this Agreement or (ii) this Agreement is terminated in whole or in part with respect to such Product (including the termination of the applicable Facility Addendum) by Customer in accordance with Section 7.3,
7.4, 7.5 or 7.6, then Manufacturer shall be responsible for all costs incurred by Manufacturer in connection with disposing and destroying such quarantined Product. 

 

	8.	 Intellectual Property. 

 

	 	8.1	 Customer’s Intellectual Property. 

Customer hereby grants to Manufacturer a non-exclusive license during the Term to use any Customer
Property and Customer-Owned Improvements and Developments solely in connection with Manufacturer performing its obligations under this Agreement or the Facility Addendum in accordance with the terms hereof or thereof, as applicable. Manufacturer
shall not acquire any other right, title or interest in or to the Customer Property or Customer-Owned Improvements and Developments as a result of its performance hereunder, and any and all goodwill arising from Manufacturer’s use of any
Customer Property or Customer-Owned Improvements and Developments shall inure to the sole and exclusive benefit of Customer. 
  

	 	8.2	 Improvements and Developments.  

 

	 	(a)	 Each Party acknowledges and agrees that improvements or modifications to Customer Property may be made by or on
behalf of Manufacturer (“Improvements”), and creative ideas, proprietary information, developments, or inventions may be developed under or in connection with this Agreement by or on behalf of Manufacturer
(“Developments”), in each case either alone or in concert with Customer or Third Parties. 

  

	 	(b)	 Manufacturer acknowledges and agrees that, as between the Parties, any Improvements or Developments that are
specific to and otherwise solely relate to, the manufacturing, processing or packaging of Products (such Improvements and Developments, collectively, “Customer-Owned Improvements and Developments”) shall be the exclusive property of
Customer, and Customer shall own all rights, title and interest in and to such Customer-Owned Improvements and Developments. Manufacturer agrees to and hereby does irrevocably transfer, assign and convey, and shall cause its Personnel to irrevocably
transfer, assign and convey, all rights, title and interest in and to each of the Customer-Owned Improvements and Developments to Customer free and clear of any encumbrances, and Manufacturer agrees to execute, and shall cause its subcontractors and
Personnel to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any country. 

  
 -55- 

	 	(c)	 Customer acknowledges and agrees that, as between the Parties, all Improvements and Developments made by or on
behalf of Manufacturer in the conduct of activities under this Agreement or a Facility Addendum other than Customer-Owned Improvements and Developments (such Improvements and Developments, collectively, “Manufacturer-Owned Improvements and
Developments”) shall be the exclusive property of Manufacturer, and Manufacturer shall own all rights, title and interest in and to such Manufacturer-Owned Improvements and Developments. Customer agrees to and hereby does irrevocably
transfer, assign and convey, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to each of the Manufacturer-Owned Improvements and Developments to Manufacturer free and clear of any
encumbrances, and Customer agrees to execute, and shall cause its Personnel and subcontractors to execute, all documents necessary to do so. All such assignments shall include existing or prospective Intellectual Property rights therein in any
country. 

  

	 	8.3	 Ownership of Other Property.  

Unless otherwise agreed by the Parties or specified in the Separation Agreement, Customer is the sole owner of any and all tools,
specifications, blueprints and designs directly owned and supplied or paid for by Customer (i.e., not any materials that are included in the Price of Product), and Manufacturer shall not use, transfer, loan or publicize any of the above,
except as necessary for its performance under this Agreement. 
  

	 	8.4	 Limited Right to Use.  

Subject to the provisions of Section 8.1, nothing set forth in this Agreement shall be construed to grant to
Manufacturer any title, right or interest in or to any Intellectual Property controlled by Customer or any of its Affiliates. Use by Manufacturer of any such Intellectual Property shall be limited exclusively to its performance of this Agreement.

  

	9.	 Joint Advisory Committee. 

 

	 	9.1	 Formation and Role. 

The Parties shall, as soon as practicable but not later than within ninety (90) days after the Effective Date, form a joint advisory
committee (the “Joint Advisory Committee” or “JAC”). The JAC will provide a forum for the good faith discussion of major matters related to this Agreement, including in particular (but not limited to) matters
of commercial performance, supply, overall performance, capital investment and business planning (strategy and management), and the transition to Customer-Supplied Materials arrangements contemplated by Section 12.1(f), but
also any other items, matters or activities, including with respect to any Facility. 

  
 -56- 

	 	9.2	 Membership; Chairs. 

 

	 	(a)	 Membership. The JAC shall consist of up to five (5) representatives appointed by each Party in
writing, or such other number of representatives as the Parties may agree in writing from time to time (each, a “JAC Member”). Either Party may invite any person that is not a JAC Member (including consultants and advisors of a
Party) to participate in meetings of the JAC, without a right to participate in the discussions of the JAC, so long as (i) such person is under an appropriate obligation of confidentiality, (ii) the inviting Party provided at least three
(3) Business Days’ prior notice to the other Party identifying such person and (iii) the non-inviting Party does not reasonably object to such person participating in the discussions of the JAC
prior to such meeting. 

  

	 	(b)	 JAC Chairs. The JAC shall be co-chaired by one JAC Member of
each Party (each, a “JAC Chair”), to be elected by the respective Party when naming its JAC Members. The JAC Chairs shall cooperate in good faith to: (i) notify the JAC Members of each Party of each JAC Meeting, which
notice shall be provided at least thirty (30) calendar days in advance of such meeting (to the extent practicable) with respect to the ordinary quarterly JAC Meetings; (ii) collect and organize agenda items for each JAC Meeting, and
circulate such agenda to all JAC Members at least two (2) Business Days prior to each meeting date; provided, however, that any JAC Member shall be free to propose additional topics to be included on such agenda,
either prior to or in the course of any JAC Meeting; (iii) preside at JAC Meetings; and (iv) prepare the written minutes of each JAC Meeting and circulate such minutes for review and approval by the JAC Members of each Party, and identify
action items to be carried out. 

  

	 	9.3	 Meetings. 

 

	 	(a)	 Ordinary JAC Meetings. During the Term of this Agreement, the JAC shall meet on a quarterly basis or as
otherwise determined in writing by the Parties, and such meetings may be conducted in person, by videoconference or by telephone conference (each such meeting, a “JAC Meeting”). In-person
meetings of the JAC will alternate between appropriate venues of each Party, as reasonably determined by the Parties. The Parties shall each bear all expenses of their respective representatives relating to their participation on the
JAC. The members of the JAC also may convene or be polled or consulted from time to time by means of telecommunications, video or telephone conferences, electronic mail or correspondence, as deemed necessary or appropriate.

  

	 	(b)	 Additional JAC Meetings. Either Party may call an additional meeting of the JAC at any time upon twenty
(20) Business Days’ prior written notice if such Party reasonably determines that there is a need for discussions at the level of a JAC Meeting on top of the ordinary quarterly JAC Meetings, and reasonably specifies such grounds in its
notice to the other Party. 

  
 -57- 

	 	(c)	 Provision of Information. Upon the request of the JAC Chairs or at least four (4) members of the
JAC, each Party will provide written materials and information relating to matters within the purview of the JAC in advance of a JAC Meeting. In addition, the JAC shall be informed by each Party in good faith about any matters or issues within the
purview of the JAC which a Party should reasonably deem to be of high importance for the other Party. 

  

	 	9.4	 Areas of Responsibility. 

Subject to the terms of this Agreement, the JAC shall act as a forum to discuss in good faith in particular the following major items, matters
and areas of interest: 
  

	 	(a)	 Oversee, review and coordinate the activities of the Parties under this Agreement; 

 

	 	(b)	 Each Facility’s overall performance under this Agreement; and 

 

	 	(c)	 Any other major matters, roles, obligations and responsibilities under this Agreement, to the extent any Party
reasonably provides such matter to the JAC for discussion. 

  

	 	9.5	 Advisory Role; No Decision-Making Authority. 

 

	 	(a)	 Advisory Role. The JAC and its members shall only have an advisory role and shall discuss in good faith
and provide to the Parties its opinion on the matters in its purview. The Parties agree to reasonably take into account the opinions and views expressed by the JAC and its members for performing their respective obligations under this Agreement.

  

	 	(b)	 No Decision-Making Authority. The JAC shall have no decision-making authority over the matters in its
purview unless the Parties mutually decide in writing to delegate the decision-making authority on such specific item or matter to the JAC. Moreover, it shall not be within the authority of the JAC to (i) directly impose on either Party or its
Affiliates any additional obligation(s) or a resolution on the Parties with respect to any dispute regarding the existence or extent/amount of any obligation, including payments obligations, under this Agreement, or to (ii) amend, modify or
waive compliance with this Agreement. 

  

	10.	 Indemnification; Limitations of Liability. 

 

	 	10.1	 Indemnification of Customer. 

 

	 	(a)	 Subject to the provisions of this Section 10 and, for clarity, without limiting
anything in the Separation Agreement or any other Ancillary Agreements, Manufacturer shall indemnify, defend and hold harmless Customer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and
each of the heirs, executors, 

  
 -58- 

	 	
successors and assigns of any of the foregoing (each, a “Customer Indemnified Party”) from and against any and all Losses of such Customer Indemnified Parties to the extent
relating to, arising out of or resulting from any Action of a Third Party arising out of or resulting from any of the following items (without duplication): (i) any breach by Manufacturer or its Personnel of this Agreement or any Facility Addendum;
(ii) any injury or death of any Person due to any breach by Manufacturer or its Personnel of this Agreement or any Facility Addendum; (iii) the infringement or misappropriation of a Third Party’s Intellectual Property by the use or
practice by Manufacturer or its Affiliate of any Product manufacturing process that has been changed (including as to the facility in which such manufacturing process takes place) on or following the Effective Date without the written approval of
Customer to make such change; (iv) Manufacturer’s supply of Non-Complying Product under this Agreement; or (v) the gross negligence, fraud or willful misconduct of Manufacturer or its Personnel
in connection with the performance or non-performance of this Agreement. 

  

	 	(b)	 Notwithstanding the foregoing, Manufacturer shall not be liable for Losses described in
Section 10.1(a) to the extent such Losses are: (i) caused by the gross negligence, fraud or willful misconduct of a Customer Indemnified Party in connection with the performance or
non-performance of this Agreement; (ii) caused by the breach of any of the terms of this Agreement or a Facility Addendum by a Customer Indemnified Party, including in connection with the performance or non-performance of this Agreement or (iii) subject to Customer’s indemnification obligations pursuant to Section 10.2. 

 

	 	10.2	 Indemnification of Manufacturer. 

 

	 	(a)	 Subject to the provisions of this Section 10 and, for clarity, without limiting
anything in the Separation Agreement or any Ancillary Agreements, Customer shall indemnify, defend and hold harmless Manufacturer, its Affiliates and its and their respective directors, officers, managers, members, employees and agents, and each of
the heirs, executors, successors and assigns of any of the foregoing (each, a “Manufacturer Indemnified Party”) from and against any and all Losses of such Manufacturer Indemnified Parties to the extent relating to, arising out of
or resulting from any Action of a Third Party arising out of or resulting from any of the following items (without duplication): (i) any breach by Customer or its Personnel of this Agreement or any Facility Addendum; (ii) the gross negligence,
fraud or willful misconduct of Customer or its Personnel in connection with the performance or non-performance of this Agreement; (iii) the infringement or misappropriation of a Third Party’s
Intellectual Property by the use or practice by Manufacturer or its Affiliate in performance of this Agreement of any Product manufacturing process that has been changed with the written approval of Customer to make such change;
(iv) Customer’s supply of Non-Complying Customer-Supplied Materials or Non-Complying Buy-Sell Materials under this
Agreement; or (v) the use, sale, offer for sale, import or other commercialization of any Product (including any injury or death of any Person due to any of the foregoing in this clause (v)). 

  
 -59- 

	 	(b)	 Notwithstanding the foregoing, Customer shall not be liable for Losses described in
Section 10.2(a) to the extent such Losses are: (i) caused by the gross negligence, fraud or willful misconduct of a Manufacturer Indemnified Party in connection with the performance or
non-performance of this Agreement; (ii) caused by the breach of any of the terms of this Agreement or any Facility Addendum by a Manufacturer Indemnified Party or (iii) are subject to
Manufacturer’s indemnification obligation pursuant to Section 10.1. Furthermore, Customer shall not be liable for Losses pursuant to Section 10.2(a)(iii) above to the extent such infringement
or misappropriation is caused by Manufacturer’s unauthorized use or unauthorized modification of any Customer Property, Customer-Owned Improvements and Developments, Buy-Sell Materials or
Customer-Supplied Materials. 

  

	 	10.3	 Indemnification Procedures. 

 

	 	(a)	 If, at or following the date of this Agreement, any Person entitled to be indemnified under this
Section 10 (the “Indemnitee”) shall receive notice or otherwise learn of the assertion by a Person (including any Governmental Authority) who is not a member of the Pluto Group or the Spinco Group of any
claim or of the commencement by any such Person of any Action with respect to which the Party from whom indemnification may be sought under this Section 10 (the “Indemnifying Party”) (such claim, a
“Third-Party Claim”), such Indemnitee shall give such Indemnifying Party written notice thereof as promptly as practicable, but in any event within thirty (30) days (or sooner if the nature of the Third-Party Claim so requires)
after becoming aware of such Third-Party Claim. Any such notice shall describe the Third-Party Claim in reasonable detail, including the facts and circumstances giving rise to such claim for indemnification, and include copies of all notices and
documents (including court papers) received by the Indemnitee relating to the Third-Party Claim. Notwithstanding the foregoing, the failure of any Indemnitee to provide notice as provided in this Section 10.3(a) shall not
relieve an Indemnifying Party of its obligations under this Section 10, except to the extent, and only to the extent, that such Indemnifying Party is materially prejudiced by such failure to give notice in accordance with
this Section 10.3(a). 

  
 -60- 

	 	(b)	 An Indemnifying Party may elect (but shall not be required) to defend (and seek to settle or compromise), at
such Indemnifying Party’s own expense and by such Indemnifying Party’s own counsel (which counsel shall be reasonably satisfactory to the Indemnitee), any Third-Party Claim; provided that the Indemnifying Party shall not be entitled
to defend such Third-Party Claim and shall pay the reasonable fees and expenses of one separate counsel for all Indemnitees if the claim for indemnification relates to or arises in connection with any criminal action, indictment or allegation or if
such Third-Party Claim seeks an injunction or equitable relief against the Indemnitee (and not any Indemnifying Party or any of its Affiliates). Within thirty (30) days after the receipt of notice from an Indemnitee in accordance with
Section 10.3(a) (or sooner, if the nature of such Third-Party Claim so requires), the Indemnifying Party shall notify the Indemnitee of its election whether the Indemnifying Party will assume responsibility for defending
such Third-Party Claim, which election shall specify any reservations or exceptions to its defense. After notice from an Indemnifying Party to an Indemnitee of its election to assume the defense of a Third-Party Claim, such Indemnitee shall have the
right to employ separate counsel and to participate in (but not control) the defense, compromise, or settlement thereof, but the fees and expenses of such counsel shall be the expense of such Indemnitee; provided, however, in the event that
the Indemnifying Party has elected to assume the defense of the Third-Party Claim but has specified, and continues to assert, any reservations or exceptions in such notice, then, in such case, the reasonable fees and expenses of one separate counsel
for all Indemnitees shall be borne by the Indemnifying Party; and provided further that the Indemnifying Party will pay the reasonable fees and expenses of such separate counsel if, based on the reasonable opinion of legal counsel to the
Indemnitee, a conflict or potential conflict of interest exists between the Indemnifying Party and the Indemnitee which makes representation of both parties inappropriate under applicable standards of professional conduct. 

 

	 	(c)	 If an Indemnifying Party elects not to assume responsibility for defending a Third-Party Claim, or fails to
notify an Indemnitee of its election as provided in Section 10.3(b), then the applicable Indemnitee may defend such Third-Party Claim at the cost and expense of the Indemnifying Party to the extent indemnification is
available under the terms of this Agreement. If an Indemnifying Party elects not to assume responsibility for defending a Third-Party Claim, or fails to notify an Indemnitee of its election as provided in Section 10.3(b),
then, it shall not be a defense to any obligation of the Indemnifying Party to pay any amount in respect of such Third-Party Claim that the Indemnifying Party was not consulted in the defense thereof, that such Indemnifying Party’s views or
opinions as to the conduct of such defense were not accepted or adopted, that such Indemnifying Party does not approve of the quality or manner of the defense thereof or, subject to Section 10.3(d), that such Third-Party
Claim was incurred by reason of a settlement rather than by a judgment or other determination of liability. 

  
 -61- 

	 	(d)	 Neither Party may settle or compromise any Third-Party Claim for which either Party is seeking to be
indemnified hereunder without the prior written consent of the other Party, which consent may not be unreasonably withheld, conditioned or delayed, unless such settlement or compromise is solely for monetary damages that are fully payable by the
settling or compromising party, does not involve any admission, finding or determination of wrongdoing or violation of Law by the other Party and provides for a full, unconditional and irrevocable release of the other Party from all Liability in
connection with the Third-Party Claim. 

  

	 	10.4	 Limitations on Liability. 

 

	 	(a)	 Except in the event of (i) Third Party Claims subject to a Party’s indemnification obligations
pursuant to Section 10.1, (ii) Third Party Claims subject to a Party’s indemnification obligations pursuant to Section 10.2, (iii) the gross negligence, fraud or willful misconduct of a Party
or its Personnel, (iv) a Party’s willful breach of this Agreement, (v) a breach of Section 13 or (vi) customer liabilities pursuant to, and subject to the limitations set forth in,
Section 2.5(e), neither Party’s aggregate liability to the other Party (or its Personnel that are indemnitees under Section 10.1 or Section 10.2, as applicable) under
this Agreement for the initial twelve (12) month period immediately following the Effective Date, and for any twelve (12) month period thereafter during the Term, shall exceed, on a cumulative basis, the amount that is one and one half (11⁄2) times the aggregate amounts paid or payable pursuant to this Agreement in the preceding twelve (12) month period preceding the loss date by Customer to
Manufacturer but solely with respect to the supply hereunder of Product (or Products) for which such corresponding liability arose (the “Affected Products”) and not any other Products (or if, as of the time the liability arises,
this Agreement has not been in effect for twelve (12) months, then the amounts paid or payable by Customer to Manufacturer hereunder during the period from the Effective Date until such time the liability arises, shall be annualized to a full
twelve (12) months but solely with respect to the supply hereunder of the Affected Product(s) and not any other Products). 

  

	 	(b)	 NOTWITHSTANDING ANY OTHER PROVISION OF THIS AGREEMENT TO THE CONTRARY, EXCEPT FOR DAMAGES OR CLAIMS ARISING OUT
OF (I) A BREACH OF SECTION 13 OF THIS AGREEMENT, (II) CUSTOMER LIABILITIES PURSUANT TO, AND SUBJECT TO THE LIMITATIONS SET FORTH IN, SECTION 2.5(E), (III) A PARTY’S OR ITS
PERSONNEL’S GROSS NEGLIGENCE, FRAUD OR WILLFUL MISCONDUCT, (IV) A PARTY’S WILLFUL BREACH OF THIS AGREEMENT, OR (V) A PARTY’S INDEMNIFICATION OBLIGATION WITH RESPECT TO THIRD PARTY CLAIMS UNDER SECTION 10.1 OR
SECTION 10.2, IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY OR ANY INDEMNIFIED PARTY HEREUNDER FOR ANY CONSEQUENTIAL DAMAGES, SPECIAL DAMAGES, INCIDENTAL OR INDIRECT DAMAGES, LOSS OF REVENUE OR PROFITS,
DIMINUTION IN VALUE, DAMAGES BASED ON MULTIPLE OF 

  
 -62- 

	 	
REVENUE OR EARNINGS OR OTHER PERFORMANCE METRIC, LOSS OF BUSINESS REPUTATION, PUNITIVE AND EXEMPLARY DAMAGES OR ANY SIMILAR DAMAGES ARISING OR RESULTING FROM OR RELATING TO THIS AGREEMENT,
WHETHER SUCH ACTION IS BASED ON WARRANTY, CONTRACT, TORT (INCLUDING NEGLIGENCE OR STRICT LIABILITY) OR OTHERWISE. 

  

	 	10.5	 Indemnification Obligations Net of Insurance Proceeds and Other Amounts. 

 

	 	(a)	 The Parties intend that any Loss subject to indemnification or reimbursement pursuant to this
Section 10 will be net of Insurance Proceeds or other amounts actually recovered (net of any out-of-pocket costs or expenses incurred in the
collection thereof) from any Person by or on behalf of the Indemnitee in respect of any indemnifiable Liability. Accordingly, the amount that any Indemnifying Party is required to pay to any Indemnitee will be reduced by any Insurance Proceeds or
other amounts actually recovered (net of any out-of-pocket costs or expenses incurred in the collection thereof) from any Person by or on behalf of such Indemnitee in
respect of the related Loss. If an Indemnitee receives a payment (an “Indemnity Payment”) required by this Agreement from an Indemnifying Party in respect of any Loss and subsequently receives Insurance Proceeds or any other amounts
in respect of the related Loss, then the Indemnitee will pay to the Indemnifying Party an amount equal to the excess of the Indemnity Payment received over the amount of the Indemnity Payment that would have been due if the Insurance Proceeds or
such other amounts (net of any out-of-pocket costs or expenses incurred in the collection thereof) had been received, realized or recovered before the Indemnity Payment
was made. 

  

	 	(b)	 An insurer that would otherwise be obligated to pay any claim shall not be relieved of the responsibility with
respect thereto or, solely by virtue of any provisions contained in this Agreement, have any subrogation rights with respect thereto, it being expressly understood and agreed that no insurer or any other Third Party shall be entitled to a
“wind-fall” (i.e., a benefit that such insurer or other Third Party would not be entitled to receive in the absence of the indemnification provisions) by virtue of the indemnification provisions hereof. Each Party shall, and shall
cause the members of its Group to, use commercially reasonable efforts (taking into account the probability of success on the merits and the cost of expending such efforts, including attorneys’ fees and expenses) to collect or recover any
Insurance Proceeds that may be collectible or recoverable respecting the Liabilities for which indemnification may be available under this Section 10. Notwithstanding the foregoing, an Indemnifying Party may not delay
making any indemnification payment required under the terms of this Agreement, or otherwise satisfying any indemnification obligation, pending the outcome of any Action to collect or recover Insurance Proceeds, and an Indemnitee need not attempt to
collect any Insurance Proceeds prior to making a claim for indemnification or receiving any Indemnity Payment otherwise owed to it under this Agreement or any Ancillary Agreement. 

  
 -63- 

	 	10.6	 Additional Matters. 

 

	 	(a)	 Indemnification payments in respect of any Liabilities for which an Indemnitee is entitled to indemnification
under this Section 10 shall be paid reasonably promptly (but in any event within sixty (60) days of the final determination of the amount that the Indemnitee is entitled to indemnification under this
Section 10) by the Indemnifying Party to the Indemnitee as such Liabilities are incurred upon demand by the Indemnitee, including reasonably satisfactory documentation setting forth the basis for the amount of such
indemnification payment, documentation with respect to calculations made and consideration of any Insurance Proceeds that actually reduce the amount of such Liabilities. 

 

	 	(b)	 If (i) a Party incurs any Liability arising out of this Agreement or any Ancillary Agreement; (ii) an
adequate legal or equitable remedy is not available for any reason against the other Party to satisfy the Liability incurred by the incurring Party; and (iii) a legal or equitable remedy may be available to the other Party against a Third Party
for such Liability, then the other Party shall use its commercially reasonable efforts to cooperate with the incurring Party, at the incurring Party’s expense, to permit the incurring Party to obtain the benefits of such legal or equitable
remedy against the Third Party. 

  

	 	(c)	 If payment is made by or on behalf of any Indemnifying Party to any Indemnitee in connection with any
Third-Party Claim, such Indemnifying Party shall be subrogated to and shall stand in the place of such Indemnitee as to any events or circumstances in respect of which such Indemnitee may have any right, defense or claim relating to such Third-Party
Claim against any claimant or plaintiff asserting such Third-Party Claim or against any other Person. Such Indemnitee shall cooperate with such Indemnifying Party in a reasonable manner, and at the cost and expense of such Indemnifying Party, in
prosecuting any subrogated right, defense or claim. 

  

	 	(d)	 In the event of an Action in which the Indemnifying Party is not a named defendant, if either the Indemnitee or
Indemnifying Party shall so request, the Parties shall endeavor to substitute the Indemnifying Party for the named defendant or otherwise add the Indemnifying Party as party thereto, if at all practicable. If such substitution or addition cannot be
achieved for any reason or is not requested, the named defendant shall allow the Indemnifying Party to manage the Action as set forth in this Section 10, and the Indemnifying Party shall fully indemnify the named defendant
against all costs of defending the Action (including court costs, sanctions imposed by a court, attorneys’ fees, experts fees and all other external expenses), the costs of any judgment or settlement, and the cost of any interest or penalties
relating to any judgment or settlement with respect to such Third-Party Claim. 

  
 -64- 

	11.	 Insurance. 

 

	 	11.1	 Requirements to Maintain. During the Term, Manufacturer shall self-insure or shall
provide and maintain such insurance coverage, in minimum types and amounts as described below in this Section 11. 

  

	 	(a)	 Any and all deductibles or retentions for such insurance policies shall be assumed by, for the account of, and
at Manufacturer’s sole risk. 

  

	 	(b)	 To the extent of the liabilities assumed by Manufacturer under this Agreement, such insurance policies of
Manufacturer shall be primary and non-contributing with respect to any other similar insurance policies available to Customer or its Affiliates. 

 

	 	(c)	 Manufacturer shall furnish to Customer certificates of insurance (electronic is acceptable), evidencing the
required insurance coverage, upon execution of this Agreement and annually, thereafter. 

  

	 	11.2	 Amounts and Limits. The insurance required under this
Section 11 shall be written for not less than any limits of liability specified herein or as required by applicable Law, whichever is greater. All insurance carriers shall have a minimum of
“A-” A.M. Best rating. Manufacturer shall have the right to provide the total limits required by any combination of self-insurance, primary and umbrella/excess coverage; said insurance to include the
following: 

  

	 	(a)	 Insurance for liability under the workers’ compensation or occupational disease Laws of any state of the
United States (or be a qualified self-insurer in those states of the United States) or otherwise applicable with respect to Persons performing the services and employer’s liability insurance covering all claims by or in respect to the employees
of Manufacturer, providing: 

  

	 	(i)	 Coverage for the statutory limits of all claims under the applicable State Workers’ Compensation Act or
Acts. If a Facility Addendum will result in exposures under the U.S. Longshore and Harbor Workers’ Compensation Act and its amendments (work dockside or on water), the Jones Act (involving seamen, masters and crew of vessels) or the Federal
Employers’ Liability Act (railroad exposure), coverage shall be extended to include insurance coverages mandated thereby; 

  

	 	(ii)	 Employer’s liability insurance with a limit of not less than $1,000,000; 

  
 -65- 

	 	(iii)	 Manufacturer warrants that all of its employees involved in this Agreement are covered by statutory
workers’ compensation; and 

  

	 	(iv)	 Where allowed by Applicable Law, Customer and its Affiliates shall be provided a waiver of subrogation, except
for losses due to the sole negligence of Manufacturer. 

  

	 	(b)	 Commercial general liability insurance with the following limits and forms/endorsements: 

Each Occurrence:    $2,000,000 
  

	 	(i)	 Occurrence form including premises and operations coverage, property damage, liability, personal injury
coverage, products and completed operations coverage, and transit. 

  

	 	(ii)	 To the extent of Manufacturer’s indemnification obligations, Customer and its Affiliates shall be
additional insureds via ISO form CG20101185 or its equivalent. 

  

	 	(c)	 Automobile and Truck Liability Insurance: $2,000,000 combined single limit for bodily injury and property
damage arising out of all owned, non- owned and hired vehicles, including coverage for all automotive and truck equipment used in the performance of this Agreement and including the loading and unloading of
same. 

  

	 	(d)	 Umbrella (excess) liability coverage in an amount not less than $3,000,000 per occurrence and in the aggregate.

  

	 	(e)	 If Manufacturer has care, custody or control of Customer-Supplied Material, Manufacturer shall be responsible
for any loss or damage to it and provide all risk property coverage at full replacement cost for property and at the costs-per-unit as specified in the Facility Addendum
for inventory. 

  

	12.	 Customer-Supplied Materials; Buy-Sell Materials;
Transition. 

  

	 	12.1	 Supply; Rejection; Transition.  

 

	 	(a)	 Customer shall at its own expense supply Manufacturer with the Customer-Supplied Materials identified in the
applicable Facility Addendum. Customer shall supply Manufacturer with the Buy-Sell Materials at a price that Customer determines, subject to Section 3.2(c), and communicates to
Manufacturer. At Customer’s option, the Customer-Supplied Materials and Buy-Sell Materials may be delivered directly from Customer’s Third-Party vendor to Manufacturer at the vendor’s or
Customer’s expense. Customer or its vendor shall supply Manufacturer with a copy of the certificate of analysis for the Customer-Supplied Materials and Buy-Sell Materials no later than delivery of the
Customer-Supplied Materials or Buy-Sell 

  
 -66- 

	 	
Materials to Manufacturer. Customer hereby covenants to Manufacturer that each Customer-Supplied Material and
Buy-Sell Materials furnished by or on behalf of Customer to Manufacturer or its Affiliate or designee under this Agreement will, upon delivery by Customer to Manufacturer pursuant to this Agreement, comply
with, and have been used, handled and stored in accordance with, the specifications for such Customer-Supplied Materials or Buy-Sell Materials (as applicable), all
applicable Laws, the Quality Agreement, this Agreement and the applicable Facility Addendum and otherwise have no defects. Manufacturer’s obligations to manufacture and supply Product under this Agreement are subject to and conditioned upon
Customer’s timely delivery of Customer-Supplied Material and Buy-Sell Materials in accordance with this Section 12. 

 

	 	(b)	 Manufacturer shall provide to Customer a monthly rolling forecast of its requirements for Customer-Supplied
Materials and Buy-Sell Materials based upon Customer’s Forecasts for Products, and Manufacturer shall issue to Customer “pro forma” purchase orders for Customer-Supplied Materials and actual
purchase orders for Buy-Sell Materials, in each case, according to parameters included in the applicable Facility Addendum, including safety stock and lead time requirements. Manufacturer shall be responsible
to receive, sample, store and maintain the inventory of such ordered Customer-Supplied Materials and Buy-Sell Materials at Manufacturer’s Facility. 

 

	 	(c)	 Within each calendar month during the Term, Manufacturer will provide a monthly inventory report of
Customer-Supplied Materials substantially in the format attached as Attachment C to this Agreement. The Parties acknowledge and agree that the Manufacturer’s timely providing the referenced monthly inventory report is a critical
component of the Customer’s Customer-Supplied Materials management program and further that any such failure on the part of Manufacturer to timely provide such monthly inventory report shall be addressed at the immediately following scheduled
JAC Meeting. 

  

	 	(d)	 Manufacturer may reject any Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Materials by (i) providing Customer with no less than sixty (60) days’ prior written notice of
Manufacturer’s intention to reject along with the documentation setting forth in reasonable detail the basis for rejection, (ii) meeting with Customer at Customer’s request to discuss the basis for the proposed rejection, and
(iii) providing Customer with notice of rejection in the event that Manufacturer rejects the subject Non-Complying Buy-Sell Materials or Non-Complying Customer-Supplied Materials (as applicable) at the end of such sixty (60) day period (or such other time frame as the Parties may agree upon). 

  
 -67- 

	 	(e)	 Customer shall submit invoices to Manufacturer upon delivery to Manufacturer or its applicable Affiliate of Buy-Sell Materials, and Manufacturer shall make payments with respect thereto, in accordance with the invoice and payment requirements set forth in Section 3.5, applied correlatively, and
the parties shall discuss in good faith further requirements with respect to the supply of Buy-Sell Materials. 

  

	 	(f)	 Customer shall use its commercially reasonable efforts to convert all
Buy-Sell Materials arrangements to Customer-Supplied Materials arrangements as promptly as practicable after the Effective Date; provided that Customer shall provide updates with respect to such efforts
at each JAC Meeting until all such Buy-Sell Materials arrangements shall have been converted to Customer-Supplied Materials arrangements. 

 

	 	12.2	 Title and Risk of Loss. 

 

	 	(a)	 Title to the Customer-Supplied Materials supplied by Customer to Manufacturer shall remain with Customer;
provided, however, that risk of loss shall pass to Manufacturer at the time Customer-Supplied Materials are delivered to the Manufacturer DDP (Incoterms 2010) at the applicable Facility. Manufacturer shall not use Customer-Supplied
Materials for any purposes other than those related to the manufacture of a Product pursuant to this Agreement. 

  

	 	(b)	 The risk of loss or damage to Customer-Supplied Materials during the possession thereof by Manufacturer shall
be solely with Manufacturer. 

  

	 	(c)	 Manufacturer shall insure or self-insure the Customer-Supplied Materials and Products while such is in
Manufacturer’s possession at an agreed-upon value. 

  

	 	(d)	 The title and risk of loss for Buy-Sell Materials shall pass to
Manufacturer upon delivery to the Manufacturer DDP (Incoterms 2010) at the applicable Facility. 

  

	 	12.3	 Reimbursement for Loss of Customer-Supplied Materials. Manufacturer shall reimburse Customer for
excess Customer-Supplied Materials used as a result of Manufacturer’s failure to achieve the minimum average yield or usage (as applicable) set forth in the applicable Facility Addendum. During the first quarter of each Fiscal Year during the
Term of this Agreement, Manufacturer will report to Customer the actual yield achieved for all Customer-Supplied Materials used during the previous calendar year on a
Facility-by-Facility basis. If the achieved yield is lower than the minimum average yield specified in the applicable Facility Addendum on an aggregated basis for all
Customer-Supplied Materials for each applicable Facility Addendum, then Manufacturer will reimburse to Customer the actual cost of the excess Customer-Supplied Materials used as set forth in the applicable
Facility Addendum. For the avoidance of doubt, (a) rejected batches and all Customer-Supplied Material that is, for any reason other than a determination that such Customer-Supplied Materials are
non-conforming, not incorporated into Product delivered hereunder, shall be included in the annual yield calculation and (b) Customer-Supplied Materials for which Manufacturer is responsible for
reimbursing Customer pursuant to Section 4.11(b) shall not be included in the annual yield calculation. 

  
 -68- 

	13.	 Confidentiality. 

The confidentiality obligations of the Parties and their respective Groups with respect to disclosures of information hereunder shall be
governed, mutatis mutandis, by Section 6.08, Section 6.09 and Section 6.10 of the Separation Agreement. 
  

	14.	 Supply Chain Security. 

 

	 	14.1	 Supply Chain Representations. 

Manufacturer represents, warrants and covenants to Customer that: 

Manufacturer has reviewed its supply chain security procedures and that these procedures and their implementation are, and shall remain during
the Term of this Agreement, in accordance with the importer security criteria set forth by the “C-TPAT.” Manufacturer represents and warrants that it has developed and implemented, or shall develop
and implement within sixty (60) calendar days of its execution of this Agreement, procedures for periodically reviewing and, if necessary, improving its supply chain security procedures to assure compliance with
C-TPAT minimum security criteria. 
  

	 	14.2	 C-TPAT. 

Manufacturer acknowledges that Customer is a certified member of C-TPAT. As a C-TPAT member, Customer is required to make periodic assessment of its international supply chain based upon C-TPAT security criteria. Manufacturer agrees to conduct and
document an annual security audit at each of its Facilities and to take all necessary corrective actions to ensure the continued participation of Customer in C-TPAT. Manufacturer agrees to share with Customer
the results of such annual audits and agrees to prepare and submit to Customer a report on the corrective actions taken in response thereto. In addition, Customer may audit Manufacturer’s Records and Facilities for the purpose of verifying that
Manufacturer’s procedures are in accordance with the C-TPAT security criteria, and Manufacturer shall provide Customer with access to Manufacturer’s Records and Facilities reasonably necessary for
the purpose of conducting such audit. Manufacturer agrees to notify Customer of any event that has resulted in or threatens the loss of its C-TPAT Benefits (if it is a member of the C-TPAT program) or alternatively jeopardizes Customer’s retention of its own C-TPAT Benefits. In an effort to secure each part of the supply chain, Manufacturer agrees to
work in good faith to become a member of the C-TPAT program, if Manufacturer is organized or incorporated in the United States, Mexico or Canada, or the equivalent supply chain security program criteria
administered by the customs administration in Manufacturer’s home country if Manufacturer is not organized or incorporated in the United States, Mexico or Canada. 

  
 -69- 

	15.	 Records and Audits. 

 

	 	15.1	 Records. 

Manufacturer will maintain complete and accurate Records. Any Records that are financial in nature such as, but not limited to, time sheets,
billing Records, invoices, payment applications, payments of consultants and subcontractors and receipts relating to reimbursable expenses shall be maintained in accordance with applicable Law in the jurisdiction in which the applicable Facility is
located. Manufacturer shall maintain such Records for a period equal to the later of (x) three (3) years after the expiration or termination of this Agreement or the applicable Facility Addendum, (y) the expiration of the statute of
limitation for the Tax period applicable to such Records, or (z) for such period as otherwise may be required by applicable Law (the “Record Retention Period”). 

 

	 	15.2	 Audits.  

Customer or its representatives, including its external auditors, may audit such Records of Manufacturer, including all Records related to
Manufacturer’s compliance with applicable Laws, at any time during the Term of this Agreement or applicable Facility Addendum or the Record Retention Period, during normal business hours and upon reasonable advance written notice to
Manufacturer (but in no event more than one (1) time per year except “for cause”). Manufacturer shall make such Records readily available for such audit. Any Records or information accessed or otherwise obtained by Customer or its
representatives in connection with any audit (including any audit pursuant to Section 3.4) shall be deemed Manufacturer’s confidential and proprietary Information and each representative of Customer will be subject to non-use and other confidentiality obligations substantially comparable to those set forth herein for Customer. Except as otherwise provided in Section 3.4, if any financial audit reveals
that Manufacturer has overcharged Customer, Manufacturer shall reimburse Customer for such overcharge within thirty (30) days of Manufacturer’s receipt of the relevant audit results, and in the event that any such overcharge equals an
amount equal to or greater than five percent (5%) of the total amounts invoiced during the period under such audit, then Manufacturer shall promptly reimburse Customer for all reasonable Third Party costs and expenses actually incurred in the
conduct of such audit. If any financial audit reveals that Customer has underpaid Manufacturer, Customer shall reimburse Manufacturer for such underpayment within thirty (30) days of Customer’s receipt of the relevant audit results. For
clarity, if there is a conflict between Section 3.4(a) and this Section 15.2 with respect to the review of a Price increase, Section 3.4(a) shall govern and control. 

  
 -70- 

	16.	 AG and Branded Product Supply Agreement. Notwithstanding anything to the contrary herein,
the Parties hereby agree that all determinations for purposes of this Agreement which include calculations or other determinations that involve the aggregation of data related to more than one Product (under this Agreement or under the AG and
Branded Product Supply Agreement) shall be made by taking into account the aggregate manufacture of Products pursuant to the AG and Branded Product Supply Agreement and this Agreement. Notwithstanding anything to the contrary herein, and without
limiting the foregoing, the Parties hereby agree that (i) all Facility-level determinations for purposes of this Agreement, including with respect to Facility Actual Product Materials Cost, Facility Estimated Product Materials Cost, Facility
Conversion Cost, Facility Conversion Cost Threshold, Facility Conversion Cost Adjustment Fiscal Year, Facility Conversion Cost Baseline Fiscal Year and other matters relating to potential adjustments to the Price of Product, shall be made by taking
into account the aggregate manufacture of Products at the applicable Facility pursuant to the AG and Branded Product Supply Agreement and this Agreement, and shall not be limited to the manufacture of Products at such Facility pursuant to the
applicable Facility Addendum under this Agreement and (ii) all calculations or other determinations relating to the aggregate liability of each Party under Section 10.4(a) or the aggregate liability of Manufacturer in the event of a
Triggering Event under Section 2.5(e) for purposes of this Agreement shall be made by taking into account the aggregate manufacture of Products pursuant to the AG and Branded Product Supply Agreement and this Agreement, and shall not be
limited to the manufacture of Products under this Agreement. 

  

	17.	 Notices. 

All notices or other communications hereunder shall be deemed to have been duly given and made if in writing and (a) when served by
personal delivery upon the Party for whom it is intended; (b) one (1) Business Day following the day sent by overnight courier, return receipt requested; (c) when sent by facsimile; provided that the facsimile is promptly
confirmed; or (d) when sent by e-mail; provided that a copy of the same notice or other communication sent by e-mail is also sent by overnight courier,
return receipt requested, personal delivery, or facsimile as provided herein, on the same day as such e-mail is sent, in each case to the Person at the address, facsimile number or e-mail address set forth below, or such other address, facsimile number or e-mail address as may be designated in writing hereafter, in the same manner, by such Person: 

If to Customer:            Viatris Inc. 

1000 Mylan Boulevard 

Canonsburg, PA 15317 

ATTENTION:              Michael Goettler 

EMAIL ADDRESS:     michael.goettler@viatris.com 

  
 -71- 

					
	 with copies (which shall not constitute notice) to:

		
		  	Viatris Inc.
		  	1000 Mylan Boulevard
		  	Canonsburg, PA 15317
		  	Attention:	  	Brian S. Roman, Global General Counsel
		  	Facsimile:	  	(724) 514-1871
		  	Email:	  	Brian.Roman@viatris.com
		
		  	Cravath, Swaine & Moore LLP
		  	825 8th Ave
		  	New York, New York 10019
		  	ATTENTION:	  	Mark I. Greene
		  		  	Thomas E. Dunn
		  		  	Aaron M. Gruber
		  	EMAIL ADDRESS:	  	mgreene@cravath.com
		  		  	tdunn@cravath.com
		  		  	agruber@cravath.com
			
	 If to Manufacturer:
	  	Pfizer Inc.	  	
		  	235 East 42nd Street
		  	New York, New York 10017
		  	ATTENTION:	  	Douglas M. Lankler
		  		  	Bryan A. Supran
		  	EMAIL ADDRESS:	  	douglas.lankler@pfizer.com
		  		  	bryan.supran@pfizer.com
	
	 with a copy (which shall not constitute notice) to:

		
		  	Wachtell, Lipton, Rosen & Katz
		  	51 West 52nd Street
		  	New York, New York 10019
		  	ATTENTION:	  	Edward D. Herlihy
		  		  	David K. Lam
		  		  	Gordon S. Moodie
		  		  	Zachary S. Podolsky
		  	EMAIL ADDRESS:	  	EDHerlihy@WLRK.com
		  		  	DKLam@WLRK.com
		  		  	GSMoodie@WLRK.com
		  		  	ZSPodolsky@WLRK.com

 Either Party may, by notice to the other Party, change the addresses and names applicable to such Party given
above. 

  
 -72- 

	18.	 Miscellaneous. 

 

	 	18.1	 Negotiations of Dispute. 

The dispute resolution procedures set forth in Article VII of the Separation Agreement shall apply mutatis mutandis with respect
to any controversy, claim, counterclaim, dispute, difference or misunderstanding arising out of or relating to the interpretation or application of any term or provisions of this Agreement, a Purchase Order or Facility Addendum. Further, the
requirement to attempt to resolve a dispute in accordance with this Section 18.1 does not affect a Party’s right to terminate this Agreement or a Purchase Order as provided in Section 7
hereof, and neither Party shall be required to follow these procedures prior to terminating this Agreement. 
  

	 	18.2	 Publicity.  

Manufacturer shall not use the name, trade name, service marks, trademarks, trade dress or logos of Customer (or any of its Affiliates) in
publicity releases, advertising or any other publication, nor identify Customer as a customer, without Customer’s prior written consent in each instance. Customer shall not use the name, trade name, service marks, trademarks, trade dress or
logos of Manufacturer (or any of its Affiliates) in publicity releases, advertising or any other publication, without Manufacturer’s prior written consent in each instance. Nothing in this Section 18.2 shall or is
intended to limit any Party’s rights under the Separation Agreement or any Ancillary Agreement. 
  

	 	18.3	 Governing Law and Venue. 

 

	 	(a)	 This Agreement and all Actions (whether in contract or tort) that may be based upon, arise out of or relate to
this Agreement or the negotiation, execution or performance hereof or thereof shall be governed by and construed in accordance with the Law of the State of Delaware, without regard to any Laws or principles thereof that would result in the
application of the Laws of any other jurisdiction. The Parties expressly waive any right they may have, now or in the future, to demand or seek the application of a governing Law other than the Law of the State of Delaware. 

 

	 	(b)	 Each of the Parties hereby irrevocably and unconditionally submits to the exclusive jurisdiction of the Court
of Chancery of the State of Delaware or, if such court shall not have jurisdiction, the United States District Court for the District of Delaware, and any appellate court from any appeal thereof, in any Action arising out of or relating to this
Agreement or the transactions contemplated hereby, and each of the Parties hereby irrevocably and unconditionally (i) agrees not to commence any such Action except in such courts, (ii) agrees that any claim in respect of any such Action
may be heard and determined in the Court of Chancery of the State of Delaware or, to the extent permitted by Law, in such other courts, (iii) waives, to the fullest 

  
 -73- 

	 	
extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such Action in the Court of Chancery of the State of Delaware or such
other courts, (iv) waives, to the fullest extent permitted by Law, the defense of an inconvenient forum to the maintenance of such Action in the Court of Chancery of the State of Delaware or such other courts and (v) consents to service of
process in the manner provided for notices in Section 17. Nothing in this Agreement will affect the right of any Party to serve process in any other manner permitted by Law. 

 

	 	(c)	 EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO
INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT, ANY OF
THE OTHER ANCILLARY AGREEMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (INCLUDING THE FINANCING). EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE SUCH WAIVERS, (II) IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVERS, (III) IT MAKES SUCH WAIVERS VOLUNTARILY AND (IV) IT HAS
BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 18.3(C). 

  

	 	18.4	 Relationship of the Parties. 

The relationship hereby established between Customer and Manufacturer is solely that of independent contractors. Manufacturer has no authority
to act or make any agreements or representations on behalf of Customer or its Affiliates. This Agreement is not intended to create, and shall not be construed as creating, between Manufacturer and Customer, the relationship of fiduciary, principal
and agent, employer and employee, joint venturers, co-partners, or any other such relationship, the existence of which is expressly denied. No employee or agent engaged by Manufacturer shall be, or shall be
deemed to be, an employee or agent of Customer and shall not be entitled to any benefits that Customer provides to its own employees. 

  
 -74- 

	 	18.5	 Assignment; Binding Effect. 

 

	 	(a)	 Except as otherwise provided in this Section 18.5, neither Party shall assign this
Agreement or any rights, benefits or obligations under or relating to this Agreement, in each case whether by operation of law or otherwise, without the other Party’s prior written consent (not to be unreasonably withheld, conditioned or
delayed). 

  

	 	(b)	 Either Party may assign its rights and obligations under this Agreement to one or more of its Affiliates
without the other Party’s consent; provided that such Affiliate remains at all times during the Term an Affiliate of such Party; provided, further, that no such assignment shall release such Party from its obligations under
this Agreement. 

  

	 	(c)	 Customer may, without Manufacturer’s consent, assign the rights and obligations of this Agreement
(i) on a Product-by-Product basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of all or substantially all of its business to
which such Product relates or in the event of such business’s spin-off, merger or consolidation with another company or business entity or (ii) to any Third Party which acquires or succeeds to all or
substantially all of the assets of the business of Customer to which this Agreement and the Facility Addenda relate (including in connection with such business’s spin-off, merger or consolidation with
another company or business entity). 

  

	 	(d)	 Subject to Section 7.4, Manufacturer may, without Customer’s consent, assign the rights and
obligations of this Agreement (i) on a Facility-by-Facility basis, to a Third Party in connection with a bona fide transfer, sale or divestiture of such Facility or
(ii) to any Third Party which acquires or succeeds to all or substantially all of the assets of the business of Manufacturer to which this Agreement and the Facility Addendum relates (including in connection with such business’s spin-off, merger or consolidation with another company or business entity). 

  

	 	(e)	 Notwithstanding anything to the contrary in this Agreement, neither Party may assign this Agreement in whole or
in part to a Restricted Party. 

  

	 	(f)	 In the event of a permitted assignment, this Agreement shall be binding upon and inure to the benefit of the
Parties and their respective permitted successors and permitted assigns. Any attempted assignment that contravenes the terms of this Agreement shall be void ab initio and of no force or effect. Notwithstanding anything contained in this Agreement,
each Party hereby acknowledges and agrees that the other Party may perform any of its obligations, and exercise any of its rights, under this Agreement, any Facility Addendum and Quality Agreement through any of its Affiliates.

  
 -75- 

	 	18.6	 Force Majeure. 

Subject to Manufacturer’s obligations under Section 2.5(a), no Party shall be liable for any failure to perform
or any delays in performance, and no Party shall be deemed to be in breach or default of its obligations set forth in this Agreement, if, to the extent and for so long as, such failure or delay is due to any causes that are beyond its reasonable
control and not to its acts or omissions, including, without limitation, such causes as acts of God, natural disasters, hurricane, flood, severe storm, earthquake, civil disturbance, lockout, riot, order of any court or administrative body, embargo,
acts of Government, war (whether or not declared), acts of terrorism, or other similar causes (“Force Majeure Event”). For clarity, raw material price increases, unavailability of raw materials, and labor disputes shall not be
deemed a Force Majeure Event. In the event of a Force Majeure Event, the Party prevented from or delayed in performing shall promptly give notice to the other Party and shall use commercially reasonable efforts to avoid or minimize the delay. In the
event that the delay continues for a period of at least sixty (60) calendar days, the Party affected by the other Party’s delay may elect to (a) suspend performance and extend the time for performance for the duration of the Force
Majeure Event or (b) cancel all or any part of the unperformed part of this Agreement or any Purchase Orders. 
  

	 	18.7	 Severability. 

If any provision of this Agreement or the application of any provision thereof to any Person or circumstance, is held invalid or unenforceable
by any court of competent jurisdiction, the other provisions of this Agreement shall remain in full force and effect. The Parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect
under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise
modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the Parties. 

 

	 	18.8	 Non-Waiver; Remedies. 

Waiver by any Party of any default by the other Party of any provision of this Agreement shall not be deemed a waiver by the waiving Party of
any subsequent or other default, nor shall it prejudice the rights of the other Party. No failure or delay by a Party in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof, nor shall a single or partial
exercise thereof prejudice any other or further exercise thereof or the exercise of any other right, power or privilege. 
 All remedies
specified in this Agreement shall be cumulative and in addition to any other remedies provided at Law or in equity. 

  
 -76- 

	 	18.9	 Further Documents. 

Each Party hereto agrees to execute such further documents and take such further steps as may be reasonably necessary or desirable to
effectuate the purposes of this Agreement. 
  

	 	18.10	 Forms. 

The Parties recognize that, during the Term of this Agreement, a Purchase Order acknowledgment form or similar routine document (collectively,
“Forms”) may be used to implement or administer provisions of this Agreement. The Parties agree that the terms of this Agreement shall govern and control in the event of any conflict between terms of this Agreement and the terms of
such Forms, and any additional or different terms contained in such Forms shall not apply to this Agreement. 
  

	 	18.11	 Headings; Interpretation. 

(a) The captions in this Agreement are for convenience only and shall not be considered a part of or affect the construction or interpretation
of any provision of this Agreement. 
 (b) The definitions in Section 1 shall apply equally to both the singular
and plural forms of the terms defined. 
 (c) Unless the context of this Agreement otherwise requires: 

(i) (A) words of any gender include each other gender and neuter form; (B) words using the singular or plural number also
include the plural or singular number, respectively; (C) derivative forms of defined terms will have correlative meanings; (D) the terms “hereof,” “herein,” “hereby,” “hereto,” “herewith,”
“hereunder” and derivative or similar words refer to this entire Agreement; (E) the terms “Section” and “Attachment” refer to the specified Section or Attachment of this Agreement and references to
“paragraphs” or “clauses” shall be to separate paragraphs or clauses of the Section or subsection in which the reference occurs; (F) the words “include,” “includes” and “including” shall be
deemed to be followed by the phrase “without limitation”; (G) the word “or” shall be disjunctive but not exclusive; and (H) the word “from” (when used in reference to a period of time) means “from and
including” and the word “through” (when used in reference to a period of time) means “through and including”; 

(ii) references to any federal, state, local, or foreign statute or Law shall (A) include all rules and regulations
promulgated thereunder and (B) be to that statute or Law as amended, modified or supplemented from time to time; and 

(iii) references to any Person include references to such Person’s successors and permitted assigns, and in the case of
any Governmental Authority, to any Person succeeding to its functions and capacities. 

  
 -77- 

 (d) Whenever this Agreement refers to a number of days, such number shall refer to calendar
days unless Business Days are specified. If any action is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action may be deferred until the next Business Day. 

(e) The phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not mean
simply “if.” 
 (f) The terms “writing,” “written” and comparable terms refer to printing, typing and other
means of reproducing words (including electronic media) in a visible form. 
 (g) All monetary figures shall be in United States dollars
unless otherwise specified. 
 (h) All references to “this Agreement” or any “Facility Addendum” shall include any
amendments, modifications or supplements thereto. 
  

	 	18.12	 Rules of Construction. 

The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent. The Parties
acknowledge that each Party and its attorney has reviewed and participated in the drafting of this Agreement and that any rule of construction to the effect that any ambiguities are to be resolved against the drafting Party, or any similar rule
operating against the drafter of an agreement, shall not be applicable to the construction or interpretation of this Agreement. 
  

	 	18.13	 Counterparts.  

This Agreement may be executed in two (2) or more counterparts (including by electronic or .pdf transmission), each of which shall be
deemed an original, but all of which together shall constitute one and the same instrument. Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature page. 

 

	 	18.14	 Amendments.  

No provisions of this Agreement shall be deemed waived, amended, supplemented or modified by any Party, unless such waiver, amendment,
supplement or modification is in writing and signed by the authorized representative of the Party against whom it is sought to enforce such waiver, amendment, supplement or modification. 

  
 -78- 

	 	18.15	 Entire Agreement.  

This Agreement, the Separation Agreement, the other Ancillary Agreements, including any related annexes, exhibits, schedules and attachments,
as well as any other agreements and documents referred to herein and therein, shall together constitute the entire agreement between the Parties relating to the transactions contemplated hereby and supersede any other agreements, whether written or
oral, that may have been made or entered into by or among any of the Parties or any of their respective Affiliates relating to the transactions contemplated hereby. 
  

	 	18.16	 Non-Disturbance. 

Except as set forth in Section 16 and as may be otherwise expressly agreed upon in writing between the Parties in
accordance with the terms thereof, the AG and Branded Product Supply Agreement is not assigned, amended, modified or in any other manner affected by the provisions of this Agreement whatsoever. No amendment to the AG and Branded Product Supply
Agreement shall affect this Agreement unless expressly incorporated herein by reference in accordance with the terms hereof. No amendment to this Agreement shall affect the AG and Branded Product Supply Agreement unless expressly incorporated
therein by reference in accordance with the terms thereof. 
 [Signature Page Follows] 

  
 -79- 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed and
delivered as of the date first written above. 
  

									
	UPJOHN INC.	 	        	 	PFIZER INC.
					
	By:	 	 /s/ Sanjeev Narula
	 		 	By:	 	 /s/ Douglas E. Giordano

					
	Name:	 	 Sanjeev Narula
	 		 	Name:	 	 Douglas E. Giordano

					
	Title:	 	 Authorized Officer
	 		 	Title:	 	 Senior Vice President, Worldwide Business Development

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]